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Development of Trimethoprim Chemical Tags for Single Molecule Imaging in Live Cells 
 




By tagging biomolecules with bright and photostable fluorophores, chemical tags enable single 
molecule (SM) detection and imaging for the study of biological mechanism. One of these tags. 
the trimethoprim chemical tag (TMP-tag), labels biomolecules using the high affinity interaction 
between E.coli dihydrofolate reductase and fluorescent derivatives of the antibiotic trimethoprim. 
The TMP-tag is one of the few chemical tags that has enabled live cell SM imaging. In this work, 
I present the development of the TMP-tag as a versatile tool for SM imaging. First, I establish 
that the TMP-tag is a robust tool for labeling proteins with organic fluorophores that enable SM 
detection and imaging. I then examine the properties of novel organic fluorophores that expand 
the palette of dyes that can be used with SM imaging. I also investigate fluorescent 
nanodiamonds for expanded imaging and sensing capabilities in live cells using the TMP-tag. 
Finally, I explore applications of the TMP-tag to label and image ion channels for the 
identification of pharmacological chaperones as therapeutics for protein mistrafficking diseases. 
Together, these studies highlight the versatility of the TMP-tag, furthering our ability to study 
biomolecules under challenging imaging and biological conditions.  
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Chapter 1  




1.1 Chapter Overview 
 
 The development of methods for single molecule (SM) microscopy and imaging has 
revolutionized the study of biological systems. Using fluorescently labeled biomolecules, SM 
imaging can provide unique insights into molecular mechanisms that are otherwise obscured in 
ensemble measurements. Great strides have been made in overcoming the technical demands of 
detecting fluorescence from individual molecules amid background and signal noise. Single 
molecule methods are becoming increasingly routine for examining biological systems in vitro. 
However, in vivo studies, especially intracellular studies that take place within the complex and 
dynamic environment of the living cell, require more sophisticated techniques for single 
molecule imaging in these demanding environments.  
 Historically, fluorescent proteins are used to label biomolecules, but their relatively low 
total photon outputs, in comparison to organic fluorophores, impose greater challenges in 
detection and imaging of single molecules. In contrast, chemical tags label proteins with high 
performance fluorophores that are suitable for live cell SM imaging. With chemical tags, a 
protein of interest is modified to include a polypeptide that is subsequently modified by an 
organic fluorophore. The specificity afforded by genetic encoding of the polypeptide, combined 
with the photophysical properties of organic fluorophores, give the chemical tags distinct 
advantages over other labeling modalities for SM imaging. Thus, this chapter will detail the 
development of the microscopy and labeling methods that enable single SM in live cells. We 
highlight the ability of chemical tags to overcome obstacles in fluorophore detection and protein 
labeling, emphasizing their utility for improved biological imaging.   
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1.2 Introduction  
 
 SM studies provide valuable mechanistic and kinetic information about biological 
processes. Chemical reactions arise from the stochastic behavior of single molecules, where the 
state of a molecule undergoing a chemical reaction is determined by random probability 
distributions for each step of that reaction. While ensemble measurements probe multiple 
molecules simultaneously, the result is an average formed by contributions of each molecule's 
state and can suggest that the collective of molecules assumes the same state. Consequently, 
reactions in ensemble measurements smoothly progress from beginning to end state, despite the 
fact that individual molecules go through discrete states. By measuring and tracking individual 
molecules through a reaction with SM fluorescence imaging, the presence of transient states, 
sub-populations, and other heterogeneities that have significant impacts on reaction dynamics 
and mechanics can be revealed. Probing the behavior of single molecules by imaging has 
emerged as a powerful tool for studying biological systems, and has been used to study the 
mechanisms of myosin motor protein motility, cholesterol oxidase enzymatic turnover, and 
tRNA translocation during ribosomal translation, among others.
1-6
  
 While providing tremendous biological insights, the majority of SM fluorescence 
imaging investigations are performed using reconstituted systems in vitro that are not reflective 
of the crowded, compartmentalized, and steady state conditions of the living cell. There are 
examples of SM studies performed in live cells, but the technical challenges of fluorophore 
detection and selective biomolecule labeling are magnified in the cellular environment. 
7-10
 
Multiple metabolites exhibit autofluorescence, creating high background noise that obscures 
signal from single molecules.
11
 In addition, the diversity of biological functional groups can 
cause nonspecific fluorophore binding and labeling.
12
 Combined advancements in microscopy, 
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fluorophore development, and protein labeling strategies can overcome these hurdles and enable 
routine live cell SM imaging for studying mechanistic biology.  
 Advancement of microscopy methods was critical for the development of SM 
fluorescence imaging in biological systems. SM microscopy was originally limited by equipment 
detection sensitivity, restricting experiments to non-biologically relevant conditions in 
specialized laboratories.
13,14
 Improvements in optics significantly eased SM detection and 
increased the accessibility of SM methods to study biological processes. The application of 
optical sectioning became critical for reducing background fluorescence that could easily 
overwhelm signal, while additional methods were developed to ensure resolvability of individual 
molecules. Dozens of microcopy techniques have been developed for SM imaging and the 
success of these techniques requires fluorophores with sustained fluorescence or specialized 
photophysical properties under experimental conditions.
15
 
 Organic dyes are the preferred fluorophores for SM imaging due to their higher photon 
outputs relative to fluorescent proteins (FPs). Photon output is critical because fluorophores must 
remain bright and fluorescent over the experimental time course for adequate detection and 
resolvability.
16
 While FPs are widely used in biological imaging, their stability and brightness 
are generally not well suited for SM imaging. Organic dyes offer more attractive photophysical 
properties as well as the advantage of being smaller than FPs and less likely to interfere with 
native protein function. Despite the advantages of organic fluorophores, they are still ultimately 
vulnerable to photodestruction. As a result, fluorescent nanomaterials with superior brightness 
and photostability are also being investigated as candidates for SM imaging. Nanodiamonds in 
particular are emerging as desirable and biologically inert fluorophores with interesting optical 
properties for imaging and sensing applications.
17
 With a diversity of high performance organic 
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dyes and fluorescent nanomaterials, methods to selectively label proteins with fluorophores 
becomes critical for SM imaging.  
 Another emergent technology for advancing SM imaging is the use of chemical tags to 
label macromolecules of interest. Chemical tags can facilitate live cell SM imaging by providing 
a modular technology that tags proteins with high photon output fluorophores with high 
specificity. By genetically fusing a protein to a polypeptide that is modified by a cell-permeable 
fluorophore, these agents allow selective labeling of proteins with molecular probes in live cells 
without the use of microinjection or other invasive permeabilization methods. For SM imaging, 
the specificity of the chemical tags is essential for preventing nonspecific binding that could be 
misinterpreted as actual data. Chemical tags based on fluorescent ligand affinity or reactivity 
with peptides and proteins have been developed and used for live cell imaging.
18
 Among these 
tags, the trimethoprim chemical tag (TMP-tag) has the greatest engineered diversity and has been 
used in a broad range of biological imaging and sensing applications.
19-25
 In addition, the TMP-
tag is one of the few chemical tags that have been successfully used for live cell single molecule 
imaging.
26-28
 The robustness of the TMP-tag and other chemical tags under live cell conditions 
illustrates their potential in elucidating mechanisms of complex biological systems using SM 
fluorescence microscopy and imaging.  
1.3 Single Molecule Fluorescence Microscopy 
 
 Single molecule (SM) fluorescence microscopy requires that the signal from an 
individual molecule is both detectable and resolvable from its background. The first 
measurement of SM absorption and fluorescence by Moerner in 1989 and Orrit in 1990, 
respectively, illustrate the initial challenges of detecting single molecules using equipment with 
limited sensitivity. In both experiments, pentacene was immobilized within a p-terphenyl host 
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crystal and measurements were performed at liquid helium temperatures.
13,29
 Cryogenic 
temperatures were critical for suppressing photodestruction and increasing absorption cross 
section. While room temperature detection of single molecule fluorescence was later achieved in 




 In 1996, Moerner's imaging of single Nile Red molecules and Cy5 labeled proteins in 
aqueous solutions opened opportunities for SM imaging in biological systems. Using a 
polyacrylamide gel to slow diffusion, single molecules were imaged and their photophysical 
properties were characterized.
33
 Moerner used the same set-up to study the photophysics of the 
green fluorescent protein (GFP), further highlighting the ability to perform SM imaging of 
immobilized fluorophores in aqueous solutions.
34
 Although alternative methods for single 
molecule immobilization, such as biotin-streptavidin, are currently more preferred, Moerner's 
work serves the basis for in vitro study of single molecules in biological systems.
35
 Combined 
with the development of high sensitivity photodetectors and optics have made SM detection and 
imaging in aqueous solutions a relatively routine feat for research laboratories.  
 The success of Moerner's SM imaging in aqueous solution and other SM studies relies on 
the use of optical sectioning to limit background fluorescence. By limiting illumination to 
specific planes within the sample, out-of-plane fluorescence is significantly reduced, enabling 
clear resolution of signals from single molecules. One of the more popular techniques is total 
internal reflection (TIRF) microscopy, where fluorescence illumination is limited to an 
evanescent wavefront that is produced as a result of total internal reflection (Figure 1-1a).
36,37
 
With TIRF, only fluorophores within a few hundred nanometers of the slide surface exhibit 
fluorescence, making it a popular tool for in vitro studies where molecules can be restricted and 
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immobilized to the slide surface.
35
 Most notably, TIRF was used image ATP turnover of myosin 
in one of the first SM imaging experiments that probed mechanistic biology.
4
 Because TIRF 
limited fluorescence to the surface, co-localized fluorescence from a Cy3-ATP conjugate with an 
immobilized Cy5-labeled myosin directly corresponded to the binding and hydrolysis of ATP. 
While TIRF can also be used in live cells, it is limited to the study of membrane proteins and has 





Figure 1-1: Schematics of common single molecule microscopy methods  
a) Total internal reflection (TIRF) microscopy produces an evanescent wavefront from total internal reflection, 
illuminating fluorophores close to the surface. b) Highly inclined and laminated sheet (HiLo) microscopy, 
illuminates fluorophores a few microns from the surface using refraction. c) Fluorescence speckle microscopy 
(FSM) uses dilute labels to resolve individual fluorophores. d) Photoactivable localization microscopy (PALM) and 
stochastic optical reconstruction microscopy (STORM) use stochastic fluorophore activate to image a subset of 




Alternative microscopy techniques can achieve optical sectioning for in vivo imaging 
deeper inside cells. Light sheet microscopy and its variations, which use a thin and focused light 
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sheet for fluorescence illumination, are among the most widely used. Highly inclined and 
laminated optical sheet (HiLo) microscopy generates an inclined sheet of light by refraction off 
the slide surface (Figure 1-1b). HiLo is capable illumination microns from the surface and has 
been used to image nuclear pore complexes.
40
 For thicker samples, both selective plan 
illumination microscopy (SPIM) and light sheet fluorescence microscopy (LSFM) illuminate 
samples with a sheet of light and collect fluorescence signal orthogonally to the illumination to 
image at depths of 50-200 microns.
41,42
 Although additional techniques using confocal 
microscopy have also been developed for SM imaging, TIRF and HiLo remain the most 
commonly used for live cell imaging due to their relatively straightforward optical set-ups. 
43
 
Overall, SM microscopy with optical sectioning improves detection against background, but 
successful SM imaging also requires that detected fluorophores are spatially resolved from one 
another.  
 The major barrier to individual fluorophore resolvability is the diffraction limit of light. 
The maximum resolution of a point in optical microscopy is approximately 200 nm as 
determined by Abbe's diffraction limit.
44
 As a result, fluorophores that are located within 200 nm 
of one another appear as a single spot and another cannot be visually resolved from one another. 
In vitro studies can manipulate the spacing of fluorophores through the use of low concentrations 
and immobilization such that a single spot corresponds to one molecule.
35
 In addition, a number 
of in vitro and extracellular methods that further localize the spatial position of fluorophores 
beyond the diffraction limit for super resolution imaging have also been developed.
45-53
 
However, a limited number of techniques have risen to meet the challenge of resolving 
individual molecules among many in live cells.  
9 
 
 In one of the first demonstrations of live cell intracellular SM imaging, fluorescence 
speckle microscopy (FSM) employed fluorescently labeled actin at very dilute concentrations to 
resolve single actin proteins within filaments in lamellipodia (Figure 1-1c). Using concentrations 
of 1 labeled molecule to 10,000 unlabeled molecules, single actin was tracked through filament 
formation, demonstrating basal polymerization and depolymeraization throughout the filament as 
well as polyermization concentrated at filament tips.
54
 However, one of the major drawbacks of 
FSM is the use of microinjection or other cell permeabilization strategies to ensure sufficiently 
low concentrations of labeled proteins for SM resolution.
55
 As a result, other SM strategies for 
live cell imaging have been developed that are less invasive and more suitable to studying 
heterogeneous protein interactions.  
 The groundbreaking technique to bring SM imaging to live cells was the development of 
photoactivatable localization microscopy (PALM) and stochastic optical reconstruction 
microscopy (STORM).
56-58
 In both techniques, the fluorescence of only a subset of fluorophores 
is activated such that single fluorophores can be resolved (Figure 1-1d). The spatial location of 
each fluorophore is localized based on its point spread function, providing resolution beyond the 
diffraction limit called super resolution imaging. Multiple images with different subsets of 
fluorophores are taken and the final image is reconstructed from these images. While 
conceptually similar, PALM was developed using photoactivatable FPs while STORM used 
photoswitchable organic fluorophores. Both methods have been used in live cell SM imaging, 
with PALM imaging of single EosFP labeled adhesion complexes with 60 nm resolution and 
STORM imaging of single Cy3-Alexa647 labeled clathrin light chain proteins within clathrin 





 The widespread use of PALM is currently limited by the availability of suitable 
fluorescent proteins. Because PALM relies on the stochastic activation of fluorescence, only 
photoactivatable or photoswitchable FPs can be used. While reversible photoswitchable proteins 
could be used for PALM, the majority of those proteins use the same the same or similar 
wavelength for fluorescence emission and switching and cannot be easily used with PALM.
60
 
Irreversible photoactivatable or photoswitchable FPs allow controlled activation with orthogonal 
wavelengths, but requires that the FPs be photobleached before subsequent acquisitions and 
preclude multiple measurements of the same molecule. As a result, initial PALM studies were 
limited to FPs that were sufficiently bright and photostable for detection and localization, but 
could not be so photostable as to delay subsequent acquisitions.
59
 The recent development of a 
reversibly photoswitchable GFP, Dreiklang, with decoupled fluorescence and switching 
facilitates the use of PALM in live cells.
43
 Further developments in FP technology can increase 
the applications of PALM. 
 On the other hand, STORM uses photoswitching behavior of organic fluorophores for 
SM imaging with better resolution and speed compared to PALM. Originally, STORM used 
fluorophore activator-reporter pairs of Cy3- Cy5 that required cycling between different 
wavelengths for photoswitching, achieving resolutions of 20 nm (Rust).
57
 STORM was also 
developed for three dimensional (3D) imaging, using optical astigmatism to determine axial and 
lateral fluorophore positions.
61
 Both STORM and 3D STORM achieved resolutions of 25 nm and 
30 nm and frame rates of 0.5 second and 1 second, respectively, in live cells.
27
 In addition, a 
variation of STORM using individual fluorophores rather than fluorophore pairs was also 
developed (dSTORM) and used in live cell imaging of H2B nuclear histone proteins.
26,58,62
 
Overall, the use of organic dyes, which are brighter than FPs, permits faster fluorophore imaging 
11 
 
and higher resolution images, demonstrating the advantages of using high performance 
fluorophores with specialized properties.
63
 
 Developments in microscopy have greatly improved the ability to perform SM imaging, 
but all these methods require bright and photostable fluorophores for SM detection and 
resolution. For live cell imaging, the intracellular environment and protein mobility necessitates 
the use of fluorophores that are at least as bright and photostable as, if not more than, 
fluorophores used for in vitro studies. The diffusion of proteins creates additional challenges for 
SM imaging, by reducing the amount of time a protein spends within a diffraction-limited area 
and consequently lowering detectable signal for imaging. Currently, freely diffusing cytosolic 
proteins are nearly impossible to image at the SM level, limiting live cell SM imaging to proteins 
with restricted mobility.  To expand the ability to image more mobile proteins within the live 
cell, fluorophores must have photon outputs that enable sufficient detection over cellular 
background on the shorter timescales during which proteins remain within a diffraction limited 
area. While there are many different types of fluorophores that can be used for biological 
imaging, few have the requisite properties that make them compatible with both live cells and 
experimental conditions for SM imaging.  
1.4 Single Molecule Fluorophores 
 
 One of the major barriers to widespread use of SM imaging in live cells is the lack of 
suitable fluorophores. The development and discovery of fluorophores with superior 
photophysical properties is key for expanding SM imaging in live cells. The critical requirement 
for fluorophores is high total photon output, which is a product of photon flux and the 
photostability. Photon flux, the rate of photon emission, is a measure of brightness, while the 
photostability is a measure of the time a fluorophore can remain fluorescent before 
12 
 
photobleaching. So, fluorophores for biological imaging should be both bright and long-lasting 
under aqueous conditions. For SM imaging in live cells, the requirement for high photon output 
is heightened by the need to overcome background cellular autofluorescence while maintaining 
photostability over the timescale of the experiment. However, even fluorophores with sufficient 
photon outputs must meet other conditions for successful imaging. 
 Experimental demands place additional restrictions on fluorophore choice based on 
photophysical behaviors, spectral properties, and cellular compatibility. For microscopy 
requiring photoswitching, fluorophores must exhibit this behavior under live cell conditions. In 
addition, fluorophore spectral properties must be compatible with a given microscopy set-up and 
resolvable from other fluorophores if multiple colors are used. Red fluorescence is generally 
preferred for cell imaging because of reduced background fluorescence and cellular 
photodamage under red illumination.
64
 The fluorophore itself should also be non-cytotoxic and 
be sufficiently small as to not interfere with mechanisms it is probing. Despite these many 
considerations, the total photon output remains the most important criteria for SM imaging. To 
date, a diverse set of different fluorophores have been applied in both in vitro and in vivo live 
cell SM imaging, and the development of new fluorophores holds additional promise for 
expanding this palette.  
1.4.1 Fluorescent Proteins 
    
 The discovery and use of FPs was an incredible breakthrough for fluorescent imaging in 
biological systems. First isolated from Aequorea victoria, the green fluorescent protein (GFP) is 
a 238 amino acid protein (27kDa) that houses a 4-p-hydroxybene-5-imidazolinone chromophore, 
formed from the oxidation of serine, tyrosine, and glycine residues, in its beta barrel core (Figure 
1-2).
65
 After its discovery, GFP was quickly adopted as a genetically encoded label for in vivo 
13 
 
studies of protein expression and localization in E. coli and C. elegans.
66
 Later engineering of the 
FPs by Roger Tsien and others have produced a toolbox of FPs with different spectral properties 
for a wide range of cell imaging applications.
67
 One such protein, enhanced yellow fluorescent 
protein (EYFP) was one of the first fluorophores used for live cell SM molecule in bacteria cells. 
As a reporter for gene expression, the detection of single EYFPs synthesized by E. coli revealed 
the stochastic nature of protein translation.
8
 Favored FPs for SM imaging include EYFP for its 
fast chromophore maturation time, enhanced green fluorescent protein (EGFP) for its photon 
output, and TagRFP for its red fluorescence.
8,68
 The ability to genetically encode FPs gives them 
near perfect labeling specificity, making them a popular choice for live cell SM imaging.  
 
Figure 1-2: Chromophores of fluorescent proteins.  
The fluorophore in green fluorescent protein (GFP) is formed from oxidation of tyrosine, serine, and glycine. 
Threonine is sometimes used in place of serine. Different FP variants have also been engineered, each with different 
chromophores dependent on the amino acid residues and their positioning within the beta barrel core. Figure adapted 




 The development of photoactivatable, photoconvertible, and photoswitching FPs has 





 When exposed to certain wavelengths, these FPs can be classified by whether they 
switch from dark to bright states (photoactivatable) or if they switch from one color to another 
(photoconvertible) and also if they can switch between states reversibly (photoswitchable). The 
first live cell PALM used photoactivatable GFP to image the distribution of hemagglutinin on the 
cell membrane, revealing the formation of irregular clusters.
71
 Photoconvertible FPs have also be 
used in live cell PALM, notably Dendra2 without a fusion protein and EosFP tagged adhesion 
complexes.
59,72
 Two color live cell PALM was later carried out using photoactivatable GFP and 
mCherry to image transferrin and clathrin light chains within clathrin coated pits.
73
 Although it 
has not yet been used in live cells, the development of Dreiklang, a photoswitchable GFP protein 
that has little crosstalk between the fluorescence and switching wavelengths, holds promise for 
greater applications of photoswitchable FPs in PALM.
74
 The engineering of FPs with 
increasingly appealing photophysical properties has opened new opportunities for live cell SM 
imaging.  
 Despite the popularity of FPs for SM imaging, they are limited by their generally lower 
total photon output. FPs tend to photobleach within seconds under SM imaging conditions, with 
the best FP, mCherry, exhibiting fluorescence up to 20 seconds.
75
 While the FPs could be used 
for imaging biological processes on shorter timescales, extending their application to a even a 
full minute is extremely difficult. In addition, fluorescent proteins can suffer from poor folding, 
slow and oxygen dependent chromophore maturation, and oligomerization, all of which can 
cause undesirable experimental artifacts when tagging less robust or smaller proteins.
67
 In 
particular, many investigations of ion channel function and trafficking are not amenable to FP 
fusions.
76
 Most concerning, however, is that transgenic mice has demonstrated cardiovascular 
and muscular defects when GFP is tagged to myosin, even though deleterious effects appear 
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minimal at the cellular level.
77,78
 This raises the question as to whether the size of the FP fusions 
allow them to accurately reflect native protein functions. Finally, despite the identification of 
red-fluorescent proteins, there are few far red and near infrared fluorescent proteins ( > 600 nm 
excitation and emission) that have the requisite brightness and photostability that is preferred for 
cell imaging.
79
 To overcome these limitations with fluorescent proteins, organic fluorophores 
with greater stability and more general applicability have been sought for application in live cell 
imaging.  
1.4.2 Organic Dyes  
  
 The small size and photophysical properties of organic fluorophores are advantageous for 
SM imaging. Organic fluorophores have been utilized as live cell probes since 1963 when the 
catalysis and fluorescence of fluorescein-galactose was first used to report -D-galactosidase 
activity.
80
 Multiple families of organic fluorophores have been discovered and developed over 
the years, each having different chemical and photophysical properties for biological imaging 
applications.
81
 For single SM imaging, however, the xanthenes, cyanines, and oxazines are 
among the most frequently used fluorophores (Table 1-1).  
 
Table 1-1: Structures and examples of popular fluorophores for single molecule imaging 
Core Structure Key Features Examples 
O  
Inexpensive 























 Xanthenes-based fluorophores, including fluoresceins and rhodamines, are characterized 
by a core structure containing a heterocyclic ring system (Table 1-1). The early development of 
fluorogenic fluorescein diacetates that were activated upon intracellular esterase activity 
established these fluorophores as suitable for live cell imaging.
82
 However, fluorescein is a 
notoriously poor SM fluorophore, despite its popularity in conventional fluorescence 
microscopy. Rhodamines, on the other hand, have better photon output and have been used in a 
number of SM imaging applications. The commercial fluorophore, Alexa488, is a common 
substitute for fluorescein while Alexa594 is particularly popular for its red fluorescence. 
Photocaged and photoswitchable rhodamines also have promising applications for live cell SM 
imaging.
79
 Overall, the total photon output of xanthenes is not as high as other organic 
fluorophores and there are few red and far-red xanthene fluorophores. Consequently, cyanine and 
oxazine fluorophores are preferred for SM imaging.  
 Cyanines are characterized by a polymethine chain connecting two nitrogen groups 
(Table 1-1). The fluorescence of cyanines is tunable based on the length of the methine chain, 
with longer chains producing more red shifted fluorescence. Originally developed as membrane 
voltage sensors for live cells, water soluble cyanine fluorophores exhibit high extinction 
coefficients and are used in many SM and super resolution imaging experiments.
83,84
 The 
commercial fluorophores, Cy3, Cy5, and Alexa647 were used in the first demonstrations of 
STORM as well as in some of the first in vitro mechanistic SM studies of ATP turnover and 
myosin motility.
1,4,57,61
 While their brightness is valuable for SM imaging, cyanines are 
vulnerable to photobleaching. Photostability of cyanines can be enhanced by removing of 





 The applications of cyanines in seminal SM studies shows the importance of 
their brightness for detection and imaging.
1,4,57,61
 However, the need to use quenchers and 
oxygen scavenger additives to prolong their photostability limits their application in live cells. 
 Oxazine fluorophores are characterized by a core structure containing a nitrogen and 
oxygen heterocyclic ring system (Table 1-1). Similar to the cyanines, oxazines were initially 
developed for imaging cell membranes with improved photostability.
88,89
 Oxazines are generally 
bright and have exceptional photostability under aqueous conditions. In fact, Moerner's first 
room temperature detection of single molecule fluorescence in solution used Nile Red, an 
oxazine derivative.
33
 More recently, the commercially available oxazine, Atto655, has been 
extensively studied for its photoswitching behavior, which is attractive for SM super resolution 
imaging using STORM and dSTORM. Unlike cyanines and other fluorophores which require 
photoactivation, deoxygenation, or conjugation to activator fluorophores for photoswitching, 
Atto655 photoswitching is reversible, inherent to the molecule and can be catalyzed by thiol-
containing reducing agents found in cells.
26,90-92
 Finally, Atto655 and other oxazines have far red 
fluorescence, which is favorable for cells. Their spectral properties, photoswitching, and 
photostability give the oxazines tremendous potential as fluorophores that can enable routine live 
cell SM imaging.  
 Fluorophores outside these three families have also been investigated as potentially 
superior dyes for single molecule imaging. Dicyanodihydrofurans (DCDHF) have favorable 
photophysical properties and also show sensitivity to local viscosity.
93
 In addition, they have 
been employed as photoactivatable fluorophores for live cell SM imaging.
94
 With photostability 
at least an order of magnitude greater than fluorescein, acceptable water solubility for SM 
experiments, and availability of red-fluorescent derivatives, DCDHFs are appealing fluorophores 
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for SM live cell imaging. Another class of fluorophores being explored for their exceptional 
photostability are perylene dyes. While initial perylenes were completely water insoluble, their 
attractive photophysical properties prompted the development of water soluble derivatives that 
retained their excellent performance.
95,96
 Water soluble perylenes have been used to track single 
enzymes in vitro and photoswitching behavior can be induced through the introduction of redox 
reagents through similar mechanism as for Atto655.
97,98
 While both DCDHFs and perylenes have 
not yet gained widespread popularity, their superior photon outputs indicate their potential for 
surpassing cyanines and oxazines as fluorophores for SM imaging.  
 The photon output of organic fluorophores can overcome challenges in live cell SM 
imaging. However, organic dyes are still limited by their eventual vulnerability to 
photobleaching. The rational synthesis of dyes with improved photostability and the 
development of new classes of fluorophores with superior properties will certainly help improve 
the performance of organic dyes in SM imaging. At the same time, it is hypothesized that the 
lack of significant strides in photostable organic fluorophores suggests that we are approaching 
limits for small molecule photon output. As a result, there is an increased interest in using 
fluorescent nanomaterials to meet the demands for SM fluorophores. Because fluorescent 
nanodiamonds are incredibly resistant to photodestruction in comparison to organic 
fluorophores, they can have great applications for SM imaging  
1.4.3 Fluorescent Nanomaterials  
 
 Fluorescent nanomaterials, including noble metal nanoparticles, semiconductor quantum 
dots (QDs), carbon nanotubes, and nanodiamonds (NDs), are promising new fluorescent 
materials for SM imaging because of their high photon outputs and resistance to 
photobleaching.
99
 Many of these materials exhibit fluorescence on timescales that are orders of 
19 
 
magnitudes longer than those of organic fluorophores and fluorescent proteins. The adoption of 
fluorescent nanomaterials in biological imaging has greater technical hurdles due to their 
comparatively large sizes and cytotoxic properties, but significant strides have been made to 
improve nanomaterial biocompatibility. QDs are among the most frequently used nanomaterial 
for biological imaging due to their tunable and bright fluorescence. However, fluorescent 
nanodiamonds demonstrate great promise with their non-toxicity and interesting optical sensing 
capabilities.  
 QDs were among one of the first fluorescent nanomaterials used for biological imaging. 
These cadmium selenium nanocrystals exhibit size dependent fluorescence arising from 
electronic energy band gaps.
100
 While the QD itself is only a few nm in size, the coatings 
required to retain their fluorescence and render them hydrophilic can increase their size to 20-30 
nm.
101
 In addition, cadmium release from QDs has also raised concerns about cytotoxicity.
102
 
Despite these drawbacks, QDs are appealing for live cell fluorescent probes because their 
brightness and narrow excitation and emission bands permits multicolor imaging on a timescale 
of weeks.
103
 QDs enabled imaging of diffusion and localization of single glycine receptors for 20 
minutes.
104
 Surprisingly, the primary concern for this SM experiment was not the ability to detect 
the fluorophore, but rather the toxicity of continuous light illumination for the cells. QDs 
continue to have SM applications in live cells, but their use is typically restricted to extracellular 
applications due to their size and membrane impermeability.
105
 The remarkable ease of SM 
detection and imaging with QDs in comparison to organic fluorophores demonstrates how 
superior fluorescent nanomaterials can truly facilitate SM imaging for research applications.  
 More recently, fluorescent NDs (FNDs) have drawn significant interest as a material for 
biological imaging. NDs are nanometer sized diamond crystals that are biologically inert and can 
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produce fluorescence from nitrogen vacancy center defects in the crystal lattice.
106
 Contained 
within the lattice and shielded from the environment, nitrogen vacancy centers are remarkably 
photostable and can be easily used for optical SM detection.
107,108
 Interest in FNDs for live cell 
SM imaging originated from a demonstration of single FND imaging and tracking in HeLa cells 
in 2007.
109
 In this study, 35 nm FNDs were taken up by cells with no observed toxic effects and 
exhibited continuous fluorescence for at least 5 minutes, in comparison to the 10 seconds for 
Alexa546 to photobleach. Interestingly, later reports of smaller 5 nm FNDs exhibited blinking 
properties that could be useful for super resolution SM imaging.
110
 The FNDs also have special 
optical properties that were demonstrated for differentiation between individual NDs and 
magnetic field sensing in cells.
111
 While nanodiamonds have not yet been used to study 
biological processes, their optical and biological properties show extraordinary promise for 
expanding the ability to probe cellular behavior at the SM level.  
 Both organic fluorophores and FNDs have high photon outputs that are advantageous for 
single molecule imaging. However, these fluorophores inherently lack the selectivity of 
genetically encoded FPs for protein labeling. In order to tag biomolecules with organic 
fluorophores or FNDs for SM imaging, creative strategies in chemical labeling must be 
employed. Traditional biomolecular crosslinking strategies can label purified proteins, but 
require the microinjection of these proteins for live cell studies, which is damaging to 
cells.
55,112,113
 Bioorthogonal labeling chemistry, such as including azide-alkyne reactions and 
others, can selectively label proteins in cells.
12,114
 However, the incorporation of appropriate 
reactive handles for these bioorthogonal reactions require sophisticated techniques, such as 
unnatural amino acid incorporation. Chemical tags bridge the gap between selective labeling and 
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the ability to use superior fluorophores in live cells using genetic encoding of polypeptide 
fusions and cell-permeable fluorophore ligands.    
1.5 Chemical Tags for Fluorescent Protein Labeling  
 
 Chemical tags can selectively label biomolecules with a wide array of fluorophores with 
SM imaging capabilities. The selectivity of fluorophore labeling is essential for SM experiments 
because contributions from nonspecifically bound fluorophores are measured and not averaged 
out. Particularly in experiments with low protein concentrations that are within the partition 
coefficient for nonspecific labeling, there can be significant contributions for nonspecific 
fluorophores. For chemical tags, specificity of labeling is afforded by genetic encoding of the 
polypeptide and high affinity, selective ligand binding. Consequently, chemical tags can offer 
selectivity similar to genetically encoded FPs and at similar, if not smaller, sizes. However, the 
identification and development of both a protein or peptide and ligand that are orthogonal to 
other biomolecular interactions in mammalian cells is challenging. Many research groups have 
identified and developed chemical tags for protein labeling, but few have the robustness for 
intracellular labeling in live cells. For those tags that can overcome these hurdles, they confer a 
major benefit over the FPs in their ability to label proteins with organic fluorophores that have 
significantly better photophysical properties.  
1.5.1 Peptide Chemical Tags 
 
 The first report of a chemical tag designed for live cell imaging was the FlAsH tag, 
developed by Roger Tsien in 1998. With FlAsH, protein is tagged with a six amino acid 
sequence containing a tetracysteine motif (CCXXCC). A cell permeable biarsenical fluorescein 
reagent is introduced and binds to the tetracysteine, rendering the label fluorescent.
115
 Further 
development of this technology has provided a number of biarsenical fluorophores of different 
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colors, with the original green-fluorescent FlAsH and red-fluorescent ReAsH being the most 
frequently used.
116-118
 Most notably, the small size of the FlAsH and ReAsH tags were used to 
label and image the transportation of small gap junction proteins that would have otherwise had 
impacted function with FPs.
119
 Despite its small size and fluorgenicity, the FlAsH tag suffers 
from nonspecific binding to cysteine-rich proteins due to the affinity between arsenic and 
thiols.
79
 In addition, toxicity from the biarsenical reagents is also a concern. Other peptide-heavy 
metal affinity tags suffer from similar problems and have comparatively worse selectivity and 
binding affinities. Of note are both the oligo-asp tag (D4 tag) and his-tag, which bind to 
fluorescent zinc complexes, and are limited to extracellular labeling. 
120,121
 
 A variation of peptide affinity based chemical tags are enzymatic peptide tags. In this 
approach, a protein is tagged with a peptide sequence that is recognized and modified by an 
enzyme to incorporate a fluorophore or a chemical handle that is subsequently modified by a 
fluorophore. The Ting lab engineered a coumarin ligase based on an E. coli lipoic acid ligase, 
which labels the lysine side chain of a 13 amino acid recognition sequence with coumarin for 
highly specific live cell protein labeling.
122
 The one-step incorporation of a fluorophore offers 
significant advantages over previous two-step technology in which an engineered ligase 
incorporates a bioorthogonal handle that is subsequently modified.
79
 Unfortunately, engineered 
ligases that can accommodate additional fluorophores have yet to be reported and the UV-to-blue 
fluorescence of coumarins are not ideal for live cell imaging. Additional enzymatic peptide tags 
have developed based on the activity of biotin ligase, human transglutaminase (Q-tag) and 
bacterial sortase (SorTag), but their applications so far have been limited to extracellular 
labeling.
123-127
 Enzymatic peptide tags show great promise because of their small size, but cross-
reactivity, condition dependent activity of the enzymes, and compatibility with multiple 
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fluorophores can be problematic. The limitations of both affinity based and enzymatic peptide 
tags have made protein based chemical tags the preferred option for live cell single molecule 
imaging.  
1.5.2 Protein Chemical Tags 
 
 Affinity-based protein chemical tags rely on the specific interaction between a protein 
domain and a ligand. Developed by Kai Johnsson in 2003, the first protein chemical tag reported 
for live cell imaging was the SNAP-tag. The target protein is tagged with an engineered mutant 
of the human DNA repair protein O
6
-alkylguanine-DNA alkyltransferase (20kDa), which 
irreversibly reacts to and binds with a fluorescent O
6
-benzylguanine substrate (Figure 1-3a). The 
SNAP tag exhibits high selectivity and fast reactivity, while the formation of a covalent bond 
between the tag and the fluorophore ensures stable labeling.
128
 A variation of the SNAP-tag, 





 The SNAP-tag has been used in a wide variety of both imaging and 
sensing applications.
130
 In particular, the use of organic fluorophores with SNAP-tag has been 
exploited for deep tissue imaging of protein half-life in mice and reduced background of 
intracellular FRET between receptor proteins.
131-133
 While the SNAP-tag is one of the most 
commonly used chemical tags, other tags have been developed and have also enjoyed success in 








Figure 1-3: Protein based chemical tags used in live cell imaging  
a) The SNAP-tag uses fluorescent O
6
-benzylguanine suicide substrates to label proteins tagged with a modified O
6
-
alkylguanine-DNA alkyltransferase. b) The CLIP-tag uses fluorescent O
6
-benzylcytosine suicide substrates to label 
proteins tagged with an orthogonally engineered SNAP-tag. c) The HaloTag uses fluorescent chloroalkane suicide 
substrates to label proteins tagged with haloalkane dehalogenase. d) The TMP-tag uses fluorescent trimethoprim 




 The HaloTag is another popular chemical tag that has demonstrated intracellular labeling 
capabilities.
134
 Using the same suicide enzyme substrate labeling mechanism as the SNAP-tag, 
the HaloTag tags a protein with an engineered bacterial haloalkane dehalogenase (34kDa) that 
forms a covalent attachment to fluorescent chloroalkane conjugates (Figure 1-3c). The HaloTag 
enjoys fast reactivity and high specificity and has been used in a number of live cell imaging 
applications.
18,135,136
 One interesting application of the HaloTag in protein expression and pull 
down assays. The high selectivity and water solubility of the tag increases purity and reduces 
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aggregates of insoluble proteins.
137
 The solubility of the HaloTag may be useful to tagging more 
challenging proteins and its reactivity for fast fluorophore labeling is advantageous for live cell 
imaging.  
 Overall, the SNAP-tag, CLIP-tag, and HaloTag are among the tags that have the greatest 
use in biology research because their fluorescent substrates are commercially available. 
However, additional protein-based chemical tags have been developed by other research groups. 
The Kikuchi group has engineered two tags, the BL-tag and the PYP-tag for live cell imaging. 
The BL-tag uses an engineered bacterial beta lactamase (29kDa) that binds to fluorescent beta-
lactam prodrug ligands.
138
 The PYP-tag(Hori) is based on the direct binding of a small water 
soluble protein from bacteria (14 kDa) to 7-hydroxycoumarin-3-carboxylic acid derivatives and 
is among one of the smallest protein based chemical tags.
139
 Finally, the cutinase tag (22 kDa) 
which is based on fungal cutinase and has been used for extracellular protein labeling, may have 
future applications for intracellular labeling due to the lack of native cutinases in mammalian 
cells.
140
 While these tags meet the criteria of selectivity and affinity for live cell labeling with 
fluorescent probes, most of these tags use one mechanism for ligand binding and reactivity to 
label proteins. Creative engineering of different ligands can achieve fluorogenic substrates for 
some tags, but none of these tags have been engineered with multiple labeling mechanisms that 
can be exploited for a broad variety of applications.
138,139,141
 
1.5.3 Trimethoprim-Based Chemical Tags  
 
 Of the chemical tags used for live cell imaging, the trimethoprim based chemical tags 
(TMP-tags) offer the greatest versatility with multiple engineered variants. Developed by 
Virginia "The Boss Lady" Cornish in 2005, target proteins are tagged with E. coli dihydrofolate 





 The high affinity between eDHFR and TMP (KD = ca. 1nM) permits highly 
specific labeling using low concentrations of fluorescent ligand, reducing background. 
Developed as an antibiotic, the TMP ligand shows incredible orthogonality to mammalian 
dihydrofolate reductases and is highly cell permeable. Early demonstrations of the TMP-tag 
technology illustrated the compatibility of the tag for live cell imaging of multiple cell lines of 
nuclear, cytosolic, and plasma membrane proteins. The high affinity of the TMP-tag allowed 
noncovalent labeling that was at similar levels to the covalent labeling with the SNAP-tag.  
 A covalent TMP-tag was then engineered to further expand its versatility and labeling 
capabilities. The first covalent TMP-tag used an engineered eDHFR mutant that contained a 
cysteine residue proximal to the TMP binding pocket (eDHFR:L28C) and a trifunctional TMP-
fluorophore-acrylamide ligand. Upon binding of the TMP ligand to the eDHFR, the cysteine 
undergoes a nucleophilic attack on the acrylamide group, producing a covalent bond.
142
 Further 
optimization of the positioning between the TMP and acrylamide moiety improved the reactivity 
of labeling to an 8 minute reaction half life. As a result, the covalent TMP-tag succeeded in 
imaging both abundant and diffuse cytosolic proteins.
20
 The improvement of rendering labeling 
covalent improved the versatility of the TMP-tag to study the diverse array of proteins within 
living cells.  
 Finally, a fluorogenic TMP-tag has been developed to further reduce background signal 
from unlabeled fluorophores. A trifunctional TMP-fluorophore-quencher was developed in 
which the quencher molecule was linked to the TMP-fluorophore with a tosylate group. Binding 
of the TMP-fluorophore-quencher to eDHFR:L28C causes the cysteine nucleophile to attack and 
displace the tosylate linked quencher, activating fluorescence. The fluorogenic TMP-tag exhibits 
a 20-fold increase in fluorescence upon binding, greatly reducing background signal for 
27 
 
nonspecifically bound fluorophores that was previously observed with the covalent TMP-tag.
21
 
Another fluorogenic variant of the TMP-tag has also been developed using increased 
fluorescence lifetime of a fluorophore that is rotationally constricted due to binding with a 
protein. However, this variation only produces a 2-fold increase in fluorescence.
143
 The 
technological achievements of engineering the TMP-tag clearly illustrate its many potential 
applications for not only live cell imaging, but also a range of biological studies.  
 The TMP-tag has been used to label proteins with both fluorophores and other molecules 
to probe different types of biological activities. By labeling differentially localized proteins with 
Cy3, the TMP-tag was used to measure local environmental viscosity within live cells based on 
Cy3 fluorescence lifetime readout. Fluorescent lanthanides labels for live cell time resolved 
FRET have installed on extracellular, unpurifiable proteins.
24
 Focal adhesion complexes have 
been labeled with magnetic iron oxide nanoparticles and magnetically manipulated in live cells.
25
 
The conjugation of a photosensitizer to myosin with the TMP-tag was also used for chromophore 
assisted laser inactivation to study myosin in cytoskeletal coherence.
22
 Altogether, the TMP-tag 
and other chemical tags provide important tools for both live cell imaging and other research 
applications.  
1.6 Single Molecule Imaging under Live Cell Conditions with Chemical Tags 
 
 The ability of chemical tags to conjugate fluorophores with exceptional photophysical 
properties to proteins in live cells make the tags well suited for SM imaging. Single clathrin light 
chain proteins within clathrin coated pits have been imaged with the SNAP-tag and HaloTag, 
while single nuclear histone H2B proteins have been imaged with the SNAP-tag and the TMP-
tag.
26-28,58
 In addition, the SNAP-tag and HaloTag have been used in other live cell SM imaging 





Recently, the SNAP-tag was also used to label and image single RNA polymerases in the cell 
nuclei.
145
 The use of STORM, dSTORM and other SM microscopy techniques in these proof-of-
principle experiments illustrate the advantages of using organic fluorophores with chemical tags 
for single and multi-color SM imaging in live cells. Additionally, the modularity of the chemical 
tags has been exploited for labeling with fluorescent nanomaterials. The SNAP-tag and Halo-Tag 
were used to attach QDs to extracellular Notch receptor and neurexin synaptic adhesion protein, 
respectively, for demonstrations of comparatively straightforward live cell SM imaging.
146,147
 
While applications of chemical tags to address SM mechanistic questions in live cells has been 
limited, the success of the tags in these investigations firmly establishes their potential for 
widespread SM imaging applications.  
 In particular, the TMP-tag and SNAP-tag are very promising for probing SM intracellular 
biology as demonstrated by their use in deciphering the order of binding events in spliceosome 
assembly.
148
 The spliceosome is a challenging system to reconstitute as it is composed of 
approximately 100 core proteins.
149
 Therefore, in vitro examination of the spliceosome takes 
place in whole cell extracts where the photon output of FPs is insufficient to overcome 
autofluorescence.
150
 The TMP-tag and SNAP-tag were used to label spliceosome complex 
proteins with organic fluorophores, enabling the multi-color imaging of complex protein binding 
events that form functional spliceosomes. The live cell conditions of this seminal study confirms 
that the chemical tags and their ability to use organic fluorophores lends superior capabilities for 
probing complex macromolecular machinery of the cell. 
1.7  Outlook 
 
 The advancement of SM imaging in live cells requires the ability to selectively label 
biomolecules with fluorophores that can withstand demanding imaging conditions. SM imaging 
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can reveal incredibly detailed mechanistic information that revolutionizes our understanding of 
biology. The studies conducted so far have confirmed that molecular heterogeneity is 
fundamental to biological mechanism and drive our curiosity to perform SM studies in additional 
systems. Live cell SM imaging would allow us in depth study of complex cellular processes in 
their native environments. While live cell SM imaging has been achieved, these experiments are 
far from routine. Similar to how the first in vitro SM experiments were initially restricted to 
dedicated laboratories due to photodetection limits, live cell SM imaging is currently faced with 
limits in fluorophore performance that prevent its widespread adoption for studying biology.  
 Chemical tags allow photophysically desirable fluorophores to used for protein labeling, 
offering great advantages for SM imaging. At the same time, though, current organic 
fluorophores are inherently limited in their total photon output by photobleaching. Further 
investigations are needed to ensure that the chemical tags are compatible with organic 
fluorophores. The identification and development of new fluorophores with improved photon 
output and bioorthogonality is also necessary to improve the palette of fluorophores for live cell 
imaging. Finally, the robustness and size of chemical tags can be applied for studying more 
fragile biological systems, such as ion channels. The concurrent exploration of chemical tag 
applications with fluorophore development can enable routine SM imaging for mechanistic 
studies in biology.   
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2.1 Chapter Outlook 
 
 Fluorophore modularity with chemical tags is critical for their advantageous properties 
over the FPs. With the TMP-tag, a protein can be labeled with virtually any fluorophore that can 
be chemically conjugated to TMP. While enabling SM imaging with high performance 
fluorophores, the TMP-tag and other chemical tags are presumed to not affect fluorophore 
photophysical properties. With the demand for high photon output, it is imperative that the 
chemical tags do not affect fluorophore brightness and photostability. The local chemical 
environment can strongly affect fluorophore performance. Conjugation of a ligand to a 
fluorophore or bringing the fluorophore in close proximity to a protein may adversely affect a 
fluorophore that is being used with chemical tags. Unfortunately, the effect of the chemical tags 
on fluorophore photon output had not been systematically investigated.  
 This chapter examines the effect that the covalent TMP-tag has on the performance of 
common oxazine and cyanine SM imaging fluorophores. We examine the SM properties of 
fluorophores with and without the TMP-tag under conditions that simulate those of the live cell. 
In addition, we also investigate whether ensemble properties of fluorophores can act as indicators 
of SM properties for screening fluorophores. We demonstrate that the covalent TMP tag 
generally does not affect the total photon output fluorophores, establishing the benefit of using 
chemical tags with organic fluorophores for SM live cell imaging. I am the main contributor to 
this project. I designed and carried out the experiment to study both ensemble and single molecule 
properties of fluorophores under the guidance of Wei Min, Aaron Hoskins, and Larry Friedman. I 






 Single molecule (SM) imaging of biomolecules has transformed our ability to probe 
biology.
1-4
 Over the past decade, SM imaging has provided insights into the molecular 
mechanism of motor protein walking, conformational transitions of the ribosome, and structural 
heterogeneity in enzyme catalysis, among others.
5-12
 However, these studies are often rely on 
reconstituted pathways, which are not representative of native cell conditions and not suitable for 
investigating biological processes such as spliceosome, replisome, and protein kinase signaling 
activity.
13-15
 Broadly accessible SM imaging in live cells or whole-cell extracts would be 
transformative for studying biological mechanism, but requires the ability to selectively label 
proteins with bright and photostable fluorophores that can overcome background and cellular 
autofluorescence. Fluorescent proteins are genetically encoded and inherently selective, but 
generally lack sufficient photon output for SM imaging. While the best organic fluorophores 
have nearly an order of magnitude greater photon output than the FPs, they lack labeling 
selectivity.
5,16-20
 By combining genetic encoding with the advantages of organic fluorophores, 
chemical tags can overcome the need for selective fluorescent labels in SM imaging.  
 Chemical tags fluorescently label proteins for high performance imaging applications by 
genetically fusing proteins to a polypeptide that binds to an organic fluorophore. The modularity 
of the chemical tags allows labeling with a wide variety of commercially available organic 
fluorophores with similar selectivity as the FPs.
21,22
 Chemical tags, such as the TMP-tag, SNAP-
tag, and Halo-tag have been used extensively for biological imaging including live cell SM super 
resolution imaging.
23-28
 Based on the high affinity interaction between trimethoprim (TMP) and 
Escherichia coli dihydrofolate reductase (eDHFR), the covalent TMP-tag (A-TMP-tag), is 
particularly well-suited for SM imaging (Figure 2-1A). 
23
 Target proteins are tagged with 
43 
 
eDHFR that has an engineered cysteine nucleophile outside the TMP-binding pocket 
(eDHFR:L28C) and covalently labeled by an acrylamide-TMP-fluorophore (A-TMP-
fluorophore) via a proximity-induced Michael reaction between the cysteine and the acrylamide 
following TMP-eDHFR binding.
29,30
 The selectivity and fast labeling kinetics of the A-TMP-tag 
has permitted high resolution live cell imaging of both nuclear and cytoplasmic proteins.
30
 
Permanent labeling by the A-TMP-tag can expand the utility of the non-covalent TMP-tag, 
which has established SM imaging capabilities in studies of spliceosome assembly in whole cell 
yeast extracts and demonstrations of super resolution imaging of nuclear H2B in live cells.
27,31
 
Combining the advantage of covalent labeling with the performance of the non-covalent TMP-
tag, the A-TMP-tag meets the rigorous demands for selectively labeling proteins with organic 
fluorophores in for SM imaging. 
 
 
Figure 2-1: The covalent trimethoprim chemical tag 
(A) Schematic cartoon of the covalent trimethoprim chemical tag (A-TMP-tag). A target protein is tagged with 
an E. coli dihydrofolate reductase cysteine mutant (eDHFR:L28C) and covalently bound to a cell-permeable 
acrylamide-trimethoprim-fluorophore (A-TMP-fluorophore). (B) Schematic of fluorophores and their A-TMP-tag 
conjugates examined in this investigation. 
 
 Broad application of the A-TMP-tag and other chemical tags for SM imaging is 
dependent on the tags maintaining the photophysical properties of the organic fluorophores used 
with them. Although the chemical tags are assumed to not impact the properties of organic 
44 
 
fluorophores, the tags introduce alterations to both chemical structure and local environment that 
can significantly impact a fluorophore's SM imaging capabilities. With the A-TMP-tag, 
fluorophore conjugation to the electron-rich small molecule A-TMP may cause quenching by 
intramolecular electron transfer, which has been previously observed with fluorophores 
conjugated to O-benzylguanine in SNAP-tag.
32,33
 Furthermore the A-TMP-fluorophore is 
covalently bound to the eDHFR:L28C protein. While protein binding may recover quenched 
fluorescence, as in the case of SNAP-tag, the fluorophore may remain quenched by proximity to 
electron-rich amino acid residues such as tryptophan, phenylalanine, tyrosine, and/or  
histidine.
34-37
 These interactions and other effects caused by the A-TMP-tag, such as sterics, local 
polarity and electrostatics, may considerably influence fluorophore photon output and resultant 
SM imaging performance.  
 Systematic evaluation of the photophysical properties of fluorophores with chemical tags 
is crucial to realizing the potential of the tags for SM imaging. To understand the impact 
chemical and environmental modifications of the A-TMP-tag have on fluorophore SM imaging 
performance, we measure both SM and ensemble properties of fluorophores, fluorophores 
conjugated to A-TMP (A-TMP-fluorophore) and fluorophores conjugated to A-TMP bound to 
eDHFR:L28C (tagged fluorophore) (Figure 2-1B). Because overcoming cellular 
autofluorescence and background noise while minimizing photobleaching are major challenges 
for biological SM imaging, we focus our investigation on properties corresponding to brightness 
and photostability. We determine SM photon flux, survival lifetime and total photon output 
under different buffer conditions that mimic the intracellular environment. Since SM 
measurements are technically challenging and require specialized imaging equipment to perform, 
we sought to measure ensemble properties that could serve as indicators of photon flux and 
45 
 
survival lifetime. As a result, we also measure quantum yield and ensemble photostability 
lifetime. While ensemble properties are not equivalents for SM properties, correlation between 
these properties indicates that ensemble measurements can be adapted for more rapid screening 
of fluorophores and chemical tags that are suitable for SM imaging. We focus our investigation 
on two fluorophores, an oxazine, Atto655, and a cyanine, Alexa647, because these two 
fluorophores were used with chemical tags to label nuclear H2B and clathrin coated pits in the 
cytosol in demonstrations of live cell SM super resolution imaging.
26,27
 Studying these 
fluorophores with the A-TMP-tag gives insights to the properties that allow for successful SM 
imaging. We assess the impact of the A-TMP-tag on fluorophore SM imaging performance by 
comparing the SM and ensemble properties of Atto655, Alexa647, and their A-TMP-tag 
conjugates.  
2.3 Experimental Methods 
  
2.3.1 Chemical Synthesis 
  
 Chemical structures of fluorophores and A-TMP-fluorophores are shown in Figure 2-2. 
Alexa647-NHS ester (Invitrogen), Atto655-NHS ester (Atto tec), Atto680-NHS ester (Atto tec), 
and Cy3-NHS ester (GE Life Sciences) were used without further purification to characterize 
unmodified fluorophores and synthesize A-TMP-fluorophore conjugates. Atto655-biotin was 
purchased from Sigma and used without further purification for SM experiments.  
 A-TMP was synthesized as previously described.
30
 A-TMP-fluorophores were 
synthesized by adding 1 mg of fluorophore NHS ester to 500 L DMF, 1 equivalent of A-TMP 
and 5 L triethylamine (Figure 2-2). The mixture was stirred at RT for 16 hours before being 





Figure 2-2: Scheme of fluorophore modification by A-TMP-tag. 
A) Commercially available succinimidyl ester fluorophores react with acrylamide-trimethoprim-amine (A-TMP-
NH2) to form the A-TMP-fluorophore. B) Covalent attachment of A-TMP-Fl to E. coli dihydrofolate reductase 
cysteine mutant (eDHFR:L28C) is initiated by the high affinity binding between eDHFR and TMP and followed by 
the proximity induced reaction between the cysteine thiol and acrylamide, forming the tagged-fluorophore. C) 
Chemical structures of Atto655, Alexa647, Atto680 and Cy3. 
 
 Alexa647-biotin for SM experiments was synthesized by adding 1 mg Alexa647 NHS 
ester and 1 mg Amine-PEG2-biotin (Thermo Scientific) with 5 L triethylamine in DMF (Figure 
2-3). The mixture was stirred at RT for 16 hours before being concentrated. The reaction was 







Figure 2-3: Scheme of biotin-Alexa647 synthesis 
 
2.3.2 Protein Expression, Purification, Labeling and Biotinylation 
  
 The vector encoding eDHFR:L28C for E.coli over-expression and protein purification 
has been previously published.
29
 Plasmids were expressed in BL21(DE3) pLysS cells 
(Invitrogen). Cells were grown at 37°C to an OD600 of 0.6, induced with 0.4 mM IPTG for three 
hours and purified using a nickel sepharose column (HisTrap HP, GE Life Sciences). The protein 
was dialyzed in phosphate buffered saline (PBS) at 4°C, snap frozen and stored at −80°C.  
 For preparation of tagged-fluorophores, 200 M eDHFR:L28C in PBS was thawed at 
4°C and incubated with 1mM A-TMP-fluorophore and 1mM NADPH (Sigma) for two hours 
(Figure 2-4). Unlabeled A-TMP-fluorophore was separated from tagged-fluorophores using 7000 






Figure 2-4 : Demonstration of covalent fluorophore labeling of eDHFR:L28C  
Binding of eDHFR (18 kDa) with A-TMP-Fl results in a shift of approximately 1 kDa that can be fluorescently 
visualized. A) Gel shift assay of eDHFR:L28C-A-TMP-Fl and B) Merged image of in-gel green fluorescence (Cy3) 
and red fluorescence (Atto655, Alexa647) of labeled eDHFR:L28C. The fluorescence of Atto680 is too red-shifted 
to be easily detected. Column 1: protein ladder. Column 2: wt eDHFR. Column 3: eDHFR:L28C. Column 4: 
eDHFR:L28C with A-TMP-Cy3. Column 5: eDHFR:L28C with A-TMP-Alexa647. Column 6: eDHFR:L28C-A-
TMP Atto655. Column 7: eDHFR:L28C-A-TMP-Atto680.  
 
 The vector encoding of eDHFR:L28C-bioseq, for E. coli expression and protein 
purification has been previously published.
38
 eDHFR:L28C expression and purification were 
carried our as previously described.
39
 eDHFR:L28C-bioseq biotinylation was carried as 
previously described.
39,40
 Biotinylated eDHFR:L28C was dialyzed in phosphate buffered saline 
(PBS) at 4°C, snap frozen and stored at −80°C and thawed at 4°C before use in SM experiments. 
For preparation of biotinylated tagged-fluorophores, 1 M biotinylated eDHFR:L28C with 2 M 
A-TMP-Atto655 or A-TMP-Alexa647 and 2 M NADPH in PBS was incubated for two hours 
and used for imaging without further separation. 
2.3.3 Single Molecule Methods  
 
 Single molecule imaging of fluorophore-biotin and biotinylated tagged-fluorophores was 
performed on a homebuilt TIRF microscope. Samples were immobilized on glass slides 
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passivated with PEG and PEG-streptavidin Samples were excited with 633 nm laser at 250 
Watt and imaged until at least 90% of molecules were photobleached. Photostability survival 
time was calculated by plotting the individual traces of 300-500 individual molecules, 
identifying the photobleaching time, and fitting those times to a maximum likelihood single 
exponential fit of survival times. Photon flux was measured by picking 10-20 well resolved 
single molecules and integrating the total Gaussian fluorophore signal over time. The 
background, as determined by the average signal after photobleaching, was subtracted from the 
average fluorescence signal. The resulting signal was converted to photon flux using the ADU 
conversion factor that had been determined for that camera using the calibration protocol 
previously described.
41
 Total photon output was calculated by multiplying photon flux by 
survival lifetime.  
2.3.4 Ensemble Methods  
 
 The quantum yields were determined using the comparative method.
42
 Aqueous solutions 
of fluorophore, A-TMP-fluorophore, and tagged-fluorophore in PBS buffer were diluted to 
absorbances less than 0.1 to prevent inner filter effects. Absorbance measurements and spectra 
were measured using a Tecan Infinite 200 and fluorescence measurements and spectra were 
obtained with a Horiba Scientific Fluorolog-3 spectrofluorometer. The slope of the plot of 
fluorescence emission compared to absorbance was compared to that of a quantum yield 
reference solution under the same excitation and collection conditions. This measurement was 
repeated in triplicate for each fluorophore. Fluorescence quantum yield standards used were 
cresyl violet in methanol and nile blue in methanol.  
 Photobleaching time constants were determined using a microdroplet photobleaching 
assay, similar to one used by Tsien and coworkers.
43
 Aqueous microdroplets of fluorophore, A-
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TMP-fluorophore, and tagged-fluorophore in PBS buffer were created under mineral oil that had 
been previously extracted with PBS buffer. The microdroplets were bleached using laser 
excitation (532 nm or 633 nm) such that the laser beam incidence is greater than the size of 
individual droplets.  
 The absorbance and emission spectra for fluorophores and their A-TMP-tag conjugates 
were measured. We observe no differences between fluorophores and their A-TMP-tag 
conjugates for all fluorophores.  
2.4 Results  
2.4.1 Single Molecule Total Photon Output 
  
 To examine the effect the A-TMP-tag has on SM imaging performance, we determine the 
total photon output of fluorophores and tagged-fluorophores (Figure 2-1B). Using total internal 
reflection (TIRF) microscopy, we measure SM photon flux and survival lifetime, which are used 
to calculate total photon output. The need to biotinylate fluorophores for biotin-streptavidin 
immobilization in TIRF microscopy limits our SM evaluation to fluorophores and the tagged-
fluorophore. Photon flux and survival lifetimes for fluorophores and tagged-fluorophores are 
measured in PBS buffer, PBS buffer containing 10 mM β-mercaptoethylamine (MEA) to 
reproduce the reducing environment of the cell, and PBS containing 40% whole cell yeast extract 
(YE) to reproduce the macromolecular density of the cell. SM photon fluxes and survival 
lifetimes for fluorophores and tagged-fluorophores for Atto655 and Alexa647 are displayed in 





Figure 2-5: Single molecule photon fluxes and survival lifetimes 
Fluorophores (Fl) and tagged-fluorophores (Tagged-Fl) for Atto655 and Alexa647 in PBS buffer, 10 mM β-
mercaptoethylamine (MEA), and 40% yeast extract (YE) with 250 W 633 nm laser illumination. A) SM photon 
flux, which is determined by the number of detected photons. B) Average SM survival lifetime before 
photobleaching.  
 
Table 2-1: Single molecule photon flux and survival lifetime 
 Photon flux a (103 photons/s)   Survival lifetime (min) 
 PBS MEA YE  PBS MEA YE 
Atto655 5 ± 2 4.3 ± 0.8 4.6 ± 0.7  8.5 ± 0.5- 0.93 ± 0.03 4.0 ± 0.2- 
Tagged-Atto655 4.3 ± 0.6   4.2 ± 0.8-  3.4 ± 0.4-  5.8 ± 0.5- 1.43 ± 0.08 3.5 ± 0.2- 
        
Alexa647 13 ± 2- 13 ± 2- 16 ± 2-  0.20 ± 0.01 0.097 ± 0.005 0.35 ± 0.02 
Tagged-Alexa647 13 ± 2- 10.1 ± 0.7- 11 ± 1-  0.25 ± 0.02 0.13 ± 0.01 0.29 ± 0.02 
a





 Differences in photon flux and survival lifetimes between fluorophores and tagged-
fluorophores are generally within fifty percent and vary between buffer conditions. The photon 
fluxes of the tagged-fluorophores are either the same or lower than those of their counterparts. In 
PBS, the tagged-fluorophores have no differences in photon flux from the fluorophores. On the 
other hand, in yeast extract, the tagged-fluorophores have thirty percent lower photon fluxes than 
those of the untagged fluorophores. In 10 mM MEA, tagged-Atto655 has the same photon flux 
as that of Atto655 but tagged-Alexa647 has a twenty percent lower photon flux than that of 
Alexa647.  
 The survival lifetimes of the tagged-fluorophores are either higher or lower than those of 
the fluorophores. In PBS, tagged-Atto655 has a thirty percent shorter survival lifetime than that 
of Atto655 while tagged-Alexa647 has a twenty percent longer survival lifetime than that of 
Alexa647. In the presence of 10 mM MEA, the tagged-fluorophores have longer survival 
lifetimes than those of the fluorophores, with fifty percent longer survival lifetime for tagged-
Atto655 and a thirty percent longer survival lifetime for tagged-Alexa647. In yeast extract, the 
tagged-fluorophores have twenty and ten percent shorter survival lifetimes than those of the 
fluorophores for Atto655 and Alexa647, respectively.  
 The fluorophores have greater differences in photon flux and survival lifetime between 
buffer conditions than between the fluorophore and tagged-fluorophores in the same conditions. 
Both Atto655 and Alexa647 have lower survival lifetimes in MEA than those in PBS, with the 
survival lifetime of Atto655 in MEA nearly an order of magnitude less than that in PBS. 
Although the survival lifetime of Atto655 in yeast extract is less than half of that in PBS, the 
survival lifetime of Alexa647 in yeast extract is thirty percent longer than that in PBS. The 
fluorophores have no differences in photon flux between the buffer conditions. Overall, the 
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photon fluxes of Alexa647 are two to three times higher than those of Atto655 across the 
investigated conditions. However, the survival lifetimes of Atto655 are nearly an order of 
magnitude greater than those of Alexa647.  
 SM total photon flux for fluorophores and tagged-fluorophores for Atto655 and Alexa647 
are displayed in Figure 2-6 and Table 2-2. Although the tagged fluorophores exhibit some 
differences in photon flux and survival lifetime from the untagged fluorophores, the total photon 
output of the tagged-fluorophores is the same or on the same order of magnitude as that of the 
fluorophores. The total photon outputs of the tagged-Atto655 are the same as Atto655 across all 
the investigated conditions. The total photon outputs of tagged-Alexa647 are the same as 
Alexa647 in PBS and in 10 mM MEA. Alexa647 in yeast extract is the only fluorophore that 
exhibits a difference in photon output between the fluorophore and the tagged-fluorophore, with 
the tagged-Alexa647 having thirty percent less photon output than that of Alexa647. However, 
the photon output of tagged-Alexa647 in yeast extract is the same as the photon output of both 
Alexa647 and tagged-Alexa647 in PBS. The TMP-tag does not affect the overall SM imaging 
performance of Atto655 and Alexa647.  
 
Figure 2-6: Total photon output  
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Fluorophores (Fl) and tagged-fluorophores (Tagged-Fl) for Atto655 and Alexa647 in PBS buffer, 10 mM β-
mercaptoethylamine (MEA), and 40% yeast extract (YE) with 250 W 633 nm laser illumination. Total photon 
output is determined by multiplying photon flux by the average survival lifetime.  
Table 2-2: Single molecule total photon output  
 Total photon output b (x105 photons) 
 PBS MEA YE 
Atto655 27 ± 9 2.4 ± 0.6 10 ± 2 
Tagged-Atto655 15 ± 3 3.7 ± 0.9 -7 ± 1- 
    
Alexa647 1.6 ± 0.3 0.8 ± 0.1 3.3 ± 0.5 
Tagged-Alexa647 2.0 ± 0.4 0.7 ± 0.1 1.9 ± 0.3 
b
 Total photon output is determined by multiplying photon flux by survival lifetime. 
 
 
 Overall, the total photon output of Atto655 is approximately an order of magnitude 
greater than that of Alexa647. Atto655 has the greatest photon output in PBS, which is 2,700,000 
± 900,000 photons. However, in yeast extract, Atto655 photon output is sixty percent less than 
the output in PBS. Alexa647 has the greatest photon output in yeast extract at 330,000 ± 50,000 
photons, which is nearly double the photon output in PBS. Both fluorophores have lowest photon 
output in MEA with Atto655 having nearly an order of magnitude lower output than that in PBS 
and Alexa647 having nearly half the output than that in PBS.  
2.4.2 Quantum Yield and Ensemble Photostability Lifetime 
  
 We measure the quantum yields and photostability lifetimes of Atto655, Alexa647 and 
their corresponding A-TMP-fluorophores and tagged-fluorophores (Figure 2-1B) to examine the 
correlation between ensemble and SM properties. We also perform ensemble measurements on 
an additional oxazine, Atto680, and cyanine, Cy3, to more broadly understand the impacts of the 
A-TMP-tag on oxazines and cyanines. The ensemble properties of these fluorophores and their 




Figure 2-7: Quantum yield and photostability lifetime  
Fluorophores (Fl), A-TMP-fluorophore (A-TMP-Fl) and tagged-fluorophores (Tagged-Fl) for Atto655 and 

















Atto655 0.21 ± 0.02 23 ± 3- 663 680 
A-TMP-Atto655 0.08 ± 0.01 7.7 ± 0.8 663 680 
A-TMP-tagged Atto655 0.23 ± 0.02 8.9 ± 0.3 663 680 
     
Atto680 0.17 ± 0.02 37 ± 7- 680 702 
A-TMP-Atto680 0.09 ± 0.01 20 ± 1- 680 702 
A-TMP-tagged Atto680 0.19 ± 0.02 12.5 ± 0.7- 680 702 
     
Alexa647 0.29 ± 0.03 0.148 ± 0.007 651 660 
A-TMP-Alexa647 0.34 ± 0.03 0.35 ± 0.01 651 660 
A-TMP-tagged Alexa647 0.36 ± 0.04 0.18 ± 0.01 651 660 
     
Cy3 0.05 ± 0.01 12.8 ± 0.2 550 555 
A-TMP-Cy3 0.11 ± 0.01  21 ± 2- 550 555 
A-TMP-tagged Cy3 0.13 ± 0.02 14.4 ± 0.3 550 555 
 
 The two fluorophore classes exhibit trends in quantum yield and photostability lifetime 
between the fluorophores and their A-TMP-tag conjugates. For Atto655 and Atto680, the tagged-
oxazines have the same quantum yield as the oxazines even though the A-TMP-oxazines have a 
lower quantum yield. However, the photostability lifetimes of the A-TMP-oxazines and tagged-
oxazines are both shorter than those the oxazines. For the cyanines Alexa647 and Cy3, the A-
TMP-cyanines and the tagged-cyanines have greater or the same quantum yields as the cyanines. 
Although the tagged-cyanines have shorter photostability lifetimes than those the A-TMP-
cyanines, they are still longer than those of the cyanines. 
 Overall, the tagged-fluorophores have the same if not better quantum yield than the 
fluorophores. While the tagged-cyanines are more photostable than the cyanines, the tagged-
oxazines are less photostable than the oxazines. The A-TMP-tag does not affect the ensemble 
photophysical properties of the cyanines or the quantum yield of oxazines, but does reduce the 
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photostability of the oxazines. Alexa647 has the highest quantum yield, but is the least 
photostable out of the examined fluorophores. Atto680, Atto655 and Cy3 are approximately an 
order of magnitude more photostable than Alexa647, with Atto680 being the most photostable. 
2.5 Discussion  
 
 These results establish that the A-TMP-tag complements the advantageous SM imaging 
properties of Atto655 and Alexa647, facilitating SM imaging with these fluorophores. Based on 
the SM examination of these fluorophores and their tagged-counterparts under buffers that mimic 
the reducing potential and macromolecular density of the cell, we determine the A-TMP-tag has 
buffer dependent effects on photon flux and survival lifetime. However, the A-TMP-tag does not 
affect total photon output in most cases. Although the A-TMP-tag lowers Alexa647 photon 
output in yeast extract, this output is the same as that for Alexa647 in PBS. With the best organic 
fluorophores having photon outputs only approximately ten-fold greater than the best FPs, the A-
TMP-tag's preservation of Atto655 and Alexa647 photon output is significant for upholding 
these fluorophores' SM imaging performances.
5,16-20
 These findings also reveal that Atto655 is 
superior to Alexa647 for imaging on longer timescales, with survival lifetimes and total photon 
outputs nearly an order of magnitude greater than those of Alexa647. At the same time, the 
photon fluxes of Alexa647 are two to three times greater than those of Atto655, making 
Alexa647 better suited for applications requiring positional localization.
44
 The comparative 
advantages of survival lifetime and photon flux between these two fluorophores are not altered 
by the A-TMP-tag, further indicating that the A-TMP-tag is valuable tool for labeling proteins 
for SM imaging applications.  
 These findings reflect Atto655 and Alexa647 performance for SM imaging and highlight 
the importance of fluorophore characterization under different conditions. Recent studies of 
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fluorophore performance in various buffer conditions and in fixed cells have begun to provide 
guidelines for selecting appropriate fluorophores for SM and super resolution imaging.
45,46
 Our 
investigation goes a step further by characterizing fluorophores with chemical tags under 
conditions that imitate those of the live cell. While we examine fluorophores in a reducing 
environment and a macromolecularly dense environment, we do not include oxygen scavengers 
because these conditions are not representative of the native, live cell. As a result, the measured 
photon output of Alexa647 in this study is lower than that of Atto655, which is the opposite of 
what has been previously observed with these fluorophores in low oxygen, super resolution SM 
imaging conditions.
46
 While differences in photon output can vary between experimental set-ups, 
Alexa647's lower photon output in this investigation is likely attributed to its sensitivity to photo-
oxidative bleaching as a cyanine along with the use of non-deoxygenated buffers.
47,48
 These 
results suggest that Atto655 may be more advantageous for oxygenated conditions in live cell 
imaging, but further investigation is needed to account for fluorophore interactions in cell 
environments, such as non-specific binding, which may further impact imaging performance.  
 Ensemble evaluation of fluorophores gives valuable insights regarding the utility of 
ensemble properties as indicators of SM imaging performance. As a measure of the probability 
of fluorescence emission, quantum yield is not an ensemble equivalent of photon flux, which is 
the rate of photon emission from the fluorophore. While photostability lifetime and survival 
lifetime are both direct measures of photostability, differences in illumination intensities and 
imaging conditions can affect these lifetimes as high illumination causes fluorophores to 
experience more dark state transitions from which they are photobleached.
43,49,50
 However, we do 
observe a correlation between the ensemble and SM properties as both Atto655 and Alexa647 
experience no change in quantum yield and photon flux with the addition of the A-TMP-tag in 
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PBS. In addition, the A-TMP-tag lowers both photostability lifetime and survival lifetime for 
Atto655 while the tag raises Alexa647 photostability lifetime and survival lifetime. The ability to 
measure ensemble properties without specialized equipment and the correlation between the 
ensemble and SM properties indicates that these ensemble measurements can be applied for 
wider screenings of chemically tagged fluorophores with advantageous properties that can be 
later confirmed by SM investigation.  
 Ensemble measurements also allow separate examination of chemical and environmental 
effects from the A-TMP-tag because the properties of fluorophores, A-TMP-fluorophore, and the 
tagged-fluorophores can be measured individually. With the oxazines Atto655 and Atto680, we 
observe that the A-TMP-oxazines have lower quantum yields, which is consistent with previous 
observations of quenching by intramolecular electron transfer after conjugation to electron-rich 
molecule in these fluorophores and other oxazines.
32,34,51
 We also observe that tagged-Atto655 
and tagged-Atto680 have quantum yields that are unchanged for the original fluorophores, an 
effect that was similarly observed with oxazines and the SNAP-tag, and may be caused by 
inhibited electron transfer due to the interaction of A-TMP with the eDHFR binding pocket.
32,33
 
For the cyanine Cy3, we observe stepwise increases in quantum yield from Cy3, to A-TMP-Cy3 
and to tagged-Cy3, which is consistent with the tag causing steric inhibition of cis-trans 
photoisomerization in the methinine chain, a mechanism of non-radiative decay.
52,53
 Although a 
similar trend in quantum yield is not observed with the cyanine Alexa647, its longer methinine 
chain has a lower rate of cis-trans isomerization that likely reduces the steric effects of the A-
TMP-tag on quantum yield.
54,55
 Examining fluorophores with chemical tags using ensemble 
measurements can provide insights to their interactions and predict whether fluorophores in the 
same chemical class will behave similarly.  
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2.6 Conclusion and Outlook  
 
 Chemical tags are emerging as a strategic experimental tool for selectively labeling 
proteins with organic fluorophores to meet the demand for fluorescent labels with high photon 
outputs in SM imaging. As the chemical tags make SM imaging more accessible, there is a 
growing need for characterization to not only understand the effects the chemical tags have on 
fluorophores, but also identify chemically tagged fluorophores with suitable properties for SM 
imaging. We examined both SM and ensemble photophysical properties of the fluorophores, 
Atto655 and Alexa647, and their A-TMP-tag conjugates. We demonstrated that the A-TMP-tag 
is an effective labeling reagent for SM imaging because it upholds Atto655 and Alexa647 total 
photon output. Characterizing these commercially available fluorophores with the A-TMP-tag 
provides photophysical benchmarks to compare and guide the selection of fluorophores and 
chemical tags. As the capabilities of chemical tags evolve with the developments of new organic 
fluorophores and fluorescent materials for biological imaging, this framework can continue to 
evaluate and identify the most promising fluorophores and chemical tags for SM imaging. By 
using SM imaging to decipher the complex dynamics of protein function and interaction in live 




2.7 NMR Spectra of Synthesized TMP-Fluorophores 




Figure 2-8: Alexa647-A-TMP 
1
H NMR 
 (400 MHz, Methanol-d4) δ 8.36 (s, 3H), 7.94 – 7.85 (m, 5H), 7.45 (t, 3H), 7.30 (s, 1H), 6.75 (d, 1H), 6.58 (s, 3H), 
6.50 (d, 2H), 6.31 – 6.22 (m, 1H), 6.18 (d, 1H), 5.62 (d, 1H), 4.89 – 4.79 (m, 3H), 4.37 (s, 6H), 3.96 (t, 3H), 3.81 (s, 
7H), 3.67 (s, 3H), 3.21 (t, 4H), 3.04 – 2.98 (m, 4H), 2.89 (d, 1H), 2.70 (dd, J = 22.5, 6.7 Hz, 2H), 2.47 (s, 1H), 2.29 
– 2.15 (m, 8H), 2.04 (d, J = 7.8 Hz, 3H), 1.86 (t, J = 6.1 Hz, 2H), 1.73 (dd, J = 17.4, 5.4 Hz, 16H), 1.63 (s, 2H), 1.48 




Figure 2-9: Atto655-A-TMP 
1
H NMR  
(400 MHz, Methanol-d4) of. δ 7.83 (dd, J = 1.8, 1.0 Hz, 1H), 7.50 (s, 1H), 7.28 (d, J = 1.0 Hz, 1H), 7.09 (s, 1H), 
6.97 (s, 1H), 6.50 (d, J = 0.8 Hz, 2H), 6.32 – 6.12 (m, 2H), 5.63 (ddd, J = 9.9, 2.1, 0.8 Hz, 1H), 4.80 (td, J = 6.7, 1.5 
Hz, 1H), 3.97 – 3.87 (m, 2H), 3.77 (s, 11H), 3.70 – 3.53 (m, 14H), 3.52 – 3.35 (m, 6H), 3.24 (td, J = 6.9, 1.4 Hz, 
2H), 3.09 – 2.93 (m, 3H), 2.74 (dd, J = 15.0, 6.3 Hz, 1H), 2.67 – 2.51 (m, 2H), 2.43 (q, J = 6.4 Hz, 2H), 2.08 (q, J = 







Figure 2-10: Atto680-A-TMP 
1
H NMR 
(400 MHz, Methanol-d4) δ 7.84 (s, 1H), 7.44 (d, J = 1.3 Hz, 1H), 7.25 (d, J = 0.9 Hz, 1H), 7.04 (s, 1H), 6.92 (s, 1H), 
6.47 (s, 2H), 6.31 – 6.11 (m, 2H), 6.03 (s, 1H), 5.62 (dd, J = 9.8, 2.1 Hz, 1H), 4.80 (t, J = 6.7 Hz, 1H), 4.05 (s, 2H), 
3.94 (t, J = 5.7 Hz, 2H), 3.77 (s, 14H), 3.69 – 3.53 (m, 12H), 3.24 (td, J = 6.8, 1.9 Hz, 2H), 2.99 – 2.86 (m, 3H), 2.73 
(dd, J = 15.0, 6.4 Hz, 1H), 2.62 (dd, J = 15.0, 7.1 Hz, 1H), 2.45 (t, J = 6.6 Hz, 2H), 2.18 (s, 2H), 2.10 – 2.04 (m, 






Figure 2-11: Cy3-A-TMP 
1
H NMR  
(400 MHz, Methanol-d4) δ 8.36 (s, 2H), 7.94 – 7.85 (m, 4H), 7.45 (t, 2H), 7.30 (s, 1H), 6.75 (d, 1H), 6.58 (s, 2H), 
6.50 (d, 2H), 6.28 (dd,1H), 6.17 (d, 1H), 5.62 (d,1H), 5.37 (t, J = 4.8 Hz, 1H), 4.81 (s, 1H), 4.37 (s, 5H), 3.96 (t,2H), 
3.81 (s, 6H), 3.67 (s, 2H), 3.63 – 3.52 (m, 8H), 3.51 – 3.42 (m, 6H), 3.22 (d,5H), 3.02 (d, J = 0.5 Hz, 1H), 2.89 (d, J 
= 0.7 Hz, 1H), 2.66 (s, 1H), 2.47 (s, 1H), 2.29 – 2.15 (m, 6H), 2.04 (d,3H), 1.90 – 1.82 (m, 2H), 1.78 – 1.67 (m, 









Figure 2-12: Biotin-Alexa647 
1
H NMR  
(400 MHz, Methanol-d4) δ 8.27 (q, 2H), 7.86 – 7.76 (m, 4H), 7.37 (t, 2H), 6.45 – 6.37 (m, 2H), 4.49 – 4.37 (m, 1H), 
4.28 (d, 5H), 3.67 – 3.39 (m, 10H), 3.28 (dd, J = 9.5, 5.5 Hz, 3H), 3.13 (dq, J = 9.3, 4.6 Hz, 1H), 2.94 – 2.75 (m, 
5H), 2.63 (d, 1H), 2.19 – 2.07 (m, 8H), 1.97 (t, 2H), 1.71 – 1.63 (m, 9H), 1.61 – 1.47 (m, 2H), 1.37 (dq, J = 15.0, 7.2 
Hz, 4H), 1.23 (d, 4H), 1.14 (t, 2H). 
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3.1 Chapter Outlook 
 
 The photophysical properties of organic fluorophores used with chemical tags are critical 
for achieving live cell SM imaging. However, there are few fluorophores that have the requisite 
photon output for reliable SM detection and imaging. Additionally, preferred fluorophores for 
SM imaging are difficult to synthesize and, consequently, very expensive. Not only is the 
discovery of new fluorophores with attractive photophysical properties beneficial for expanding 
the accessibility of SM imaging, but the improved synthetic routes can greatly improve the 
efficiency of fluorophore production to reduce the costs. There is a need for reliable synthetic 
strategies to produce organic fluorophores with SM imaging capabilities.  
 In this chapter, a new synthesis of oxazine and xanthene fluorophores with high yield is 
presented. This work is capable of gram scale production of water soluble fluorophores with red, 
far-red and infrared fluorescence that are compatible with cell imaging. In addition, this work 
enables the synthesis of asymmetric oxazine and xanthenes that may have unique photophysical 
properties. The robustness of this synthetic route enables further investigation and discovery of 
organic fluorophores with ideal photophysical and chemical properties for live cell SM imaging. 
Andrew Anzalone and I are the main contributors of this work. Andrew Anzalone designed and 
synthesized the fluorophores with help from Zhixing Chen. I performed all photophysical 
characterizations of the fluorophores. Andrew Anzalone wrote the paper with contributions from all 
co-authors.  
3.2 Introduction  
 
 Recent advances in fluorescence spectroscopy have driven the demand for dyes with 
improved photophysical and fluorescence properties.
1-3
 In addition to their development as 
cellular and single molecule imaging tools, engineered fluorescent dyes have also been 
71 
 
developed as environmental sensors that can provide readouts of local viscosity, pH, solute 
concentration, and electrical potential.
4-8
 Current and future developments in this field, especially 
those relevant to single-molecule and cellular imaging, depend on the synthesis of customized 
fluorescent dyes that emit in the red region of the visible spectrum, have high extinction 
coefficients and quantum yields, and display high photostability.
9,10
 
 Amongst our best dyes for these purposes are those from the oxazine and xanthene 
classes, exemplified by commercial compounds ATTO-655 and Alexa Fluor-594, 
respectively.
9,11,12
 In the synthesis of derivatized or customized fluorophores, modification of 
commercially available dyes is often limited due either to cumbersome functionalization of the 
parent compounds or to prohibitive costs in obtaining sufficient quantities of dye for carrying out 
the necessary synthetic steps. Thus, the de novo synthesis of fluorescent dyes from basic organic 
building blocks is an essential aspect of technology development. Despite the obvious 
importance of these molecules and the evident need for improved synthetic methodologies, 
oxazines and xanthenes are still largely synthesized using methods reported decades or more ago 
that do not take advantage of the efficiencies of modern chemical transformations.
13-15
 
 Here, we report a novel and scalable synthetic approach to the assembly of the widely 
used oxazine and xanthene fluorophores through a common diaryl ether intermediate (Figure 3-
1). Taking advantage of recent developments in transition metal catalysis, we constructed 
electronically activated diaryl ethers to serve as tethered nucleophiles, reacting with a range of 
substrates to undergo cyclization to cationic fluorescent compounds (Figure 3-1, our work). Final 
products were provided in good overall yields, were amenable to purification using standard 






Figure 3-1: Retrosynthetic analysis for oxazine and xanthene fluorophores 
Differences in approach between prior works and our work are highlighted.  G=leaving group, X=H or RCO2−. 
 
3.3 Results  
  
 As part of our ongoing research program to develop improved technologies for in vivo 
super resolution imaging, we sought to prepare derivatives of the commonly utilized oxazine 
ATTO-655.
12
 Due to the expense associated with obtaining large quantities of this dye and the 
lack of commercial availability of other desirable analogs, we set out to synthesize the oxazines 
following previously described methods.
14,15
 These prior works rely on coupling a pair of 
aminophenol derivatives, one of which is substituted with an electrophilic nitroso or diazo 
functionality, by heating the two components in an acidic medium (Figure 3-1, prior works). 
Though the aminophenol intermediates are readily prepared, the final coupling and cyclization 
reactions frequently result in low yields (~15%) and necessitate the use of preparative scale 
reverse phase high performance liquid chromatography (prep-HPLC) in order to obtain material 
of satisfactory purity. In our hands, the quantities obtained by this method proved insufficient to 
reasonably carry out the remaining steps in the synthesis of our final targets, and we concluded 
that scaling up the process to obtain the desired quantities was impractical. As a result, we 
73 
 
concluded that the existing approach was not a viable synthetic route and chose to pursue 
alternative synthetic strategies. 
 Within the oxazine core structure, we identified a previously unexplored diaryl ether 
disconnection, which is exploited in the restrosynthetic analysis shown in Figure 3-1. We 
envisioned that a step-wise coupling and cyclization process would proceed in higher overall 
yield when compared to the classical coupling strategy and, more importantly, would yield fewer 
byproducts in the final step. Thus, isolation and purification could be carried out using standard 
flash chromatography techniques amenable to gram-scale operations. In pursuit of this synthetic 
strategy, it was necessary to examine methods for synthesizing the diaryl ether in a versatile and 
robust fashion. 
 In addition to the more traditional dihydroquinoline and tetrahydroquinoline derivatives, 
we also chose to explore an indoline-based scaffold to study this synthetic sequence. The 
precursor indoles provide a large number of building blocks from which to start, and we were 
also interested in the photophysical properties of the resulting oxazine products, which are not 
well described for the indoline class. Preparation of the indoline coupling partners proved to be 




 The Ullmann ether synthesis poses a potential route to the diaryl ether structural motif by 
copper(I) promoted reaction between phenols and aryl halides.
17,18
 Although attractive in theory, 
the classical reaction conditions typically employ strong base, stoichiometric quantities of 
copper, and heating at temperatures in excess of 200°C. Additionally, the reaction is known to be 
highly substrate dependent and, when successful, commonly results in only modest yields. To 
overcome these limitations and eliminate the harsh reaction conditions, we chose to explore a 
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more contemporary method that utilizes palladium catalysis.
19
 Unexpectedly, coupling between 
phenol 1c (Table 3-1) and its corresponding triflate resulted predominantly in reaction at C-5 of 
the indoline in a Heck-type manner, producing the biaryl phenol derivative as the major product. 
Thus, the palladium catalyzed coupling reaction does not appear to be a useful method for 
synthesizing diaryl ethers when electron rich carbon nucleophiles, such as those that exist in our 
system, are present. 
 We next turned to recent developments in ligand-assisted copper catalyzed coupling 
reactions.
20
 Based on work reported by Buchwald and coworkers, we found that the coupling 
between phenol 1b and 3-iodoaniline 2a (Table 3-1) provided the diaryl ether 3b in 82% yield 
when carried out in the presence of catalytic copper iodide (10 mol %) and 2-picolinic acid (20 
mol %) at 85°C in DMSO (Table 3-1, entry 2). This catalytic system offers the advantage of 
orthogonality with the aniline functional group. As opposed to aryl iodides, aryl bromides were 
found to be very poor substrates in our system, with nearly no product formation observed even 
at elevated temperatures (180°C) and increased catalyst loadings (50 mol %). Nonetheless, aryl 
iodides were readily prepared from the corresponding commercially available aryl bromides by 
employing a copper promoted halogen exchange reaction.
21
 Couplings carried out according to 
the aforementioned conditions provided a range of substituted diaryl ethers in good yields (Table 
3-1). Following these coupling reactions, anilines 3a and 3b were transformed to their 
dihydroquinoline derivatives via a modified Skraup reaction and subsequently alkylated and 























































 Conditions: phenol (1.2 equiv), copper(I) iodide (10 ol %), 2-picolinic acid (20 ol %),  3PO4 (2.0 equiv), 
DMSO, 85°C, 24 h. DMSO=dimethyl sulfoxide. 
 
 Having established a reliable means of synthesizing the critical diaryl ether intermediates, 
we next explored conditions for converting these compounds to their corresponding oxazine 
dyes. This transformation was readily accomplished by reaction of diaryl ether 3d with one 
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equivalent of 4-nitrobenzene diazonium tetrafluoroborate, followed by heating the corresponding 
diazene 4d with p-toluenesulfonic acid (TsOH) to 65°C in ethanol (Figure 3-2). The latter 
process proceeded with near-quantitative conversion and following trivial silica based flash 
chromatography to remove the liberated p-nitroaniline, we obtained the oxazine-tosylate salt in 
high purity and 90% yield. Implementing this strategy, several substituted oxazine dyes with 
various spectroscopic properties were synthesized in good to excellent yields from the 
corresponding diazene compounds (Table 3-2). Of note, over one gram of oxazine 6f was 
prepared by this method in 94% yield, demonstrating the scalability of our approach (Table 3-2, 
entry 6). Additionally, 6g, the sulfonated analog of 6c resembling commercially available 

































































 Diazenes were obtained and used as 
regioisomeric mixtures to cyclize to a single oxazine product. 
[d]
 Reaction conducted on a gram-scale. 
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 To further expand the scope of this methodology, we examined other popular fluorescent 
dyes for similar diaryl ether disconnections and identified xanthene dyes, exemplified by 
rhodamine and rosamine, as potential targets. The classical method for synthesizing these 
aminoxanthenes calls for heating two equivalents of an aminophenol with one equivalent of a 
carboxylic acid anhydride or aldehyde under acidic conditions (ZnCl2 or H2SO4) often at high 
temperatures (Figure 3-1, prior works).
13
 When this strategy is employed with derivatized 
analogs, the reactions typically result in modest to poor yields and make isolation of the product 
difficult by conventional purification methods.
22
 We sought to prepare these fluorescent dyes 
from our diaryl ethers in an analogous manner to the synthesis of the oxazine dyes. After 
screening several Lewis acid catalysts and reaction conditions, we found that Ga(OTf)3 catalyzed 
the tandem Friedel-Crafts acylationcyclization reaction between the aforementioned diaryl ethers 
and aromatic acid chlorides to provide the corresponding xanthene dyes in modest to good yields 







Table 3-3: Tandem catalytic Friedel–Crafts acylation/cylization reaction for the synthesis 











































7 f 36 (81) 
[a]
 Conditions: acid chloride (8 equiv), Ga(OTf)3 (15  ol %), MeNO2, 60 C, 4 Å  olecular sieves (M.S.), 16 h.      
[b]
 
Yields in brackets based on recovered starting material. 
[c]
 No Lewis acid catalyst required, TFAA (2.2 equiv) in 
CH2Cl2 at RT for 12 h. 
[d]
 Acid chloride (5 equiv) was used. 
[e]
 Reaction conducted on a gram-scale. 
 
 Supplementing the reaction with additional Ga(OTf)3 did not lead to further product 
formation, suggesting that a byproduct formed in the course of the reaction was inhibiting 
forward progression. Possibly, this was due to substrate inactivation by HCl, which is 
generated in the course of the Friedel-Crafts acylation and from hydrolysis of the acid 
chloride (water is generated in the cyclization step). Interestingly, in the case of the p-Me2N 
derivative (Table 3-3, entry 3), nearly full consumption of starting material was observed, 
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suggesting that the dimethylamino group may be capable of buffering the reaction to allow 
for increased conversion. Higher conversions of starting material could be obtained by 
resubjecting the crude product mixture (following workup) to the initial reaction conditions. 
 Of note, this synthetic strategy allows for the synthesis of asymmetrically functionalized 
xanthene dyes, which are not accessible by the classical coupling strategy. Additionally, several 
dyes were prepared in significantly higher yields when compared to traditional syntheses. For 
example, compound 7b, an asymmetric xanthene, was synthesized in 83% yield simply by 
reaction of the diaryl ether with 2.2 equivalents of trifluoroacetic anhydride at room temperature 
without a Lewis acid catalyst. By comparison, rhodamine 700, a similar dye possessing the 
trifluoromethyl substituent at the meso carbon, is reported to be prepared in only 5% yield from 
aminophenols.
25
 Although this current work is limited to the synthesis of rosamines with fully 
substituted anilines, it may be possible to synthesize mono- or non-alkylated analogs by minor 
modification of this synthetic approach. 
 Figure 3-3 shows the absorption and fluorescence spectra for several of the oxazine and 
xanthene dyes synthesized. Notably, the increased conjugation of oxazines 6a and 6b results 
in significant red-shifted absorption and fluorescence. Similarly, xanthenes 7b, 7e and 7f 
possessing electron withdrawing side chains also display red-shifted spectra. The 
dimethylamino-substituted rosamine 7c displays pH dependent fluorescence, with a near 30- 
fold increase in fluorescence intensity in acidic conditions (data not shown). Spectral 
properties of the dyes in aqueous solution are provided in Table 3-4. In summary, we have 
established a high-yielding, scalable synthetic route for the preparation of the widely used 
oxazine and xanthene based fluorescent dyes from a common diaryl ether intermediate. 
Compared to previously existing synthetic methodologies, our work provides a versatile means 
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for preparing these fluorescent dyes and eliminates the need for tedious and expensive 
purifications. Following this synthetic approach, a number of oxazine and xanthene fluorophores 
were synthesized and characterized. With proper synthetic planning, we believe this to be a 
general and widely applicable approach to the synthesis of derivatized oxazine and xanthene 




Figure 3-3: Absorbance and fluorescence spectra of oxazine and xanthene derivatives  
a) Absorbance and b) fluorescence spectra of various oxazine and xanthene derivatives. Spectra were obtained in 






Table 3-4: Spectral properties of fluorescent dyes in H2O 
[a]
 




] λfluor [nm] Fwhm
[b]
 [nm] Φf 
6 a 703 50, 000 717 42 0.08 
6 b 682 69, 000 696 44 0.09 
6 c 664 67, 000 681 45 0.24 
6 d 648 66, 000 661 43 0.11 
6 g 663 97, 000 677 43 0.20 
7 a 553 58, 000 576 49 0.19 
7 b 616 61, 000 643 90 0.08 
7 c 559 79, 000 585 53 0.14 
7 d 555 60, 000 575 47 0.21 
7 e 579 68, 000 602 44 0.27 
7 f 581 57, 000 600 42 0.24 
[a]
 Measurements were taken in H2O, with the exception of 7c, which was measured in aqueous HCl (50 mM).        
[b]
 Full-width at half-maximum height. 
 
3.4 Conclusion and Outlook 
 
 The efficient and scalable synthesis of oxazine and xanthene fluorophores can 
significantly improve the availability of fluorophores for SM imaging. High yield and purity can 
reduce production costs of currently employed SM imaging fluorophores, such as Atto655. At 
the same time, novel fluorophores with favorable SM imaging properties can be identified. The 
fluorophores synthesized in this investigation exhibited high extinction coefficients and red to 
infrared fluorescence in aqueous solutions, which are all desirable characteristics for live cell SM 
imaging. Due to the relationship between SM photon output and quantum yield with extinction 
coefficients established in the first chapter, these fluorophores exhibit promising potential for 
good SM imaging performance. Further investigation into the SM properties of fluorophores 
from this study and novel fluorophores may reveal outstanding dyes for live cell imaging.  
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3.5 Supporting Information 
 
3.5.1 General Experimental Methods 
 
 All reactions were carried out under an argon atmosphere. Anhydrous 1,4-dioxane, 
dimethylsulfoxide, tetrahydrofuran, acetonitrile and dichloromethane were purchased as Sure 
Seal™ bottles fro  Sig a-Aldridge. Potassium phosphate tribasic was purchased from Sigma-
Aldrich and ground to a fine powder just prior to use. Sodium iodide powder was purchased 
from Alfa Aesar and ground to a fine powder just prior to use. Copper(I) iodide (99.999%) 
powder was purchased from Sigma-Aldrich. 6-hydroxyindole and 6-bromoindole were 
purchased from Chem-Impex International. Gallium(III) trifluoromethanesulfonate was obtained 
from Acros. All other reagents were commercially available and used without further 
purification. Flash chromatography was performed using a Teledyne ISCO CombiFlash Rf 
system. NMR spectra were recorded on Bruker DRX-300 and DRX-400 instruments. The 
following abbreviations were used to describe multiplicities: s = singlet; d = doublet; t = triplet; q 
= quartet; m = multiplet; br = broad. High-resolution mass spectrometry (HRMS) was performed 
by the Columbia University Mass Spectroscopy Core Facility with a JOEL HX110 mass 
spectrometer by means of fast atom bombardment (FAB). Absorbance measurements and spectra 
were obtained with a Tecan Infinite 200 and fluorescence measurements and spectra were 
obtained with a Horiba Scientific Fluorolog-3 spectrofluorometer. Measurements were 
performed in quartz cuvettes with a 1-cm path length using solutions with absorbance under 0.1 
to prevent inner filter and other non-linear effects. 
3.5.2 Preparation of Hydroxyindolines and Iodoindolines 
 
 1,2,3,4-tetrahydroquinolin-7-ol (S1). 7-hydroxy-3,4-dihydroquinolin-2(1H)-one (4.90 
g, 30.0 mmol) in a slurry of THF (125 mL) was cooled in an ice bath and treated with lithium 
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aluminum hydride (1.82 g, 1.60 mmol). After complete addition, the reaction was heated to 
reflux overnight. Upon cooling to room temperature, the reaction was quenched by the addition 
of aqueous saturated ammonium chloride (50 mL) and extracted with ethyl acetate (3 x 40 mL). 
The combined organic layers were washed with brine and dried over anhydrous Na2SO4, then 





H NMR (400 MHz, CDCl3) δ 6.81 (d, J = 8.1 Hz, 1H), 6.12 (dd, J = 
8.1, 2.5 Hz, 1H), 6.01 (d, J = 2.4 Hz, 1H), 3.46 (s, 1H), 3.29 (t, J = 5.7, 2H), 2.70 (t, J = 6.4 Hz, 
2H), 1.93 (td, J = 11.4, 6.3 Hz, 2H). 
 1-ethyl-1,2,3,4-tetrahydroquinolin-7-ol (1b). A solution of S1 (1.00 g, 6.70 mmol) in 
glacial acetic acid (25 mL) was treated with sodium borohydride (1.01 g, 26.8 mmol). After 
stirring at room temperature for 2 hours, a TLC of the reaction indicated approximately 50% 
consumption of starting material. At this time, acetaldehyde was added in small portions 
(reaction T C’d after each addition) until consu ption of starting material was achieved. The 
reaction was then concentrated under reduced pressure to a thick residue, which was diluted with 
60 mL of saturated aqueous NaHCO3 and neutralized with solid NaHCO3. The resulting solution 
was extracted with ethyl acetate (3 x 35 mL). The combined organic layers were washed with 
brine (30 mL) and dried over anhydrous Na2SO4, then concentrated to a crude orange oil. 
Purification by flash chromatography (5-20% ethyl acetate/hexanes) provided 1.09 g (92%) of 
1b as a light orange crystalline solid. 
1
H NMR (400 MHz, CDCl3) δ 6.82 (d, J = 8.0 Hz, 1H), 
6.24 (s, 1H), 6.12 (d, J = 8.0 Hz, 1H), 3.33 (q, J = 7.1 Hz, 2H), 3.28 (t, J = 5.7 Hz, 2H), 2.70 (t, J 
= 6.4 Hz, 2H), 2.02 – 1.91 (m, 2H), 1.18 (t, J = 7.1 Hz, 3H). 13C NMR (300 MHz, CDCl3) δ 





: 177.1154; found 177.1162. 
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 1-ethylindolin-6-ol (1c). 6-hydroxyindole (2.66 g, 20.0 mmol) was dissolved in glacial 
acetic acid (65 mL) and treated with sodium borohydride (3.78 g, 100 mmol) in small portions at 
room temperature. After 4 hours, the reaction was concentrated in vacuo to a thick residue, 
which was then diluted with 60 mL of saturated aqueous NaHCO3 and neutralized with solid 
NaHCO3. The resulting solution was extracted with ethyl acetate (35 mL, 3x). The combined 
organic layers were washed with brine (30 mL) and dried over anhydrous Na2SO4, then 
concentrated in vacuo and dried under high vacuum to provide an orange crude solid. 
Purification by flash chromatography (5-20% ethyl acetate/hexanes) provided 2.09 g (64%) of 1c 
as a tan solid. 
1
H NMR (400 MHz, CDCl3) δ 6.90 (d, J = 7.8 Hz, 1H), 6.10 (dd, J = 7.8, 2.1 Hz, 
1H), 6.02 (d, J = 2.1 Hz, 1H), 4.87 (br s, 1H), 3.37 (t, J = 8.2 Hz, 2H), 3.12 (q, J = 7.2 Hz, 2H), 
2.90 (t, J = 8.2 Hz, 2H), 1.20 (t, J = 7.2 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 156.28, 153.81, 





163.0997; found 163.1007. 
 6-iodoindole (S2). According to the published protocol by Klapars and Buchwald, 
21
 an 
oven dried, sealable glass tube was charged with a magnetic stirbar, 6-bromoindole (4.94 g, 25.2 
mmol), freshly ground sodium iodide (7.55 g, 50.4 mmol), and copper(I) iodide (480 mg, 2.52 
mmol). The vessel was then fitted with a rubber septum, evacuated under vacuum and backfilled 
with argon. This process was repeated three times. The vessel was then charged with 1,4-dioxane 
(25   ) followed b  N,N’-dimethylethylenediamine (0.58 mL, 5.40 mmol) via syringe. The 
rubber septum was removed and the reaction vessel immediately sealed tightly with a Teflon 
screw cap and heated to 110°C for 22 hours. After cooling to room temperature, the reaction was 
diluted with saturated aqueous NH4Cl (30 mL) and extracted with dichloromethane (4 x 25 mL). 
The combined organic layers were washed with brine (30 mL) and dried over Na2SO4, then 
86 
 
concentrated to a brown residue. The residue was triturated in hexanes and concentrated to 
provide S2 (5.87 g, 99%) as a brown crystalline solid. This compound has been previously 
characterized. 
1
H NMR (400 MHz, CDCl3) δ 8.18 (br s, 1H), 7.80 (s, 1H), 7.43 (s, 2H), 7.21 – 
7.13 (t, J = 2.8 Hz, 2H), 6.56 (t, J = 2.2 Hz, 1H). 
 6-iodoindoline (2b). S2 (5.86 g, 24.1 mmol) was dissolved in glacial acetic acid (100 
mL) and cooled in an ice bath just until the solution began to become partially frozen. At this 
point, the solution was treated portion-wise with sodium cyanoborohydride (4.52 g, 72.3 mmol), 
then allowed to warm to room temperature and stir for 3 hours. The reaction mixture was 
concentrated to a thick residue, then diluted with 50 mL of saturated aqueous NaHCO3. The 
resulting solution was extracted with ethyl acetate (3 x 40 mL). The combined organic layers 
were washed with saturated aqueous NaHCO3 (30 mL) and brine (30 mL), then dried over 
anhydrous Na2SO4 and concentrated to a brown residue. Purification by flash chromatography 
(0-15% ethyl acetate/hexanes) afforded 2b (4.78 g, 81%) as a white crystalline solid. This 




H NMR (400 MHz, CDCl3) δ 7.10-6.95 (m, 
2H), 6.87 (d, J = 7.5 Hz, 1H), 3.59 (td, J = 8.4, 2.9 Hz, 2H), 3.01 (t, J = 8.4 Hz, 2H). 
 1-ethyl-6-iodoindoline (2c). S2 (729 mg, 3.00 mmol) was dissolved in glacial acetic acid 
(15 mL) and treated with sodium borohydride (681 mg, 18.0 mmol) in small portions at room 
temperature. After stirring for 1 hour, the reaction was treated with sodium cyanoborohydride 
(377 mg, 6.00 mmol). The reaction was concentrated in vacuo to a thick residue, which was then 
diluted with 25 mL of saturated aqueous NaHCO3. The resulting solution was extracted with 
ethyl acetate (25 mL, 3x). The combined organic layers were washed with saturated aqueous 
NaHCO3 and brine (30 mL), then dried over anhydrous Na2SO4 and concentrated in vacuo to a 
brown residue. Purification by flash chromatography (0-10% ethyl acetate/hexanes) afforded 2c 
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(590 mg, 76%) as a light yellow oil. 
1
H NMR (400 MHz, CDCl3) δ 6.97 (dd, J = 7.6, 1.1 Hz, 
1H), 6.80 (d, J = 7.6 Hz, 1H), 6.78 (s, 1H), 3.38 (t, J = 8.2 Hz, 2H), 3.14 (q, J = 7.2 Hz, 2H), 
2.93 (t, J = 8.2 Hz, 2H), 1.19 (t, J = 7.2 Hz, 3H). 
13
C NMR (300 MHz, CDCl3) δ 154.13, 130.53, 





: 273.0014; found 273.0011. 
 1-(4-azidobutyl)-6-iodoindoline (2d). 2b (294 mg, 1.20 mmol) was dissolved in DMF 
and treated with 1-azido- 4-iodobutane (405 mg, 1.80 mmol) and sodium carbonate (382 mg, 
3.60 mmol). The reaction was heated to 60°C for 8 hours. After cooling to room temperature, the 
reaction was diluted with water (25 mL) and extracted with ethyl acetate (3 x 25 mL). The 
combined organic layers were washed with brine (30 mL) and dried over anhydrous Na2SO4, 
then concentrated to a light brown oil. Purification by flash chromatography (0-5% ethyl 
acetate/hexanes) provided 326 mg (80%) of 2d as a colorless oil. 
1
H NMR (400 MHz, CDCl3) δ 
6.98 (dd, J = 7.6, 1.5 Hz, 1H), 6.81 (d, J = 7.6 Hz, 1H), 6.76 (d, J = 1.4 Hz, 1H), 3.49 – 3.29 (m, 
4H), 3.08 (t, J = 6.8 Hz, 2H), 2.95 (t, J = 8.2 Hz, 2H), 1.77 – 1.65 (m, 4H). 
13
C NMR (75 MHz, 
CDCl3) δ 154.39, 130.26, 126.58, 126.37, 115.77, 92.81, 53.39, 51.70, 48.71, 28.57, 27.01, 




]: 342.0341; found 342.0328. 
 ethyl 5-(6-iodoindolin-1-yl)pentanoate (2e). 2b (2.29 g, 9.34 mmol) was dissolved in 
DMF (15 mL) and treated with diisopropylethylamine (2.44 mL, 14.0 mmol), ethyl 5-
bromovalerate (2.02 mL, 12.6 mmol) and potassium iodide (1.86 g, 11.2 mmol). The reaction 
was heated to 60 °C for 12 hours. After cooling to room temperature, the reaction was diluted 
with water (30 mL) and concentrated aqueous NH4Cl (10 mL), then extracted with ethyl acetate 
(3 x 30 mL). The combined organic layers were dried over anhydrous Na2SO4 and concentrated 
to a crude brown oil. Purification by flash chromatography (0-10% ethyl acetate/hexanes) 
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provided 2e (3.10 g, 89%) as a beige oil. 
1
H NMR (400 MHz, CDCl3) δ 6.95 (dd, J = 7.6, 1.5 Hz, 
1H), 6.79 (d, J = 7.6 Hz, 1H), 6.74 (d, J = 1.3 Hz, 1H), 4.17 (q, J = 7.1 Hz, 2H), 3.38 (t, J = 8.3 
Hz, 2H), 3.06 (t, J = 7.2 Hz, 2H), 2.93 (t, J = 8.3 Hz, 2H), 2.39 (t, J = 7.2 Hz, 2H), 1.79 – 1.70 
(m, 2H), 1.69-1.60 (m, 2H), 1.30 (t, J = 7.1 Hz, 3H). 
13
C NMR (300 MHz, CDCl3) δ 173.79, 
154.36, 130.26, 126.48, 126.27, 115.81, 92.74, 60.72, 53.32, 48.80, 34.42, 28.52, 27.08, 22.96, 




]: 373.0539; found 373.0553. 
 
Figure 3-4: Scheme of palladium catalyzed coupling between a phenol and aryl triflate. 
Conditions: 1.2 eq.phenol, 2 mol% Pd(OAc)2, 3 mol% 2-(di-tert-butylphosphino)biphenyl, 2 eq. K3PO4, toluene, 
100°C. 
 
 Product isolated in Figure 3-4. Structure was confirmed by 
1
H NMR and mass 
spectrometry. The 
1
H NMR in CDCl3 shows an asymmetrical product with the expected 
multiplicities for the aromatic protons (3 singlets, 2 doublets). An additional singlet was present 
at 6.50 ppm (phenol –OH). The corresponding singlet is not present in the spectrum when 





(400 MHz, CDCl3) δ 7.15 (d, J = 7.3 Hz, 1H), 6.97 (s, 1H), 6.69 (d, J = 7.1 Hz, 1H), 6.50 (s, 
1H), 6.18 (s, 1H), 5.55 (s, 1H), 3.47-3.37 (m, 4H), 3.24 – 3.14 (m, 4H), 3.02 (t, J = 8.2 Hz, 2H), 
2.95 (t, J = 8.1 Hz, 2H), 1.27-1.18 ( , 6H). 1H NMR (400 MHz, MeOD) δ 7.05 (d, J = 7.5 Hz, 
1H), 6.93 (s, 1H), 6.78 (d, J = 7.5, 1H), 6.71 (s, 1H), 6.13 (s, 1H), 3.30 (td, J = 8.1, 1.8 Hz, 4H), 




3.5.3 Coupling of Phenols and Aryl Iodides. 
  
 According to the published protocol by Maiti and Buchwald,
20
 an oven dried, sealable 
glass vessel was charged with a magnetic stirbar, the phenol (2.40 mmol), potassium phosphate 
(4.00 mmol, 849 mg), copper(I) iodide (0.20 mmol, 38 mg), 2-picolinic acid (0.40 mmol, 49 
mg), and the aryl iodide, if a solid (2.00 mmol). The vessel was then fitted with a rubber septum, 
evacuated under vacuum and backfilled with argon. This process was repeated 3 times. The 
vessel was then charged with DMSO (4.0 mL), or if the aryl iodide is a liquid, the vessel was 
charged with the aryl iodide as a solution in DMSO. The rubber septum was removed and the 
reaction vessel was immediately sealed tightly with a Teflon screw cap. The reaction was then 
heated to 85°C for 16-24 hours. After cooling to room temperature, the reaction was diluted with 
10 mL of water and extracted with ethyl acetate (25 mL, 4x). The combined organic layers were 
washed with brine and dried over Na2SO4, then concentrated in vacuo to a crude residue. 
Purification by flash chromatography (hexanes/ethyl acetate) afforded the diaryl ethers as 
colorless oils, which were stored at -20°C under inert atmosphere (these compounds become 
colored upon prolonged exposure to air at room temperature or storage as a solution in a 
halogenated solvent, such as chloroform). 
 3,3'-oxydianiline (3a). Following the general procedure, 3-aminophenol (1a, 1.32 g, 12.0 
mmol) and 3-iodoaniline (2a, 2.18 g, 10.0 mmol) were coupled to provide 3a (1.80 g, 90%) as a 




H NMR (400 
MHz, CDCl3) δ 7.08 (t, J = 8.0 Hz, 2H), 6.42 (m, 4H), 6.34 (s, 2H), 3.67 (br s, 4H). 
 3-(1-ethyl-1,2,3,4-tetrahydroquinolin-7-yloxy)aniline (3b). Following the general 
procedure, phenol 1b (1.20 g, 12.0 mmol) and 3-iodoaniline (2a, 1.23 g, 10.0 mmol) were 
coupled to provide 3b (1.24 g, 82%) as a colorless oil. 
1
H NMR (400 MHz, CDCl3) δ 7.13 (t, J = 
8.0 Hz, 1H), 6.94 (d, J = 8.0 Hz, 1H), 6.49 (ddd, J = 8.2, 2.2, 0.9 Hz, 1H), 6.44-6.38 (m, 3H), 
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6.29 (dd, J = 8.0, 2.2 Hz, 1H), 3.70 (s, 2H), 3.39-3.29 (m, 4H), 2.80 (t, J = 6.4 Hz, 2H), 2.03 (dq, 
J = 9.0, 6.2 Hz, 2H), 1.18 (t, J = 7.1 Hz, 3H). 13C NMR (300 MHz, CDCl3) δ 159.72, 156.50, 
148.38, 146.53, 130.54, 130.12, 118.25, 109.77, 108.63, 106.63, 105.21, 102.69, 48.64, 45.84, 
28.05, 22.80, 11.18. HRMS (FAB
+




]: 268.1576; found 268.1583. 
 1-ethyl-6-(indolin-6-yloxy)indoline (3c). Following the general procedure, phenol 1c 
(196 mg, 1.20 mmol) and aryl iodide 2b (245 mg, 1.00 mmol) were coupled to provide 3c (251 
mg, 90%) as a colorless oil. 
1
H NMR (400 MHz, CDCl3) δ 7.05 (d, J = 7.9 Hz, 1H), 7.00 (d, J = 
7.9 Hz, 1H), 6.40 (dd, J = 7.9, 2.2 Hz, 1H), 6.36 (d, J = 2.1 Hz, 1H), 6.31 (dd, J = 7.8, 2.2 Hz, 
1H), 6.23 (d, J = 2.1 Hz, 1H), 4.32 (br s, 1H), 3.61 (t, J = 8.3 Hz, 2H), 3.41 (t, J = 8.3 Hz, 2H), 
3.12 (q, J = 7.2 Hz, 2H), 3.03 (t, J = 8.2 Hz, 2H), 2.96 (t, J = 8.0 Hz, 2H), 1.20 (t, J = 7.2 Hz, 
3H). 
13
C NMR (300 MHz, CDCl3) δ 158.29, 157.99, 154.12, 153.15, 125.23, 124.91, 109.08, 





]: 280.1576; found 280.1579. 
 6,6'-oxybis(1-ethylindoline) (3d). Following the general procedure, phenol 1c (412 mg, 
2.53 mmol) and aryl iodide 2c (575 mg, 2.10 mmol) were coupled to provide 3d (520 mg, 80%) 
as a clear colorless oil. 
1
H NMR (400 MHz, CDCl3) δ 6.98 (d, J = 7.8 Hz, 1H), 6.29 (d, J = 7.8 
Hz, 1H), 6.22 (s, 1H), 3.40 (t, J = 8.2 Hz, 2H), 3.11 (q, J = 7.2 Hz, 2H), 2.95 (t, J = 8.2 Hz, 2), 
1.18 (t, J = 7.2 Hz, 3H). 
13
C NMR (75 MHz, CDCl3) δ 158.26, 154.02, 125.10, 124.85, 107.64, 




]: 308.1889; found 
308.1897. 
 1-(4-azidobutyl)-6-(1-ethylindolin-6-yloxy)indoline (3e). Following the general 
procedure, the phenol 1c (166 mg, 1.02 mmol) and the aryl iodide 2d (290 mg, 0.848 mmol) 
were coupled to provide 3e (245 mg, 77%) as a colorless oil. 
1
H NMR (400 MHz, CDCl3) δ 7.01 
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(d, J = 3.5 Hz, 1H), 6.99 (d, J = 3.5 Hz, 1H), 6.32 (d, J = 2.3 Hz, 1H), 6.30 (t, J = 2.4 Hz, 1H), 
6.24 (d, J = 2.1 Hz, 1H), 6.22 (d, J = 2.1 Hz, 1H), 3.43 (t, J = 8.2 Hz, 4H), 3.39 – 3.33 (m, 2H), 
3.14 (q, J = 7.2 Hz, 2H), 3.10-3.05 (m, 2H), 2.98 (td, J = 8.1, 2.5 Hz, 4H), 1.78 – 1.67 (m, 4H), 
1.21 (t, J = 7.2 Hz, 3H). 
13
C NMR (300 MHz, CDCl3) δ 158.36, 158.18, 154.32, 154.05, 125.21, 
124.92, 124.87, 124.72, 107.67, 107.54, 99.32, 98.86, 54.00, 53.17, 51.74, 48.98, 43.33, 28.36, 




]: 377.2216; found 
377.2223. 
 ethyl 5-(6-(1-ethylindolin-6-yloxy)indolin-1-yl)pentanoate (3f). Following the general 
procedure, the phenol 1c (1.60 g, 9.77 mmol) and the aryl iodide 2e (3.04, 8.14 mmol) were 
coupled to provide 3f (2.67 g, 80%) as a colorless oil. 
1
H NMR (400 MHz, CDCl3) δ 6.98 (d, J = 
7.8 Hz, 1H), 6.29 (d, J = 7.8 Hz, 1H), 6.22 (s, 1H), 3.40 (t, J = 8.2 Hz, 2H), 3.11 (q, J = 7.2 Hz, 
2H), 2.95 (t, J = 8.2 Hz, 2), 1.18 (t, J = 7.2 Hz, 3H). 
13
C NMR (75 MHz, CDCl3) δ 173.85, 
158.28, 158.20, 154.34, 125.14, 124.83, 124.77, 107.69, 107.44, 99.33, 98.93, 60.66, 53.94, 





]: 408.2413; found 408.2408. 
 7,7'-oxybis(2,2,4-trimethyl-1,2-dihydroquinoline) (S3). 3a (400 mg, 2.00 mmol) was 
dissolved in 2,2-dimethoxypropane (5 mL) and treated with p-toluenesulfonic acid monohydrate 
and stirred at room temperature for 5 days. The reaction was quenched by the addition of 4% aq. 
NaHCO3 (30 mL) and extracted with ethyl acetate (3 x 25 mL). The combined organic layers 
were washed with brine, dried over anhydrous Na2SO4 and concentrated to a crude residue. 
Purified by flash chromatography to provide 340 mg of S3 as a white crystalline solid (47%). 
1
H 
NMR (400 MHz, CDCl3) δ 7.03 (d, J = 8.2 Hz, 1H), 6.35 (dd, J = 8.2, 1.6 Hz, 1H), 6.13 (d, J = 
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1.6 Hz, 1H), 5.26 (s, 1H), 3.63 (br s, 1H), 2.01 (s, 3H), 1.28 (s, 6H). 
13
C NMR (300 MHz, 
CDCl3) δ 158.10, 145.01, 128.38, 127.32, 125.10, 117.36, 108.00, 103.55, 52.39, 31.59, 19.07. 
HRMS (FAB
+




]: 361.2274; found 361.2280. 
 diethyl 5,5'-(7,7'-oxybis(2,2,4-trimethylquinoline-7,1(2H)-diyl))dipentanoate (S4). A 
solution of S3 (270 mg, 0.75 mmol) in anhydrous acetonitrile (4 mL) was treated with sodium 
iodide (112 mg, 0.75 mmol), sodium carbonate (476 mg, 4.50 mmol), and ethyl 5-bromovalerate 
(0.60 mL, 3.75 mmol), then heated to reflux. After 24 hours, the reaction was charged with 
additional ethyl 2-bromovalerate (0.30 mL, 1.9 mmol) and sodium carbonate (238 mg, 2.25 
mmol). After an additional 24 hours of heating, TLC of the reaction indicated a ~3:1 mixture of 
the desired bis-alkylated product to the mono-alkylated product. The reaction was then quenched 
by the addition of water (30 mL) and extracted with ethyl acetate (3 x 25 mL). The combined 
organic layers were washed with brine and dried over anhydrous Na2SO4 and concentrated to a 
crude residue. Purified by flash chromatography to provide 230 mg of S4 as a colorless oil 
(50%). 
1
H NMR (400 MHz, CDCl3) δ 6.98 (d, J =8.3 Hz, 2H), 6.25 (dd, J = 8.3, 2.1 Hz, 2H), 
6.15 (d, J = 2.2 Hz, 2H), 5.17 (d, J = 1.2 Hz, 2H), 4.14 (q, J = 7.1 Hz, 4H), 3.17 (t, J = 7.0 Hz, 
4H), 2.32 (t, J = 6.9 Hz, 4H), 1.97 (d, J = 1.1 Hz, 6H), 1.69 – 1.57 (m, 8H), 1.32 (s, 12H), 1.27 
(t, J = 7.1 Hz, 6H). 
13
C NMR (300 MHz, CDCl3) δ 173.75, 158.44, 145.65, 128.10, 127.83, 
124.81, 118.69, 105.63, 102.00, 60.65, 57.26, 44.25, 34.46, 28.88, 28.29, 22.96, 19.13, 14.64. 
HRMS (FAB
+




]: 617.3949; found 617.3947. 
 7-(1-ethyl-1,2,3,4-tetrahydroquinolin-7-yloxy)-2,2,4-trimethyl-1,2-dihydroquinoline 
(S5). A solution of S4 (1.20 g, 4.47 mmol) in acetone (80 mL) was treated with p-toluenesulfonic 
acid monohydrate (213 mg, 1.12 mmol) and stirred at room temperature for 48 hours. The 
reaction was then concentrated to a residue under reduced pressure, brought up 4% aq. NaHCO3 
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(30 mL) and extracted with ethyl acetate (3 x 25 mL). The combined organics were washed with 
brine and dried over anhydrous Na2SO4 and concentrated to a crude residue. Purified by flash 
chromatography to provide 1.17 g of S5 as a white foamy solid (75%). 
1
H NMR (400 MHz, 
CDCl3) δ 7.03 (d, J = 8.4 Hz, 1H), 6.91 (d, J = 8.0 Hz, 1H), 6.38 (d, J = 2.3 Hz, 1H), 6.35 (dd, J 
= 8.4, 2.4 Hz, 1H), 6.27 (dd, J = 8.0, 2.3 Hz, 1H), 6.14 (d, J = 2.4 Hz, 1H), 3.71 (s, 1H), 3.37-
3.27 (m, 4H), 2.77 (t, J = 6.4 Hz, 2H), 2.06 – 1.99 (m, 5H), 1.31 (s, 6H), 1.16 (t, J = 7.1 Hz, 3H). 
13
C NMR (300 MHz, CDCl3) δ 159.07, 156.45, 146.44, 145.01, 130.03, 128.60, 126.92, 125.01, 
118.14, 116.89, 107.08, 106.71, 102.71, 102.65, 52.36, 48.61, 45.81, 31.52, 28.02, 22.78, 19.07, 
11.15. HRMS (FAB
+




]: 348.2202; found 348.2186. 
 ethyl 5-(7-(1-ethyl-1,2,3,4-tetrahydroquinolin-7-yloxy)-2,2,4-trimethylquinolin-
1(2H)-yl)pentanoate (S6). According to the protocol used to synthesize S4, S5 (1.05 g, 3.00 
mmol) was subjected to alkylation and purified by flash chromatography to yield 845 mg of S6 
as a colorless oil (59%). 
1
H NMR (400 MHz, CDCl3) δ 6.97 (d, J = 8.3 Hz, 1H), 6.88 (d, J = 8.0 
Hz, 1H), 6.36 (d, J = 2.3 Hz, 1H), 6.25 (dd, J = 4.3, 2.3 Hz, 1H), 6.23 (dd, J = 4.6, 2.3 Hz, 1H), 
6.11 (d, J = 2.2 Hz, 1H), 5.15 (d, J = 1.3 Hz, 1H), 4.16 (q, J = 7.1 Hz, 2H), 3.35 – 3.25 (m, 4H), 
3.15 (t, J = 7.2 Hz, 2H), 2.74 (t, J = 6.3 Hz, 2H), 2.31 (t, J = 7.1 Hz, 2H), 2.03 – 1.93 (m, 2H), 
1.97 (s, 3H) 1.67-1.55 (m, 4H), 1.32 (s, 6H), 1.29 (t, J = 7.1 Hz, 3H), 1.13 (t, J = 7.1 Hz, 3H). 
13
C NMR (300 MHz, CDCl3) δ 173.80, 164.92, 159.31, 156.47, 146.37, 145.54, 129.94, 127.84, 
124.81, 118.14, 118.02, 106.52, 104.81, 102.60, 101.17, 60.66, 57.25, 48.58, 45.78, 44.24, 34.47, 
28.90, 28.28, 27.95, 22.94, 22.75, 19.13, 14.65, 11.13. HRMS (FAB
+





]: 477.3112; found 477.3129. 
 ethyl-5-(7-(1-ethyl-1,2,3,4-tetrahydroquinolin-7-yloxy)-2,2,4-trimethyl-3,4-
dihydroquinolin-1(2H)-yl)pentanoate (S7). A round bottom flask charged with a magnetic 
94 
 
stirbar, S6 (185 mg, 0.39 mmol) and ethyl acetate (6 mL) was evacuated under vacuum and 
backfilled with argon gas. This process was repeated three times. The vessel was then charged 
with 10% palladium on carbon (41 mg, 0.039 mmol), evacuated with vacuum, and backfilled 
with hydrogen gas. This process was repeated five times, then the reaction left to stir overnight 
under an atmosphere of hydrogen gas (balloon). The next morning, the reaction was filtered 
through a pad of celite and concentrated under reduced pressure to provide 180 mg of S7 as a 
colorless oil (97%). 
1
H NMR (400 MHz, CDCl3) δ 7.08 (d, J = 8.3 Hz, 1H), 6.91 (d, J = 8.0 Hz, 
1H), 6.41 (s, 1H), 6.31 (d, J = 8.3 Hz, 1H), 6.28 (d, J = 8.0, 1H), 6.21 (s, 1H), 4.20 (q, J = 7.1 
Hz, 2H), 3.40 – 3.25 (m, 5H), 3.08 - 2.97 (m, 1H), 2.95– 2.84 (m, 1H), 2.77 (t, J = 6.2 Hz, 2H), 
2.35 (m, 2H), 2.05 – 1.97 (m, 2H), 1.77 (dd, J = 12.9, 4.5 Hz, 1H), 1.70 - 1.54 (m, 5H), 1.43 – 
1.28 (m, 9H), 1.23 (s, 3H), 1.17 (t, J = 7.0 Hz, 3H). 
13
C NMR (300 MHz, CDCl3) δ 173.91, 
157.88, 156.64, 146.37, 146.30, 129.98, 126.73, 122.43, 117.89, 106.58, 104.62, 102.75, 101.60, 
60.72, 54.84, 48.62, 47.52, 45.82, 45.31, 34.54, 30.08, 29.01, 28.00, 27.28, 25.50, 22.94, 22.81, 
20.56, 14.74, 11.16. HRMS (FAB
+




]: 478.3195; found 478.3210. 
  (1-(5-ethoxy-5-oxopentyl)-7-(1-ethyl-1,2,3,4-tetrahydroquinolin-7-yloxy)-2,2-
dimethyl-1,2-dihydroquinolin-4-yl)methanesulfonate (S8) sodium salt. To a solution of 
fuming sulfuric acid (20% SO3, 1.2 mL) in sulfuric acid (4 mL) cooled in a brine ice bath was 
added S6 (954 mg, 2.00 mmol). The mixture was stirred on ice for 30 minutes then allowed to 
warm to room temperature and stir for 12 hours at room temperature. The reaction was then 
poured into a beaker of ice (50 grams) and the resulting solution, cooled in an ice bath, was 
neutralized to pH 7 with 10% sodium hydroxide. The precipitated sodium sulfate solids were 
filtered, and the resulting aqueous filtrate was concentrated under reduced pressure to white 
solids. This material was boiled gently in 30 mL of ethanol, filtered, and the solids washed with 
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additional hot ethanol. The filtrate was concentrated under reduced pressure and purified by flash 
chromatography to provide 825 mg of S8 as a light pink oil (72%). 
1
H NMR (400 MHz, MeOD) 
δ 7.28 (d, J = 8.4 Hz, 1H), 6.83 (d, J = 8.0 Hz, 1H), 6.27 (d, J = 1.8 Hz, 1H), 6.18 (ddd, J = 14.3, 
8.2, 1.9 Hz, 2H), 5.98 (d, J = 1.7 Hz, 1H), 5.50 (s, 1H), 4.11 (t, J = 7.2 Hz, 2H), 3.88 (s, 2H), 
3.25 (m, 4H), 3.10 (m, 2H), 2.68 (t, J = 6.2 Hz, 2H), 2.24 (t, J = 6.6 Hz, 2H), 1.96 – 1.87 
(m,v2H), 1.78 – 1.64 (m, 2H), 1.64 – 1.56 (m, 2H), 1.33 (s, 6H), 1.25 (t, J = 7.1 Hz, 3H), 1.08 (t, 
J = 7.0 Hz, 3H). 
13
C NMR (300 MHz, MeOD) δ 176.67, 174.15, 159.61, 156.29, 146.28, 145.58, 
132.49, 129.71, 125.84, 124.63, 118.30, 116.59, 106.86, 104.70, 102.72, 100.70, 67.60, 61.55, 
60.52, 57.03, 53.82, 48.28, 45.34, 43.91, 33.89, 33.62, 32.04, 28.77, 27.89, 27.67, 27.37, 22.56, 
22.46, 21.54, 13.74, 10.10. HRMS (FAB
+






3.5.4 4-Nitrobenzenediazonium Tetrafluoroborate Reactions 
 The diaryl ether (1.00 mmol) was dissolved in methanol or ethanol (2 mL), cooled to 0°C 
in an ice bath, then treated with aqueous 2N HCl (5 mL). After sufficient time to cool, the 
reaction was treated with p-nitrobenzenediazonium tetrafluoroborate (1.00 mmol) in 5 mg 
portions over 5 minutes, then stirred at 0°C for 1 hour. The reaction was then diluted with 
dichloromethane (10 mL), quenched by the slow addition of saturated aq. NaHCO3 and 
extracted with dichloromethane (3 x 20 mL). The combined organic layers were dried over 
Na2SO4 and concentrated in vacuo to a deep red-purple residue. Flash chromatography (10-30% 
ethyl acetate/hexanes) provided the diazene as a mixture of regioisomers in the case of 
asymmetrical diaryl ether starting materials (both of which transform to the same oxazine 
product upon cyclization). Full characterization of diazene 4d is provided. 
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 Diazene 4a. Following the general procedure, S4 (205 mg, 0.332 mmol) was reacted to 
give 167 mg of 4a as a deep purple residue (66%). 
 Diazenes 4b and 5b. Following the general procedure, S6 (185 mg, 0.388 mmol) was 
reacted to give 155 mg of a mixture of 4b and 5b as a deep purple residue (69%). 
 Diazenes 4c and 5c. Following the general procedure, S7 (180 mg, 0.376 mmol) was 
reacted to give 170 mg of a mixture of 4c and 5c as a deep purple residue (78%). 
 Diazene 4d. Following the general procedure, 3d (230 mg, 0.756 mmol) was reacted to 
give 270 mg of 4d as a deep red/bronze solid (79%). 
1
H NMR (400 MHz, CDCl3) δ 8.24 (d, J = 
9.1 Hz, 2H), 7.79-7.71 (m, 3H), 7.00 (d, J = 7.6 Hz, 1H), 6.34 (d, J = 7.9 Hz, 1H), 6.30 (s, 1H), 
6.06 (s, 1H), 3.67 (t, J = 8.2 Hz, 2H), 3.42 (t, J = 8.2Hz, 2H), 3.27 (t, J = 7.1 Hz, 2H), 3.13 (t, J = 
7.2 Hz, 2H), 3.08 (t, J = 8.1 Hz, 2H), 2.97 (t, J = 8.2 Hz, 2H), 1.26- 1.14 (m, 6H). 
13
C NMR (300 
MHz, CDCl3) δ 160.66, 158.73, 158.04, 157.61, 154.21, 146.99, 135.85, 127.05, 125.56, 124.98, 
122.91, 113.32, 107.55, 99.21, 96.07, 53.18, 51.95, 43.28, 41.59, 28.31, 26.97, 12.11. 
HRMS(FAB
+




]: 457.2114; found 457.2131. 
 Diazenes 4e and 5e. Following the general procedure, 3e (240 mg, 0.636 mmol) was 
reacted to give 237 mg of a mixture of 4e and 5e as a deep purple film (71%). 
 Diazenes 4f and 5f. Following the general procedure, 3f (1.42 g, 3.47 mmol) was reacted 
to give 1.46 g of a mixture of 4f and 5f as a deep purple residue (76%). 
 Diazenes 4g and 5g. A round bottom flask charged with a magnetic stir-bar, S8 (150 mg, 
0.26 mmol) and methanol (10 mL) was evacuated under vacuum and backfilled with argon gas. 
This process was repeated three times. The vessel was then charged with 10% palladium on 
carbon (30 mg, 0.026 mmol), evacuated with vacuum, and backfilled with hydrogen gas. This 
process was repeated five times, then the reaction left to stir overnight under an atmosphere of 
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hydrogen gas (balloon). The next morning, the reaction was filtered through a pad of celite and 
concentrated under reduced pressure to tan oil. The resulting oil was then brought up in methanol 
(2 mL) and cooled in an ice bath for 10 minutes. The solution was then treated with 2N aqueous 
HCl (5 mL, pre-cooled in ice bath) followed by the slow addition of p-nitrobenzenediazonium 
tetrafluoroborate (62 mg, 0.26 mmol). After stirring on ice for 1.5 hours, the reaction was diluted 
with water (20 mL) and extracted directly without neutralization (DCM, 3 x 25 mL). The 
combined organic layers were dried over Na2SO4 and concentrated in vacuo to a deep red-purple 
residue. Flash chromatography (5-30% dichloromethane/methanol) provided the regioisomeric 
mixture of the diazenes 4g and 5g (115 mg, 63%). 
3.5.5 Diazene-Diaryl Ether Cyclization to Oxazine 
 The diazene diaryl ether (0.2 mmol) was dissolved in anhydrous ethanol (20 mL) and 
treated with p-toluenesulfonic acid monohydrate (0.6 mmol). The deep red reaction mixture was 
heated to 65°C – 70°C, becoming deep blue after a short period of heating. The reaction was 
monitored by TLC (8% MeOH/DCM) and continued until complete conversion of starting 
material to the product (typically ~4-8 hrs). After cooling to room temperature, the reaction was 
treated with 4% NaHCO3 and extracted with dichloromethane (3 x 25 mL). The combined 
organics were dried over anhydrous Na2SO4, then concentrated to a crude blue-red residue. 
Products were purified by flash chromatography (silica gel) using a gradient of 0-10% 
MeOH/DCM. 
 Oxazine 6a. Following the general procedure, 4a (91 mg, 0.119 mmol) was cyclized to 
provide 70 mg of 6a as a purple film (74%). 
1
H NMR (400 MHz, MeOD) δ 7.70 (d, J = 8.1 Hz, 
2H), 7.42 (s, 2H), 7.19 (d, J = 8.0 Hz, 2H), 6.74 (s, 2H), 5.85 (s, 2H), 4.18 (q, J = 7.1 Hz, 4H), 
3.73 (br s, 4H), 2.48 (br s, 4H), 2.35 (s, 3H), 2.13 (s, 6H), 1.83 (br s, 8H), 1.59 (s, 12H), 1.28 (t, J 
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= 7.1 Hz, 6H). 
13
C NMR (300 MHz, MeOD) δ 173.92, 153.45, 149.98, 142.77, 140.44, 135.13, 
134.47, 128.71, 126.69, 125.96, 125.78, 124.72, 96.03, 61.76, 60.58, 33.42, 28.35, 27.41, 22.16, 




]: 628.3745; found 628.3775. 
 Oxazine 6b. Following the general procedure, the mixture of regioisomeric diazenes 4b 
and 5b (140 mg, 0.241 mmol) was cyclized to provide 135 mg of 6b as a deep blue film (85%). 
1
H NMR (400 MHz, MeOD) δ 7.70 (d,=J = 8.0 Hz, 2H), 7.43 (s, 1H), 7.40 (s, 1H), 7.19 (d, J = 
8.0 Hz, 2H), 6.90 (s, 1H), 6.68 (s, 1H), 5.82 (s, 1H), 4.18 (q, J = 7.1 Hz, 2H), 3.80 – 3.64 (m, 
6H), 2.94 (t, J = 5.9 Hz, 2H), 2.48 (br s, 2H), 2.35 (s, 3H), 2.11 (s, 3H), 2.09 – 2.02 (m, 2H), 1.82 
(br s, 4H), 1.58 (s, 6H), 1.37 (t, J = 7.0 Hz, 3H), 1.28 (t, J = 7.1 Hz, 3H). 
13
C NMR (300 MHz, 
MeOD) δ 173.95, 154.47, 153.30, 149.94, 148.86, 142.75, 140.48, 135.05, 134.19, 130.69, 
129.82, 128.72, 126.26, 125.96, 125.76, 124.74, 95.80, 95.31, 61.59, 60.58, 50.26, 46.16, 33.39, 





]: 488.2908; found 488.2897. 
 Oxazine 6c. Following the general procedure, the mixture of regioisomeric diazenes 4c 
and 5c (150 mg, 0.257 mmol) was cyclized to provide 148 mg of 6d as a deep blue film (87%). 
1
H NMR (400 MHz, MeOD) δ 7.68 (d, J = 8.1 Hz, 2H), 7.50 (s, 1H), 7.41 (s, 1H), 7.15 (d, J = 
8.0 Hz, 2H), 6.88 (s, 1H), 6.66 (s, 1H), 4.17 (q, J = 7.1 Hz, 2H), 3.70 (t, J = 5.6 Hz, 4H), 3.57 – 
3.44 (m, 1H), 2.98 (d, J = 6.5 Hz, 1H), 2.95 – 2.90 (m, 2H), 2.47 (br s, 2H), 2.31 (s, 3H), 2.10 – 
1.97 (m, 3H), 1.79 (br s, 4H), 1.53 (s, 3H), 1.45 (s, 6H), 1.36 (t, J = 6.9 Hz, 3H), 1.28 (t, J = 7.1 
Hz, 4H). 
13
C NMR (300 MHz, MeOD) δ 173.90, 154.75, 154.32, 149.04, 148.01, 142.96, 
140.32, 135.02, 134.20, 133.45, 130.84, 129.89, 128.68, 128.13, 125.98, 96.56, 95.30, 60.56, 
59.25, 50.34, 46.62, 44.47, 33.44, 28.40, 27.75, 27.40, 27.16, 25.26, 22.27, 20.90, 20.44, 18.49, 




]: 490.3064; found 490.3079. 
99 
 
 Oxazine 6d. Following the general procedure, diazene 4d (108 mg, 0.236 mmol) was 
cyclized to provide 105 mg of 6d as a deep blue film (90%). 
1
H NMR (400 MHz, MeOD) δ 7.71 
(d, J = 8.2 Hz, 2H), 7.40 (s, 2H), 7.22 (d, J = 8.0 Hz, 2H), 6.68 (s, 2H), 4.03 (t, J = 7.2 Hz, 4H), 
3.66 (q, J = 7.3 Hz, 4H), 3.29 (t J = 7.2 Hz, 4H), 2.36 (s, 3H), 1.35 (t, J = 7.3 Hz, 6H). 
13
C NMR 
(300 MHz, MeOD) δ 159.56, 150.80, 142.51, 140.64, 137.96, 134.66, 128.75, 125.96, 90.43, 




]: 320.1757; found 
320.1764. 
 Oxazine 6e. Following the general procedure, the mixture of regioisomeric diazenes 4e 
and 5e (157 mg, 0.298 mmol) was cyclized to provide 130 mg of 6e as a dark blue film (78%). 
1
H NMR (400 MHz, MeOD) δ 7.51 – 7.41 (m, 2H), 6.74 (s, 1H), 6.72 (s, 1H), 4.05 (q, J = 6.6 
Hz, 4H), 3.75-3.62 (m, 4H), 3.43 (t, J = 6.6 Hz, 2H), 3.31 (m, 4H), 1.92 – 1.80 (m, 2H), 1.77-
1.66 (m, 2H), 1.36 (t, J = 7.3 Hz, 3H). 
13
C NMR (300 MHz, CDCl3) δ 159.96, 159.73, 150.99, 
150.79, 138.22, 137.65, 135.03, 134.58, 126.07, 90.55, 90.43, 53.25, 52.78, 51.08, 46.74, 41.94, 




]: 389.2084; found 
389.2090. 
 Oxazine 6f. Following the general procedure, the mixture of regioisomeric diazenes 4d 
and 5d (1.05 g, 1.88 mmol) were cyclized to provide 1.04 g of 7f as a metallic red amorphous 
solid (94%). 
1
H NMR (400 MHz, MeOD) δ 7.69 (d, J = 8.0 Hz, 2H), 7.24 (s, 2H), 7.16 (d, J = 
8.0 Hz, 2H), 6.60 (s, 1H), 6.56 (s, 1H), 4.14 (q, J = 7.1 Hz, 2H), 3.97 (t, J = 6.3 Hz, 4H), 3.63 – 
3.51 (m, 4H), 3.21 (br s, 4H), 2.42 (t, J = 6.9 Hz, 2H), 2.31 (s, 3H), 1.81 – 1.65 (m, 4H), 1.31 (t, 
J = 7.2 Hz, 3H), 1.26 (t, J = 7.1 Hz, 3H). 
13
C NMR (300 MHz, MeOD) δ 173.95, 159.77, 159.43, 
150.48, 150.37, 143.03, 140.38, 138.04, 137.62, 134.61, 134.32, 128.73, 125.98, 90.66, 90.52, 
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60.54, 53.29, 52.80, 47.00, 42.04, 33.48, 26.50, 26.18, 26.14, 22.28, 20.41, 13.67, 11.35. HRMS 




]: 420.2282; found 420.2291. 
 Oxazine 6g. Following the general procedure, the mixture of regioisomeric diazenes 4g 
and 5g (102 mg, 0.144 mmol) were cyclized to provide 68 mg of 7g as a deep blue residue 
(83%). 
1
H NMR (400 MHz, MeOD) δ 7.69 (s, 1H), 7.41 (s, 1H), 6.92 (s, 1H), 6.64 (s, 1H), 4.18 
(q, J = 7.1 Hz, 2H), 3.74 (m, 5H), 3.60 (dd, J = 14.0, 4.0 Hz, 1H), 3.53 – 3.39 (m, 2H), 3.04-2.91 
(m, 3H), 2.59 (dd, J = 13.6, 4.3 Hz, 1H), 2.47 (m, 2H), 2.12 – 2.02 (m, 2H), 1.86 – 1.68 (m, 5H), 
1.54 (s, 3H), 1.46 (s, 3H), 1.38 (t, J = 7.0 Hz, 3H), 1.28 (t, J = 7.1 Hz, 3H). 
13
C NMR (300 MHz, 
MeOD) δ 173.92, 155.10, 154.26, 149.14, 147.89, 142.73, 140.50, 135.47, 133.15, 131.29, 
131.07, 130.16, 128.95, 128.72, 125.96, 96.65, 95.36, 60.57, 59.00, 55.06, 50.45, 46.60, 41.84, 







]: 570.2632; found 570.2629. 
3.5.6 Tandem Friedel-Crafts Acylation/Cyclization  
 (7a, 7b-f). A small roundbottom flask or sealable vial was purged with argon and charged 
with a magnetic stirbar, activated 4 Å molecular sieves, the diaryl ether (0.50 mmol), anhydrous 
nitromethane (0.80 mL), the acid chloride (4.0 mmol for 7a, 7d, 7e; 2.5 mmol for 7c, 7f), and 
gallium triflate (0.075 mmol). The reaction was heated to 60°C for 16 hours. After cooling to 
RT, the reaction was diluted with dichloromethane (25 mL) and 4% aq. NaHCO3 (30 mL) and 
extracted with dichloromethane (3 x 25 mL). The combined organic layers were dried over 
anhydrous Na2SO4 and then concentrated to crude darkly colored residues. Products were 
purified by flash chromatography (silica gel) using a gradient of 0-10% MeOH/DCM. 
 Xanthene 7a. Following the general procedure, diaryl ether 3d (154 mg, 0.500 mmol) 
was reacted with benzoyl chloride (0.46 mL, 4.0 mmol) to provide 120 mg of 7a as a deep purple 
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residue (56%) and 55 mg of recovered 3d (36%). 
1
H NMR (400 MHz, MeOD) δ 7.70-7.65 (m, 
3H), 7.45-7.40 (m, 2H), 6.96 (t, J = 1.7 Hz, 2H), 6.72 (s, 2H), 3.92 (t, J = 7.8 Hz, 4H), 3.60 (q, J 
= 7.2 Hz, 4H), 3.15 – 3.08 (m, 4H), 1.33 (t, J = 7.3 Hz, 6H). 
13
C NMR (300 MHz, MeOD) δ 
159.69, 159.47, 154.79, 134.33, 133.47, 129.89, 129.43, 129.00, 123.22, 114.41, 90.55, 51.93, 




]: 395.2118; found 395.2122. 
 Xanthene 7c. Following the general procedure, diaryl ether 3d (154 mg, 0.500 mmol) 
was reacted with p- (Me2N)-benzoyl chloride (460 mg, 2.5 mmol) to provide 182 mg of 7c as a 
deep red residue (77%). 
1
H NMR (400 MHz, MeOD) δ 7.30 (d, J = 8.8 Hz, 2H), 7.19 (s, 2H), 
7.02 (d, J = 8.8 Hz, 2H), 6.64 (s, 2H), 3.89 (t, J = 7.8 Hz, 4H), 3.57 (q, J = 7.2 Hz, 4H), 3.17 – 
3.08 (m, 10H), 1.32 (t, J = 7.2 Hz, 6H). 
13
C NMR (300 MHz, CDCl3) δ 159.55, 159.12, 151.82, 
133.76, 131.33, 123.76, 121.12, 120.45, 114.34, 112.31, 90.50, 51.82, 41.21, 39.67, 26.16, 10.91. 




]: 438.2540; found 438.2545. 
 Xanthene 7d. Following the general procedure, diaryl ether 3d (154 mg, 0.500 mmol) 
was reacted with p-fluorobenzoyl chloride (0.47 mL, 4.0 mmol) to provide 106 mg of 7d as a 
deep purple residue (48%) and 63 mg of recovered 3d (41%). 
1
H NMR (400 MHz, MeOD) δ 
7.50 – 7.39 (m, 4H), 6.96 (s, 2H), 6.71 (s, 2H), 3.92 (t, J = 7.8 Hz, 4H), 3.61 (q, J = 7.2 Hz, 4H), 
3.19 – 3.08 (m, 4H), 1.33 (t, J = 7.2 Hz, 6H). 
13
C NMR (300 MHz, CDCl3) δ 159.65, 159.48, 
153.65, 134.46, 131.84, 131.73, 129.45, 123.07, 116.24, 115.94, 114.50, 90.59, 51.95, 41.29, 




]: 413.2024; found 413.2017. 
 Xanthene 7e. Following the general procedure, diaryl ether 3d (154 mg, 0.500 mmol) 
was reacted with 2,3,4,5,6-pentafluorobenzoyl chloride (0.57 mL, 4.0 mmol) to provide 138 mg 
of 7e as a green/blue solid (53%) and 61 mg of recovered 3d (40%). 
1
H NMR (400 MHz, 
MeOD) δ 7.06 (s, 2H), 6.77 (s, 2H), 3.97 (t, J = 7.6 Hz, 4H), 3.64 (q, J = 7.2 Hz, 4H), 3.27 – 
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3.10 (m, 4H), 1.35 (t, J = 7.3 Hz, 6H). 
13
C NMR (300 MHz, MeOD) δ 159.87, 159.45, 145.99, 
142.80, 140.39, 137.53, 135.81, 121.90, 114.53, 107.73, 90.91, 52.21, 41.46, 26.09, 10.97. 




]: 485.1647; found 485.1663. 
 Xanthene 7f. Following the general procedure, diaryl ether 3d (154 mg, 0.500 mmol) 
was reacted with 1-methyl-1H-imidazole-2-carbonyl chloride (361 mg, 2.5 mmol) to provide 78 
mg of 7e as a deep blue-purple solid (36%) and 68 mg of recovered 3d (44%). 
1
H NMR (400 
MHz, MeOD) δ 7.95 (d, J = 1.9 Hz, 1H), 7.92 (d, J = 1.9 Hz, 1H), 6.85 – 6.81 (m, 4H), 4.01 (t, J 
= 7.5 Hz, 4H), 3.80 (s, 3H), 3.67 (q, J = 7.3 Hz, 4H), 3.26 – 3.18 (m, 4H), 1.35 (t, J = 7.3 Hz, 
6H). 
13
C NMR (300 MHz, CDCl3) δ 159.98, 159.36, 138.08, 136.83, 130.75, 125.95, 122.11, 





]: 399.2179; found 399.2197. 
 Xanthene 7b. Diaryl ether 3f (1.15 g, 2.81 mmol) in anhydrous dichloromethane (30 
mL) was treated dropwise via a pressure equalizing addition funnel with a solution of 
trifluoroacetic anhydride (0.87 mL, 6.2 mmol) in 20 mL of DCM over the course of 
approximately 2 hours. After addition was complete, the reaction was left to stir at room 
temperature overnight. The next day, the deep blue reaction mixture was quenched by the 
addition of 4% aqueous NaHCO3, then extracted with dichloromethane (3 x 30 mL). The 
combined organic layers were dried over Na2SO4 and then concentrated under reduced pressure. 
The crude product was purified by flash chromatography (0-10% methanol/dichloromethane) to 
provide 1.40 g of 7b as a green/blue solid (83%). 
1
H NMR (400 MHz, MeOD) δ 7.72 (s, 2H), 
6.76 (s, 1H), 6.74 (s, 1H), 4.15 (q, J = 7.1 Hz, 2H), 4.01 (td, J = 7.4, 3.7 Hz, 4H), 3.69 – 3.58 (m, 
4H), 3.32-3.25 (m, 4H), 2.44 (t, J = 7.0 Hz, 2H), 1.86 – 1.68 (m, 4H), 1.35 (t, J = 7.3 Hz, 3H), 
1.26 (t, J = 7.1 Hz, 3H). 
13
C NMR (300 MHz, CDCl3) δ 173.99, 159.95, 159.85, 159.51, 159.12, 
103 
 
136.61, 136.27, 120.92, 120.84, 120.77, 111.85, 111.67, 91.49, 91.33, 60.53, 52.87, 52.36, 46.61, 





487.2203; found 487.2205. 
3.5.7 Dye Characterization 
 
 All dyes were HPLC purified (C18 semi-prep, MeCN/H2O) prior to characterization. 
Measurements were performed in DI water with the exception of 7c, which required 50 mM HCl 
for fluorescence. Molar extinction coefficients were determined using the Beer-Lambert law by 
measuring absorbances of known concentrations of dye solution. Fluorescence quantum yields 
were determined using the comparative method using Nile Blue and zinc-phthalocyanine as 
reference standards.
27
 In brief, fluorescence emission was compared to that of a quantum yield 
reference solution under the same excitation and collection conditions. 
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Chapter 4  




4.1 Chapter Overview 
 
 Compared to organic dyes, fluorescent nanomaterials possess superior photophysical 
properties and are ideal fluorophores for SM imaging. In particular, fluorescent nanodiamonds 
(FNDs) are well suited for live cell imaging due to their biocompatibility. FNDs are 
extraordinarily photostable, allowing fluorescence imaging on unprecedented time scales. In 
addition, FNDs have other optical sensing capabilities that can be used for multi-color imaging, 
probing molecular orientation, and measuring magnetic field. The application of FNDs in 
biological studies would revolutionize our ability to investigate molecular mechanisms at the SM 
level, but the adoption of these fluorophores in bioimaging has been limited by the ability to 
chemically modify the FND surface for targeted labeling of biomolecules.  
 This chapter focuses on the development of FNDs for SM imaging in live cells. A 
proposal to functionalize FNDs with TMP is presented, allowing the TMP-tag to label specific 
biomolecules with FND fluorophores for fluorescence imaging applications. We explore 
methods to size select for small NDs that are less likely to interfere with biomolecular function 
during labeling. Next, we investigate chemical methods to modify the ND surface that would 
enable straightforward covalent conjugation with TMP ligands. Finally, we attempt live cell 
extracellular labeling and imaging of NDs using the TMP-tag. I am the main contributor of this 
work. I synthesized and characterized the silanized NDs with assistance from Ophir Gaaton and Abe 
Wolcott. Yongjun Li synthesized TMP-functionalized ND while I performed the live cell imaging 
experiments of TMP-NDs.  
4.2 Introduction 
 
 FNDs have emerged as an interesting class of material for biological imaging because of 
their unique structural, chemical, biological, and optical properties. NDs are nanometer sized 
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diamond crystals whose fluorescence arises from defect centers in the diamond crystal lattice. In 
particular, the red fluorescence and other optical properties of the nitrogen vacancy (NV
-
) center 
defect are appealing for live cell SM imaging. However, the natural occurrence of NV
-
 center 
defects in NDs too low for general fluorescent imaging applications.
1,2
 Consequently, methods 
have been created to implant NV
-
 centers and produce FNDs.
3-7
 Because the NV
-
 center is 
housed within the diamond lattice, manipulation of these fluorophores requires control over ND 
chemical properties. Thus, techniques to modify the surface chemistry of NDs for targeted 
biological labeling and applications have also been developed.
8
 However, the efficiency and 
costs of these methods varies significantly based on the synthetic origin of the NDs due to 
differences in size, shape, and lattice purity. For successful applications in live cell SM imaging, 
NDs must be fluorescent, small, and functionalized for targeted labeling of biomolecules.  
4.2.1 Types and Synthesis of Nanodiamonds  
 
The first synthesized, and most commonly used, NDs were created by the denotation of 
carbonaceous material with negative oxygen balance (oxygen content lower than necessary for 
complete combustion) under high pressure.
9
 These NDs are called detonation nanodiamonds 
(DNDs) or ultradisperse diamonds (UDDs). While first produced by Soviet researchers in the 
1960s, DNDs did not gain broader awareness within the international scientific community until 
researchers at Los Alamos reported their synthesis in the late 1980s.
10,11
 DNDs are typically      
4-5 nm in size, making them smaller and possessing narrower distributions compared to NDs 
synthesized from other methods. However, DNDs require extensive purification to remove metal 
impurities produced from the ignition source and reaction chamber wall.
12
 In addition, DNDs are 
especially prone to aggregation, requiring milling methods that introduce additional 
contaminants to stabilized colloidal DND solutions.
13,14
 Most importantly, DNDs are synthesized 
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with relatively few lattice impurities, which are critical for creating fluorescent NV
-
 defect 
centers. As a result, DNDs have been typically studied for non-fluorescent applications. DNDs 
have been investigated for industrial applications, particularly as additives for lubricants and 
composite materials.
15,16
 In addition, DNDs are being developed as carriers for poorly water 
soluble drugs due to their high surface area, large adsorptive capacity, and biological inertness.
17
 
 After DNDs, the second most common type of NDs is formed using high pressure and 
high temperature (HPHT) synthesis. Mimicking the conditions for natural diamond formation, 
HPHT diamonds are produced by applying high pressure and temperature to a carbon source. 
High energy ball milling of HPHT diamond microcrystals yield HPHT NDs of varying sizes. 
The major advantage of HPHT NDs is that they can be synthesized to include high nitrogen 
impurities by using starting material with high nitrogen concentrations.
18
 The high nitrogen 
content of HPHT NDs allows for the implantation of NV
-
 centers around existing nitrogen while 




 As a result, FNDs are usually 
created from HPHT NDs. However, HPHT NDs have some notable drawbacks in comparison to 
DNDs. The size distribution of HPHT NDs is not as narrow as DNDs and the yield of NDs 
smaller than 10 nm is very low.
19
 Also, the high nitrogen content can create multiple NV
-
 centers 
per diamond, which can lead to interference with certain sensing capabilities.
20
 While there are 
other methods of synthesizing high purity NDs with single NV
-
 centers using chemical vapor 
deposition, these methods are very costly.
20,21
 All in all, the relative ease and low cost of creating 
NV
-
 centers in HPHT NDs makes them the most common type of diamond used for FNDs.  
4.2.2  Nanodiamond Nitrogen Vacancy (NV-) Centers 
 
 The methodology for the creation and implantation of NV
-
 centers in HPHT NDs has 
significantly improved the production yield of FND for fluorescence imaging applications. 
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Nitrogen impurities must be accompanied by a vacancy in the diamond crystal lattice to form the 
fluorescent NV
-
 center. However, the nitrogen impurities in HPHT NDs are usually found in NV
-
 
centers. To generate the NV
-
 center, vacancies in the diamond lattice surface are produced used 
high energy electron or helium beam irradiation. Vacuum annealing of NDs migrates the 




 One of the challenge to 
generating small (<10 nm) FNDs is that the probability of containing nitrogen and receiving 
sufficient radiation for vacancy formation is lower for smaller crystals. However, FNDs as small 
as 5 nm have been reported to contain NV
-
 centers and are particularly useful for biological 





 center has unique optical properties beyond conventional fluorescence that can 
be used for imaging and sensing. Containing six electrons, the NV
-
 center is formed by three 
unpaired lone electrons from the lattice vacancy, two nitrogen lone pairs electrons, and an 
additional electron usually captured from the lattice from nitrogen donors (Figure 4-1a). The NV
-
 
center produces infrared fluorescence centered at 680 nm after excitation from the triplet ground 
state (
3




 Excitation from the 
ms = ± 1 spin sublevel, however, has a greater likelihood of intersystem crossing to the singlet 
1
A 
state, which nonradiatively decays to the 
3
A ms=0 state. As a result, resonant microwave 
radiation that induces ms=0 to ms= ± 1 transitions reduces fluorescence by as much as 30%.
24
 
Application of a magnetic field splits the ms= ±1 states, changing the resonant microwave 
wavelength (Figure 4-1d). The ability to readout ms spin state transitions by reductions in 
fluorescence is called optically detected magnetic resonance (ODMR) and can be used to 
determine magnetic field strength.
25
 When used with a known magnetic field, the orientation of 
the NV
-
 center can also be determined.
26





 centers based on different strain in the lattice structure can be used to differentiate FNDs 
and may be useful for multicolor imaging.
26
 Taken together, the fluorescence from NV
-
 centers 
can be used for both imaging and sensing applications in biological research.  
 
Figure 4-1: Diamond nitrogen vacancy (NV
-
) defect center 
 a) Atomic representation of the NV- center containing a nitrogen impurity and accompanying vacancy in the crystal 
lattice structure. b) Fluorescence emission of a single NV- center. c) Energy level diagram of the NV- center. d) 





 Importantly, the NV
-
 center is shielded by the diamond lattice, leaving it unaffected by 
changes to the FND surface and surrounding environment. As a result, the optical properties of 
the NV
-
 center remain highly preserved even under intense irradiation. The NV
-
 center is 
functionally immune to photobleaching and this remarkable photostability has enabled imaging 
resolution under 5 nm using super resolution stimulated emission depletion (STED), the highest 
resolution ever achieved using optical microscopy.
23,27-30
 In addition, the NV
-
 center has an 
unusually long fluorescence lifetime of nearly 15 ns in comparison to organic fluorophores of 1-
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4 ns, making it a useful marker for fluorescence lifetime imaging.
31
 Although smaller NDs have 
higher probabilities of having NV
-
 centers close to the surface that can be subjected to 
environmentally induced blinking, this photophysical behavior could be exploited for super 
resolution imaging using STORM.
32
 Overall, the surrounding environment and surface chemistry 
of FNDs have relatively little impact on the fluorescence of NV
-
 centers, making FNDs very 
attractive fluorophores for SM imaging in live cells. Thus, methods to functionalize the ND 
surface for targeted bioimaging have also been developed.  
4.2.3 Chemical Modification of the Nanodiamond Surface 
  
 Successful application of FNDs for live cell SM imaging requires the ability to direct 
FNDs to label specific biomolecules. At the same time, individual FNDs must also be stabilized 
in solution as their tendency to aggregate could cause adverse impacts to biological systems and 
affect the ability to perform SM imaging and measurements. Additionally, reduced aggregation 
increases the accessibility of ND surfaces for covalent conjugation of targeting molecules. While 
successful functionalization of HPHT ND surfaces has been achieved, the chemistry of DND 
surfaces is more widely reported and exhibits greater reaction diversity.
8
 Interestingly, different 
types of NDs have distinct surface properties and characteristics, limiting the applicability of 
surface chemistry from DNDs to functionalize HPHT NDs.
8,33,34
 It is hypothesized that DNDs 
are easier to functionalize because their smaller size and more spherical shape results in 
comparatively more edges that host chemically reactive functional groups. Nevertheless, a 
number of strategies to functionalize the HPHT ND surface have been developed. 
22,35,36
 
 Regardless of the surface chemistry being performed, nearly all chemical modification of 
HPHT NDs begins with surface oxidation (Figure 4-2). This step removes outer graphitic 
material and amorphous carbon that is formed during ball milling of ND production, enhancing 
113 
 
FND fluorescence. In addition, oxidation instills various oxygen-containing functional groups 
that can be used for chemistry, including ketones, alcohols, acid anhydrides and carboxylic 
acids.
36
 Oxidation was first reported using washes with strong acids and bases, but more 
environmentally friendly and convenient methods using air oxidation in tube furnaces have been 
reported.
36
 Early reports determined that carboxylic acids were the predominant functional group 
on the oxidized ND surface and could be covalently coupled to amines.
37,38
 Reduction of the 
carboxylic moieties to hydroxyl groups also allows coupling to functionalized silane reagents 
that can be later modified.
39,40
 Overall, steady progress is being made towards developing robust 





Figure 4-2: Changes to HPHT ND appearance during synthesis and oxidation 
Bulk HPHT diamond contains approxi atel  100−200 ppm of nitrogen that produces a yellow color. Ball milling 
yields nanometer sized diamond crystals ranging in size from 5 to 50 nm with a black color originating from 
graphitic and amorphous carbon produced during the milling process. Aerobic oxidation of HPHT NDs removes 
graphitic and amorphous carbon, lightening the ND powder color with increasing temperatures. Figure adapted from 




4.2.4 Nanodiamond Labeling with the TMP-tag  
  
 The advances in surface chemistry of HPHT NDs have made targeted cell labeling and 
imaging with FNDs possible. While a number of studies have used molecules adsorbed to the 
ND surface for targeted labeling, there are few examples using covalent attachments.
4,42
 The first 
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report of covalent surface modification of NDs for cellular imaging was performed in 2007, 
where 100 nm NDs were conjugated to human growth hormone and labeled extracellular growth 
hormone receptors. While not using FNDs, the study used Raman imaging based on the carbon 
sp
3
 peak at 1332 cm
-1
 to visualize the NDs.
43
 The use of FNDs for targeted fluorescent cell 
imaging was reported one year later. FNDs were conjugated to transferrin and used to label 
extracellular transferrin receptors.
44
 In both experiments, the carboxylic acids on the surface of 
oxidized HPHT NDs had been covalently linked to their targeting biomolecules using EDC (1-
Ethyl-3-(3-dimethylaminopropyl)carbodiimide) coupling to amines. These initial promising 
experiments demonstrated the compatibility of NDs for live cell imaging, but were limited by 
targeting receptors based on the identity of the ND-conjugated molecule. Recently, streptavidin 
functionalized FNDs were used to label biotin-antibodies via biotin-streptavidin binding. These 
FND-antibody complexes were then used to label extracellular carbohydrate receptors for live 
cell florescent imaging.
45
 While biotin-streptavidin labeling is robust and has high affinity, it is 
poorly suited for direct cellular labeling due to cross-reactivity with endogenous biotin. By using 
chemical tags, such as the TMP-tag, direct and single step biomolecule labeling of FNDs to 
multitude of different extracellular and intracellular proteins could be achieved.  





Figure 4-3: Fluorescent ND protein labeling strategy with the TMP-tag.  
Covalent functionalization of NDs with TMP ligands allows ND labeling of protein of interest (POI) with a eDHFR 
fusion via the selective and high affinity binding between eDHFR and TMP. The photostability of NDs allow 
labeled proteins to examine visualized with fluorescent SM imaging.  
 
 Labeling FNDs using the TMP-tag can improve the ability to use these fluorophores for 
live cell imaging applications (Figure 4-3). By covalently linking FNDs to TMP, the FND can 
label proteins of interest using an eDHFR fusion with the TMP-tag. Although the FND may be 
relatively large compared to the protein, the high affinity binding between TMP-eDHFR 
interaction should facilitate effective protein labeling. The TMP-tag has been used with magnetic 
iron oxide nanoparticles for magnetic field sensing while other chemical tags have successfully 
labeled proteins with nanomaterials for fluorescent imaging.
46-48
 Additionally, the solubility of 
the TMP moiety may help stabilize FND in solution and reduce aggregation. The synthesis and 
application of a TMP-functionalized FND for live cell imaging with the TMP-tag would 
significantly broaden our ability to perform SM imaging and open opportunities for magnetic 
sensing, orientation sensing, and molecular tracking.  
4.3  Experimental Methods  
4.3.1 Size Separation 
 
 Colloidal aqueous monocrystalline ND solution with size dispersity of 0-30 nm and 
median size of 18 nm suspended were obtained from Microdiamant. NDs were diluted to a 
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concentration of 5 mg/mL in water and centrifuged using Avanti JE or Proteome Lab XL-A 
Beckman Coulter centrifuges. Suspended NDs in the supernatant were taken as the size separated 
fraction. Sizes of NDs were analyzed using TEM images of 60-100 NDs and DLS of 1 mL of 0.1 
mg/mL solutions. Size separation of NDs was also attempted using dialysis with 20K MWCO 
Slide-A-Lyzer dialysis cassettes (Thermo Fisher) and 100K MWCO protein concentrators 
(Pierce). Gel filtration was conducted using Sephacryl S200HR (GE Healthcare Life Sciences) in 
a gravity flow column.  
4.3.2 Chemical Conjugation 
  
 Monocrystalline ND powder with size dispersion of 0-30 nm and median size of 18 nm 
were obtained from Microdiamant. 200 mg of NDs were oxidized in a tube furnace at 575°C for 
2 hours or 475°C for 24 hours. NDs were then washed in 150 mL of 1:9 HNO3: H2SO4 at 80°C 
for 24 hours, 1 M NaOH at 80°C for 24 hours, and 0.1 M HCl at 80°C for 24 hours. Synthesis of 
hydroxylated and aminosilanized NDs was carried out according to literature procedures.
8,38
 
Synthesis of alkyne coupled NDs was carried out using a modified procedure from the 
literature.
22
 10 mg of NDs and 200 L of propargylamine (Sigma) were dissolved in 5 mL of 
water with 8 mg of N-(3-dimethylaminopropyl)-N′-ethyl-carbodiimide hydrochloride (Sigma) 
and 6 mg of N-hydroxysuccinimide (Sigma). The reaction was stirred at room temperature for 24 
hours. NDs were washed thoroughly with DI water and centrifuged before use.  
 TMP-functionalized ND were prepared using unoxidized NDs. Boron reduction and 
silanization with APTES was carried out as previously described.
49
 The resulting ND-NH2 (20 
mg) was suspended in DMF (5 mL). The suspension was sonicated for 30 min. With stirring and 
under N2, 20 mg of TMP-COOH was added to the suspension, followed by 20 mg of (1-Ethyl-3-
(3-dimethylaminopropyl)carbodiimide) (EDC·HCl), 2 mg of 1-Hydroxy-7-azabenzotriazole 
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(HOAt) and 200 L N,N-Diisopropylethylamine (DIEA). The final suspension was stirred at 
room temperature for 3 days under N2. Then the suspension was transferred to 1 mL centrifuge 
tubes (5) and centrifuged at 10 k rpm for 20 min. The top layer (solvent) was removed and 1 mL 
of DMF was added to each centrifuge tube. Stir or sonicate to re-disperse the precipitate in DMF. 
Then the suspension was centrifuged again. The process was repeated for 5 times. Then 1 mL of 
methanol was added to each centrifuge tube and centrifuged at 10 k rpm for 20 min. The process 
was repeated 15 times. After removing methanol, the solid was dried under vacuum for 12 hours.  
4.3.3 Nanodiamond Characterization 
  
 Dynamic light scattering and zeta potential measurements of ND solutions of 0.1 mg/mL 
were measured in single-use polystrene cuvettes or single use zeta potential capillary cells 
(Malvern Instruments) on a Malvern Zetasizer Nano-ZS. All measurements were taken at room 
temperature using refractive index of bulk diamond for reference (n = 2.419). Measurements 
were taken in triplicate and weighted by intensity to account for greater light scattering by larger 
particles.  
 Infrared spectroscopy measurements was performed with 1 mg of ND mixed with KBr 
(0.5 g, <8 wt %). The NDs and KBr were ground in a mortar and pestle inside a nitrogen 
glovebox. The mixture was loaded into the high-temperature stage of a Thermo Nicolet 6700 
FTIR with a Praying Mantis attachment. The chamber was sealed under partial vacuum (>600 
Torr) and placed within the beam path of the DRIFTS cell. The chamber was then connected to 
another vacuum pump fitted with an liquid N2 cold trap and evacuated to <10
–4
 Torr. KBr blanks 
were taken in an identical manner for each temperature, and all data were processed by 
algorithmic baseline correction followed by the Kubelka–Munk transformation so that spectral 
intensity was proportional to concentration. 
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 Electron microscopy of NDs was performed by drying 0.001 mg/mL ND solutions on 
holey carbon 300 mesh copper electron microscopy grids (Ted Pella). Images were taken on a 
JEOL 100CX-II microscope.   
4.3.4 Cell Imaging  
 
 A vector for pDisplay-eDHFR-GFP was created for co-labeling of extracellular TMP-ND 
conjugates with GFP. The gene encoding GFP was amplified using PCR from the H2B-GFP 
vector (Addgene Cat#11680) using primers 5' -GAACTCTCACAGCTATTGCTTTGAGA 
TTCTGGAGCGGCGGGATCCACCGGTCGCCACCATG -3' and 5'- CATTCAGATCCTCT 
TCTGAGATGAGTTTTTGTTCGTCGAC CTTGTACAGCTCGTCCATGC - 3'. The backbone 
including the gene for pDisplay-eDHFR was amplified using PCR with the primers 5'- 
CCGCCGCTCCAGAATCTCAA-3' and 5'- GTCGACGAACAAAAACTCATC-3' . The final 
pDisplay-eDHFR-GFP was assembled by Gibson Assembly (New England Biolabs). 
50
  
 HEK 293T cells were cultured in Dulbecco's Modified Eagle Medium (DMEM) 
w/ glutamine (Gibco #11995) with 10% v/v fetal bovine serum (FBS) and 1% v/v 
Pen/Strep. All cells were maintained under 5% CO2 at 37°C. Cells were plated in 6 well plates at 
500,000 cells per well 12 hours before transfection. Cells were transfected with the pDisplay-
eDHFR-GFP expression plas id (2 μg per well) using Xtre e Gene HP (Roche). 12 hours after 
transfection, cells were replated in a 1:2 ratio onto 35 mm Fluorodish cell culture dishes. Cells 
were incubated with 1 M of TMP-Alexa647 or 2 ng of TMP-NDs for 1 hour, followed by two 
washes with fresh media before imaging. Confocal images were obtained using an Zeiss LSM 




4.4 Results and Discussion 
 
 To develop FNDs as fluorophores for applications with the TMP-tag requires controlled 
manipulation of FND size and surface characteristics. The ability to isolate small FNDs is critical 
for selecting fluorophores whose size is less likely to impact the function of tagged 
biomolecules. The surface of the FND must also be covalently modified to include TMP for 
selective labeling with the TMP-tag. Ideally, the FNDs would be monofunctionalized to prevent 
labeling and aggregation of multiple TMP-tagged targets around one fluorophore. However, 
methods to ensure monofunctionalization were not explored due to the overall difficulty of 
performing and confirming surface modifications. For our work, we used HPHT NDs without 
implanted NV
-
 centers due to their commercial availability. While these NDs did not undergo 
high energy ionization and vacuum annealing during the NV
-
 center production process, the 
surface properties of NDs before and after NV
-
 implantation are believed to be very similar. We 
develop methods to isolate small NDs while concurrently exploring surface chemistry methods 
to functionalize NDs with TMP. We also attempt live cell labeling of FNDs with the TMP-tag.  
4.4.1 Size Separation 
 
 Biochemical methods of protein purification and separation were employed for size-
based separation of colloid unoxidized NDs ranging in size from 0-30 nm. Because complex 
mixtures of proteins can be separated by size and molecular weight in biochemistry, these 
methods had attractive potential for separating NDs with relatively large size distributions. First, 
dialysis was attempted to select for NDs too large to diffuse across the porous membrane. 
However, no changes in size distribution between undialyzed and dialyzed ND solutions were 
observed. Gel filtration was then attempted to fractionate NDs by size, but also failed to produce 
fractions with measurable differences in size distributions. Centrifugation and ultracentrifugation 
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of NDs in solution produced two fractions consisting of smaller NDs suspended in the 
supernatant and a pellet consisting of larger NDs. The looseness of the ND pellet prevented 
complete separation between pelleted and supernatant NDs, but the supernatant NDs were easily 
separable from the pellet and measured for size distribution using TEM images and DLS analysis 
(Figure 4-4 and Table 4-1).  
 
 
Figure 4-4: Transmission Electron Microscopy of Size Separated Nanodiamonds 
Transmission electron microscopy of ND still in suspension after centrifugation, illustrating distributions of smaller 
ND sizes with greater centrifugation. a) Starting ND material 0-25 nm, b-f) Size selected fractions after 
centrifugation at b) 15,000 x g for 1 hour, c) 15,000 x g for 2 hours, d) 15,000 x g for 3 hours, e) 100,000 x g for 30 








Table 4-1: Size and distribution of NDs separated by centrifugation determined using DLS 
and TEM analysis  
 
DLS Analysis TEM Analysis 
 Median (nm)  Range (nm) Median (nm) Range (nm) 
Starting Material 18.2 11.7 - 58.8 9.7 2.2 - 31.8 
15,000 x g for 1 hour 11.17 7.5 - 37.8 7.7 1.9 -15.9 
15,000 x g for 2 hours 10.1 6.5 - 32.7 6.1 2.4 - 13.7 
15,000 x g for 3 hours 8.72 6.5 - 32.7 6.4 2.3 - 13.6 
100,000 x g for 30 minutes 6.5 4.85 - 21 - - 
100,000 x g for one 1 hour 4.85 3.12 - 15.7 2.4 1.8 - 4.3 
 
  
 Increasing centrifugation time and speed yields NDs with smaller median size and more 
narrow size distribution as observed from the TEM images and in the DLS measurements 
(Figure 4-4 and Table 4-1). The TEM images also illustrate the shape irregularity of the NDs, 
highlighting the lower accuracy of DLS size measurements that use spherical shape assumptions. 
While the size distribution of the starting material measured from DLS is 11.7 - 58.8 nm, the 
TEM images report the distribution to be 2.2 - 31.8 nm, which is much closer to the 
manufacturer's reported distribution of 0 - 30 nm. Nevertheless, both DLS measurements and 
TEM images exhibit the general trend of decreasing size with greater centrifugation. 
 Both DLS and TEM measurements also illustrate that shorter periods of 
ultracentrifugation were more effective than longer periods of normal centrifugation for isolating 
smaller NDs (Figure 4-4 and Table 4-1). Increasing centrifugation at 40,000 x g from two to 
three hours did not yield as substantial of change in median size and size distribution as observed 
in the first or second hour of centrifugation. However, thirty minutes of ultracentrifugation at 
100,000 x g isolated NDs with smaller size and size distribution than those obtained using 
normal centrifugation. Further exploration of centrifugation speed and time could produce more 
ND solutions with more varied median size and size distributions.  
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 The surface chemistry of the unoxidized NDs may explain the difficulty applying 
biochemical size separation methods successfully. These NDs are covered in graphitic material 
and are stabilized in solution through weak electrostatic interactions. In comparison, the surface 
of most biomolecules is highly hydrophilic, making these proteins soluble in aqueous solutions. 
As a result, the interaction of NDs with separation materials developed for proteins could be 
quite different. To date, there are no other reports of HPHT ND size selection through methods 
other than centrifugation, which is consistent with the difficult experienced here testing other 
methods.  
 Effective separation of the NDs to smaller sizes required increasingly higher 
centrifugation speed rather than time. This is likely due to the need for greater forces to 
overcome electrostatic stabilization and pull down the NDs from suspension. Similar results 
were observed using oxidized NDs, with the application of gradient during centrifugation 
improving the separation resolution by slowing the progress of pulled down NDs. 
19,51
 All in all, 
centrifugation is a fast and straightforward method to isolate small NDs from size disperse 
solutions for biological applications.  
4.4.2 Nanodiamond Surface Modification  
    
 Following methods previously published in the literature, two surface functionalization 
schemes based on carboxylic acid modification were attempted for oxidized 0 - 30 nm NDs 
(Figure 4-5).
35,36,52
 Rather than directly conjugate TMP to NDs in a single step, two multistep 
synthetic routes were developed that incorporate the production of functionalized ND 
intermediates that can be modified with robust and well-established chemistry. The synthesis of 
these ND intermediates allows conjugation to other biomolecules other than just TMP, 
broadening the application of NDs for other biological tagging applications. Even more 
123 
 
importantly, these intermediates include a limited number of chemical groups that can be 
detected using FT-IR for straightforward confirmation of covalent bond formation. The first 
method covalently conjugates propargylamine to ND carboxylic acids using EDC coupling, 
forming an amide bond whose presence can be verified by FT-IR (Figure 4-5a). The 
incorporated alkyne can also be detected through FT-IR to evaluate successful coupling and later 
used to react with azide-TMP or another azide-containing biomolecules. The second method 
reduces ND surface carboxylic acids to hydroxyls using borane reduction (Figure 4-5b). These 
hydroxy groups are coupled to a aminofunctionalized silane reagent, such as APTES ((3-
aminopropyl)triethoxysilane) (Figure 4-5c), whose successful conjugation can be determined by 
the presence of silicon-oxygen vibrational stretches in FT-IR. The incorporated amine is also 
detectable using FT-IR and allows later EDC coupling with carboxylic acid-TMP or other 















Figure 4-5: Schemes for nanodiamond functionalization 
Synthetic schemes for ND functionalization based on carboxylic acid modification. a) EDC coupling of 
propargylamine with ND carboxylic acids yield FT-IR detectable amide and alkyne functional groups. The alkyne 
can be modified with any number of azide compounds. b) Boron reduction of ND carboxylic acids yield 
hydroxylated NDs. c) Hydroxylated NDs are silanized with (3-aminopropyl)triethoxysilane, producing FT-IR 
detectable silicon-oxygen bonds and amine groups. The amine functionalized NDs can be coupled to any number of 
carboxylic acid compounds.  
 
 The starting material of oxidized NDs was evaluated for the presence of carboxylic acid 
groups upon which the proposed surface modification schemes are dependent. 0-30 nm NDs 
were oxidized for two hours at 575°C in a tube furnace to remove graphitic material and 
subjected to acid-base-acid washing that has previously been reported to solubilize and 
carboxylate the NDs surface.
36,53
 The FT-IR spectrum of this material reveals few features that 
indicate the presence of carboxylic acids (Figure 4-6a). Most notably, the characteristic 
carboxylic acid ketone and hydroxyl peaks at 1600-1700 cm
-1
 and 3500 cm
-1
, respectively, are 
not present. Instead, there is broad and weak absorption at 1410 cm
-1
 that could possibly be 
attributed to C-H stretches of hydrogenated surface carbons. The lack of carboxylic acids is 
further supported by the results of attempted EDC coupling with propargylamine (Figure 4-6b). 
Although additional peaks are present in the FT-IR spectra after the undergoing the reaction, the 
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characteristic peaks for amide bond formation are missing. In addition, no alkyne signal in the 
2200 cm
-1
 region is observed. Taken together, the lack of distinctive features in the FT-IR 
spectra of these NDs indicates that carboxylation and functionalization by EDC coupling was 





Figure 4-6: FT-IR of nanodiamond after surface modification treatments 
Diffused Reflectance Infrared Fourier Transform (DRIFT) of NDs in KBr and schematics of their expected 
products. a) NDs oxidized at 575°C for 2 hours used as starting material for all reactions, b) NDs after coupling of 
propargylamine with ND-carboxylic acids activated with EDC in water, c) NDs after boron reduction in THF, and d) 
Boron reduced NDs after aminosilanization with APTES in MeOH.  
  
 Despite the lack of confirmed carboxylic acids on the initial starting material, boron 
reduction of these NDs appear to produce oxygen-containing hydroxy and ketone groups (Figure 
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4-6c). The broad peak between 3600-3100 cm
-1
 that suggests the presence of hydroxyl groups. In 
addition, there is also a strong peak at 1600 cm
-1
 that likely corresponds to a ketone. The origin 
of these absorbances is unclear if in fact carboxylic acids are not present on the ND starting 
material. One possibility is that hydroxy groups are produced from boron reduction of surface 
alkenes that lack characteristic C=C vibrational stretches in the starting material due to their 
confinement on the surface. More likely, is that the hydroxyl absorbance originates from 
adsorbed water to the ND surface rather than surface functional hydroxy groups.  
 Silane coupling to hydroxylated NDs would help confirm the presence of surface 
hydroxyl groups. If hydroxylated NDs had undergone successful reaction with an aminosilane, 
the product is expected to produce characteristic FT-IR peaks in the 3500-3100 cm
-1
 range and at 
1100 cm
-1
, corresponding to stretches from the primary amine and silicon-oxygen, respectively. 




, and broad absorbances between 
3500-2700 cm
-1
 and 1500-1000 cm
-1 
(Figure 4-6d) The broad peak at 3500-2700 cm
-1
 is likely 
attributed to adsorbed water on the surface and may obscure any peaks from amine groups. 
While the broad 1500-1000 cm
-1
 peak could be due to silica, previous reports of silanizations 




 Without the characteristic peaks from the 
aminosilane on the FT-IR, the success of silanization and previous hydroxylation cannot be 
concluded.  
 Overall, the FT-IR data on the ND chemical surface modifications is not convincing of 
the covalent bond formation to the ND surface. Given the possibility that there are not carboxylic 
acids in the starting material, it is in retrospect not surprising that the reactions did not yield 
conclusive ND functionalization. The reliance on carboxylic acids for ND surface chemistry 
limits the ability to functionalize the surface, especially if those functional groups are not present 
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or present in very low numbers on the ND surface. Indeed, the lack of carboxylic acids on the 
oxidized ND surface is consistent with findings from other groups regarding HPHT NDs.
41
 In 
addition, reports of successful carboxylic acid derivatization with NDs has been limited to a few 
research groups, so the presence of these functional groups may not as abundant as initially 
reported.
35,37,45
 The use of HPHT NDs from different manufacturers may also create 
discrepancies in ND surface properties. Differing milling techniques that produce NDs with 
more or fewer edges that are hypothesized to host functional groups. While HPHT NDs between 
different manufacturers has not yet been compared, doing so could reveal the chemical basis for 
these different reactivities.  
 While changes in the FT-IR spectra are observed between reactions, these absorbances 
could be due to adsorption of reagents to the ND surface rather than covalent modification. 
Although the NDs were thoroughly washed, non-specific adhesion could have withstood 
repeated washings, especially if contained within larger ND aggregates. Improved ND dispersion 
through ultrasonication during reactions may reduce aggregation and may improve overall ND 
reactivity by providing greater exposure to limited surface functional groups. At the same time, if 
the strength of these nonspecific interactions is high enough to resistant washing and other 
methods of dispersion, then using nonspecific adsorption of targeting molecules may be explored 
as an alternative method to associate NDs with specific biomolecules. 
4.4.3 Nanodiamond Cell Labeling and Imaging  
 
 Despite the uncertainty of surface functionalization, the synthesis of TMP conjugated 
NDs was attempted for live cell labeling with the TMP-tag. 0-30 nm unoxidized NDs underwent 
boron reduction and silanization with APTES (Figure 4-5b,c). TMP-NDs were then prepared by 
EDC coupling to a carboxylic acid TMP (Figure 4-7). Comparison of the FT-IR between 
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conjugated TMP-NDs and a mixture of TMP and NDs reveals several additional absorbance with 
the TMP-NDs that are suggestive of covalent bond formation between the TMP moiety and the 




Figure 4-7: FT-IR of TMP-functionalized nanodiamonds 
Diffused Reflectance Infrared Fourier Transform (DRIFT) of NDs in KBr and schematic of their expected products. 
Top (Purple): Mixture of NDs with TMP. Middle (Green): TMP-conjugated NDs. Bottom (Red): NDs alone. Figure 
courtesy of Yongjun Li. 
 
 The TMP functionalized NDs were then evaluated for their ability to label extracellular 
proteins in live cells using the TMP-tag. Successful labeling would not only demonstrate the 
ability of the TMP-tag to label proteins with nanomaterials, but also confirm conjugation of TMP 
to the ND surface. TMP-NDs were incubated with live HEK293T cells expressing extracellular 
eDHFR-GFP fusion for colocalization of ND fluorescence with GFP fluorescence (Figure 4-8b). 
Unfortunately, ND fluorescence is not colocalized to GFP fluorescence in cells indicating 
unsuccessful ND labeling. But, attempts to label the same construct with the red organic 
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fluorophore-ligand, TMP-Alexa647, also failed to produce co-localized fluorescence (Figure 4-
8a). The unsuccessful co-labeling of cell impermeable TMP-Alexa647 indicates that the eDHFR-
GFP fusion lacks TMP-binding capabilities or is not correctly expressed on the outer membrane 
of the cell. Therefore, the lack of ND co-labeling with the TMP-tag may or may not reflect 
successful TMP-ND conjugation.  
 
Figure 4-8: Extracellular protein labeling with NDs using the TMP-tag in live cells 
Live HEK293T cells expressing an extracellular eDHFR-GFP fusion were labeled with a) TMP-Alexa647 and b) 
TMP-NDs. Scale bar = 20 m. Images from left to right: (1) green fluorescence with 488nm excitation, (2) red 
fluorescence with 639nm excitation, (3) transmitted light, (4) merged image.  
 
 Overall cell health was very poor during the ND imaging experiments, complicating 
analysis of TMP-ND binding behavior. While NDs have been demonstrated to be biologically 
inert to cells, the uptake of highly functionalized NDs may have still adverse effects on cells.
56
 
Although the TMP antibiotic has very high affinity for the eDHFR protein over endogenous 
mammalian DHFR, a TMP-ND with high concentrations of the TMP could still bind to 
mammalian DHFR and inhibit cell growth. However, rounded and floating dead cells are visible 
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in cultures that were incubated with and without NDs (Figures 4-8, 4-9). The consistency 
between these cultures suggests that the NDs are not necessarily cause of poor cell health, but the 
impact of high TMP concentrations from ND should be more thoroughly investigated. Future 
experiments should improve and optimize protocols for cell culturing and imaging to preserve 
cell health during extracellular protein expression and labeling results.  
 The high level of TMP-ND aggregation when incubated with cells suggests incomplete 
surface modification. The highly soluble TMP should stabilize individual NDs in solution if 
there is sufficient surface coverage. Given that size of individual NDs are beyond the diffraction 
limit of light, individual NDs in solution should be not visible from transmitted light images and 
fluorescence should only be visible as diffraction limited spots. However, large micron sized 
aggregates of TMP-NDs are observed (Figure 4-9). These aggregates would be completely 
unsuitable for cell imaging due to their bulky size. Further investigation of surface chemistry to 
reduce aggregation is worthwhile to develop, keeping ND and ND clusters as small as possible to 




Figure 4-9: HEK293T cells with TMP-ND aggregates  
Merged transmitted light and red fluorescence (excitation 639nm) of live HEK293T cells incubated with TMP-NDs 




 The TMP-NDs exhibit very low fluorescence when imaged with confocal microscopy 
(Figures 4-8, 4-9). Because the TMP-NDs are unoxidized, the NDs contain a significant graphitic 
material on the surface that lowers fluorescence. In addition, the NDs used did not have 
implanted NV
-
 centers. so fluorescence originates from naturally occurring NV
-
 centers. While 
small clusters of TMP-NDs are visible when they were incubated with cells, the NDs lacked 
strong red fluorescence (Figure 4-8). When cells were incubated with TMP-NDs without 
washing excess TMP-NDs from culture, the presence and fluorescence from large ND 
aggregates is more plainly visible (Figure 4-9). These images highlight the importance of using 
oxidized NDs with implanted NV
-
 centers for bright fluorescence imaging.  
 
4.5 Conclusions and Outlook 
 
 FNDs have tremendous potential to revolutionize SM imaging and biosensing in live 
cells. However, the barrier to the widespread application of FNDs in biological studies the lack 
of reliable surface modification protocols to functionalize FNDs for targeted labeling. As 
demonstrated in this chapter, replicating and developing surface modification for FNDs is 
challenging due to differences in the synthetic origin of NDs. Despite these difficulties, 
advancements in isolating small NDs may improve the surface chemistry reactivity by providing 
greater surface area relative to diamond mass. With continued development, small and 
functionalized ND fluorophores can be used with chemical tags for selective labeling of 
biomolecules.  
 The applications of FNDs for live cell imaging go beyond conventional fluorescence. 
FND biocompatibility and photophysical properties are unmatched in comparison to organic 
dyes and other fluorescent nanomaterials. The ability to image individual FNDs over long 
periods of time, as well as perform optical tracking, magnetic sensing, and orientation 
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measurements opens unprecedented opportunities for probing biomolecular mechanism. Creative 
applications of FNDs using multi-color imaging based on resonant microwave wavelengths or 
coupling to magnetic iron oxide particles for distance measurements can be explored. Along with 
simply being brighter and more photostable fluorophores, FNDs are an exciting material to use 
for live cell SM imaging  
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Chapter 5  





5.1 Chapter Overview 
 
 The full benefit of the chemical tags is realized when they are used to tag proteins that 
cannot be labeled with FPs. Ion channels are known for their poor stability when fused to GFP, 
especially during investigations of mutant or misfolded ion channels that can cause rare diseases. 
The inability to label these proteins with GFP inhibits the study their trafficking and cellular 
localization using high throughput fluorescence imaging. Chemical tags offer an alternative 
potential strategy for reliable fluorescence labeling of ion channels for high resolution imaging 
assays. The smaller size and better folding properties of the chemical tags compared to FPs can 
be used to label ion channels with fewer perturbations. By visualizing ion channels localization 
with fluorescence imaging, the chemical tags can greatly facilitate the identification of 
therapeutics that can rescue protein trafficking through the cell and be used for drug 
development.  
 In this chapter, we detail the development of a fluorescence imaging assay to identify 
compounds that pharmacologically rescue misfolded and mistrafficked ion channels. We explore 
the use of the TMP-tag to fluorescently label the hERG potassium ion channel and its mutants 
without interfering with protein trafficking. We compare differences between fluorescent 
labeling with GFP and the TMP-tag for imaging hERG ion channel localization. I am the main 
contributors of this work. Inspiration for this work came from Dr. Stuart Licht. I created the cell 
constructs, cultured the cells, and performed imaging with assistance from Mia Shandell.  
5.2 Introduction 
 
 The mistrafficking of proteins is responsible for many different and rare genetic diseases, 
including cystic fibrosis, familial hypercholesterolemia, diabetes mellitus, oestogenesis 
imperfecta, and retinitis pigmentosa.
1
 Certain proteins, such as receptors and ion channels, must 
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be expressed on the cell membrane for correct cell function. Properly trafficked proteins are first 
synthesized in the endoplasmic reticulum by ribosomes, progress through the Golgi apparatus 
where they may undergo post-translation modifications, and then placed in the cell membrane. 
Mutations, however, can inhibit normal trafficking due to protein misfolding. Instead of reaching 
the cell membrane, misfolded proteins are redirected to lysosomes for degradation or accumulate 
in the endoplasmic reticulum, causing cellular stress.
2,3
 The lack of protein activity on the cell 
membrane is the pathogenesis of these mistrafficking diseases. One strategy to treat these 
mistrafficking diseases is to use pharmacological chaperones that assist in protein folding to 
restore conformation, trafficking, and functioning.  
 Chaperones help misfolded or partially folded proteins assume their correct 
conformation. There are three classes of chaperones; molecular, chemical, and pharmacological. 
Molecular chaperones, such as heat shock proteins and GroEL, are endogenously expressed by 
cells and either actively support protein folding or simply prevent aggregation during folding.
4
 
Chemical chaperones are small molecule osmolytes, such as glycerol and DMSO, which 
nonspecifically assist in protein folding. While mechanisms for each osmolyte are slightly 
different, chemical chaperones generally improve the solubility and thermodynamic stability of 
the folded state.
5
 Since chemical chaperones are non-specific and require high concentrations, 
they are unsuitable as therapeutics. One the other hand, pharmacological chaperones are most 
relevant for drug development because they are small molecules that interact and assist in the 
folding of a specific protein. A pharmacological chaperone assists with folding by stabilizing the 
folded conformation, facilitating folding from an intermediate or unfolded state, or possibly both 
(Figure 5-1).
6
 Pharmacological chaperones that encourage proper protein folding while 







Figure 5-1: Mechanism of pharmacological chaperone assisted protein folding.  
Without the pharmacological chaperone (red), the unfolded state is favored (F to U). The pharmacological 
chaperone can either facilitate folding (Uc to Fc), stabilize the folded state (F to Fc) or both. Figure courtesy of Dr. 
Stuart Licht  
 
 Pharmacological chaperones have already been developed as cystic fibrosis (CF) 
therapeutics. Previous treatments for CF were aimed at symptom management without targeting 
the disease cause. CF is caused by mutations to the cystic fibrosis transmembrane conductance 
regulator (CFTR), which encodes for a chloride ion channel. One of more common mutations to 
the CFTR is the F508del mutation, which causes improper protein folding and reduced ion 
channel gating activity. Ultimately, the F085del mutation prevents the expression of properly 
functioning CFTR chloride ion channels on the cell membrane.
7
 To develop targeted therapeutics 
for the F508del CF genotype, pharmacological chaperones that rescue trafficking and gating 
activity of the ion channel were identified. In a study using high throughput voltage clamping, 
scientists at Vertex screened over 164,000 small molecules for their ability to restore CFTR 
expression. The presence of voltage gated activity identified pharmacological chaperones that 





One of the identified molecules, VX-809, has recently been submitted for FDA approval in 
2014.
9
 The success of developing targeted CF therapeutics demonstrates the potential of using 
pharmacological chaperones as therapeutics for other ion channel mistrafficking diseases.  
5.2.1 Cellular Trafficking of hERG Ion Channels 
 
 The success of pharmacological chaperones in CF lends hope to the development of such 
therapeutics for genetic long QT type 2 syndrome (LQT2). LQT2 is one of seven types of long 
QT syndrome that are all characterized by a prolonged QT interval on cardiovascular EKG, 
corresponding to delayed repolarization of cardiac tissue. The prolonged QT interval can cause 
arrhythmias that lead to sudden decreases in blood pressure, resulting in fainting, seizures, and 
even death. LQT2 is the second most common type of long QT syndrome, affecting 25-30% of 
all patients, and is caused by mutations to the human ether related a go-go gene (hERG).
10
 Over 
70 different mutations have so far been identified in LQT2 patients, with the majority of these 
mutations causing hERG ion channel misfolding and mistrafficking.
11
 Like CF, there are 
currently no targeted therapeutics for LQT2, raising the potential of pharmacological chaperones 
for drug development.  
 Some compounds have been identified that can rescue hERG ion channel trafficking. 
Because properly trafficked hERG undergoes 20 kDa of post-translational glycosylation in the 
Golgi apparatus, successful hERG expression on the cell membrane can be evaluated by the 
presence of both pre- and post-glycosylated hERG using Western Blot analysis.
12
 The 
compounds astemizole, cisapride, terfenadine, E-4031 and fexofenadine have thus far been 
identified as chaperones that rescued trafficking of both N470D and G601S hERG mutants. 
However, later electrophysiological evaluations revealed that only fexofenadine was capable of 
rescuing both trafficking and ion gated voltage activity.
13-15
 The other compounds managed to 
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promote proper folding of mutant hERG ion channels for membrane trafficking, but bind to the 
ion channel pore and inhibit activity.
16
 With only fexofenadine identified as a suitable candidate 
for drug development so far, there is an obvious need to discover additional compounds that 
rescue both trafficking and activity of the wide array of hERG mutations that affect patients with 
LQT2.  
 In addition, there is another distinct need to identify therapeutics that interfere with wild 
type hERG ion channel trafficking. The hERG ion channel has a large pore that is known to bind 
to many small molecule drugs, destabilizing the channel and causing mistrafficking.
17,18
 This 
condition induces long QT syndrome in patients and is called acquired long QT (acqLQT). Not 
limited to a certain class or family of drugs, acqLQT has been associated with the anti-
protozoical pentamidine, the antidepressant fluoxetine (trade name: Prozac), and the cholesterol-
lowering drug probucol, among others.
19
 Currently, small molecules are not routinely screened 
for acqLQT activity during drug development, despite the side effects of acqLQT being just as 
dangerous as those of genetic LQT. The development of a convenient and cheap assay to 
evaluate hERG trafficking and localization could significantly improve the ability to identify 
either pharmacological chaperones for mutant hERG channels or therapeutics for other diseases 
that do not induce acqLQT.  
 Current methods to evaluate hERG localization and trafficking are not amenable to high 
throughput screening, hampering the ability to swiftly screen small molecules as 
pharmacological chaperone drug leads. Previous work with CFTR chaperones for CF 
therapeutics evaluated a library of over 164,000 compounds.
8
 This work was accomplished using 
high throughput electrophysiology, which is still time consuming and technically challenging to 
perform in comparison to other high throughput screening methods.
7
 With hERG, 
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pharmacological chaperones were previously evaluated used Western Blots, which require large 
cell culture preparations and are also difficult to perform as a high throughput method.
20
 The 
holistic cellular activity of ion channel folding and trafficking requires the development of a cell-
based assay that can be adapted for rapid screening. Because LQT2 is an orphan disease with 
multiple mutant phenotypes, screens for hERG pharmacological chaperones would also benefit 
from being both cost and time effective. Such an assay could also be applied to the development 
of therapeutics for other orphan protein trafficking diseases. Fluorescence imaging is an 
appealing option for high throughput screens of ion channel trafficking in live cells because it 
can be performed quickly using small volumes. However, labeling hERG and other ion channels 
for fluorescence imaging presents a substantial challenge.  
5.2.2 Visualizing hERG Ion Channel Trafficking with the TMP-tag 
 
 There are limited methods for reliably and conveniently tagging ion channels with 
fluorescent labels for imaging. Immunofluorescence labeling of ion channels in fixed cells can be 
used, but they have limited applicability in live cells and require expensive antibodies. 
Genetically encoded GFP fusions are among the most straightforward for protein labeling in 
living cells, but ion channel GFP fusions are known for their poor stability. When fused to 
misfolded ion channel mutants, GFP itself can become improperly folded and have inhibited 
chromophore formation.
21
 Consequently, GFP is a poor fluorescent label for investigating 
mistrafficking diseases caused by misfolded ion channels. The incorporation of fluorescent 
unnatural amino acid is another technique that is widely being explored for direct labeling of ion 
channels with minimal perturbations.
22
 However, the use of fluorescent unnatural amino acid is 
very technically challenging to carry out, requiring highly engineered t-RNA synthetases and 
many controls to reduce nonspecific incorporation.
23
 Given these limitations, GFP fusions are 
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cautiously employed for fluorescence imaging experiments, and subjected to careful evaluations 
to ensure preservation of native activity before use.  
 In the case of the hERG ion channel, various GFP fusions have been created and assessed 
for their impact on function and trafficking. N-terminal GFP fusions to wild type hERG have 
been demonstrated to inhibit activity and membrane trafficking based on electrophysiology and 
fluorescence imaging analysis.
24,25
 However, N-terminal GFP fusions to the G601S hERG 
mutant ion channel showed no impact on trafficking.
26
 Also, C-terminal GFP fusions shows little 
interference with trafficking and activity for both the wild type, N598Q, and N629Q hERG 
glycosylation mutant ion channels.
25,27
 While certain GFP fusions have little impact on hERG 
ion channel activity, the difference in activity between wild type and mutant hERG ion channel 
using N-terminal GFP fusions raises concerns for mutant dependent fusion behavior.
22
 The use 
of a smaller and more robust fluorescent label enable more convenient hERG ion channel 
imaging by eliminating mutant and fusion dependent effects on trafficking and function.  
 The TMP-tag has the potential to overcome the challenges of fluorescent labeling hERG 
and other ion channels. With the TMP-tag, the ion channel would be fused to an E. coli 
dihydrofolate reductase (eDHFR) protein domain. The introduction of a cell permeable 
fluorescent trimethoprim (TMP) ligand would label the ion channel based on the high affinity 
and selective interaction between eDHFR and TMP (Figure 5-2). The eDHFR protein domain 
used with the TMP-tag is two-thirds the size of GFP, and its smaller size is less likely to interfere 
with ion channel function and trafficking. The eDHFR protein domain is also well behaved with 
stable folding, allowing the tag to retain its binding and labeling abilities even when fused to 
mutant misfolded ion channels. In addition, the TMP-tag can be used with virtually any 





 The demonstrated live cell labeling and imaging capabilities of the TMP-tag further 
demonstrate its compatibility for imaging hERG ion channel trafficking in mammalian cells.
28-30
 
With the TMP-tag, localization and trafficking of fluorescent labeled hERG ion channels can be 





Figure 5-2: Imaging hERG trafficking using the TMP-tag  
The TMP-tag can label the hERG potassium ion channel to image cellular trafficking. a) A hERG-eDHFR fusion 
protein is labeled by binding of the eDHFR domain to a cell permeable fluorescent TMP ligand. b) Localization of 
the hERG-eDHFR is fluorescently imaged in cells. Traffic-competent or rescued hERG will exhibit fluorescence at 
the cell membrane, while traffic-deficient hERG will have fluorescence localized only on the endoplasmic 
reticulum.  
 
 Fluorescence microscopy of TMP-tagged mutant hERG ion channels can be used to 
quickly screen for pharmacological chaperones that rescue trafficking to the cell membrane. The 
localization and trafficking response of fluorescently labeled hERG ion channels to potential 
drugs can be visually assessed, identifying lead compounds for LQT2 drug discovery (Figure 5-
2). While fluorescence imaging is unable to directly probe for the rescue of hERG ion channel 
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activity, this microscopy-based assay can be used as a preliminary screen that identifies a smaller 
subset of compounds that are later evaluated using more demanding high throughput 
electrophysiology. With future developments in voltage sensitive fluorophores that can be used 
with the TMP-tag, simultaneous analysis of hERG trafficking and activity based on fluorescence 
based readout activity could also be accomplished. By allowing fluorescent readout of hERG ion 
channel trafficking, the TMP-tag has the potential to significantly speed the discovery of 
pharmacological chaperones as therapeutics for LQT2 and other protein mistrafficking diseases.   
5.3  Materials and Methods 
 
 A vector containing the hERG gene (pcDNA3-hERG) was graciously given by the Kass 
laboratory. Constructs for hERG gene expression as fusion proteins were created using Gibson 
assembly. A hERG fusion with GFP was created, as well as a fusion with GFP containing a 
SGLRST linker. The same was created with eDHFR. The hERG gene was amplified by PCR 
using the primers in table for different constructs. The backbone of the published vector 
pLM1208 containing eDHFR was amplified using the primers 5'- 
CACGCCTACCGCCCATTTGCG - 3' and 5' - ATCAGTCTGATTGCGGCGTTAG - 3'(Miller). 
The backbone of the published vector pH2B-GFP (Addgene Cat#11680) containing GFP was 
amplified using the primers 5' - CACGCCTACCGCCCATTTGCG - 3' and 5' - 
ATGGTGAGCAAGGGCGAGGA - 3'. hERG fusion constructs were assembled using Gibson 
Assembly of the PCR amplified hERG gene and the GFP or eDHFR containing vector 
backbones.
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Table 5-1 : Primers for cloning the hERG gene for Gibson Assembly 
Construct hERG gene primers 
pcDNA-hERG-GFP 
5' - CGTAACAACTCCGCCCCATTGA - 3' 
5' - GCACCACCCCGGTGAACAGCTCCTCGCCCTTGCTCACCAT 
ACTGCCCGGGTCCGAGCCGT - 3' 
pcDNA-hERG-eDHFR 
5' - CGTAACAACTCCGCCCCATTGA - 3' 
5' - CGATAACGCGATCTACCGCTAACGCCGCAATCAGACTGA 
TACTGCCCGGGTCCGAGCCGT - 3' 
pcDNA-hERG-linker-
GFP 
5' - CGTAACAACTCCGCCCCATTGA - 3' 
5' - GCTCCTCGCCCTTGCTCACCAT TGTACTTCGCAATCCACT 
ACTGCCCGGGTCCGAGCCGT - 3' 
pcDNA-hERG-linker-
eDHFR 
5' - CGTAACAACTCCGCCCCATTGA - 3' 
5' - CTAACGCCGCAATCAGACTGATTGTACTTCGCAATCCACT 
ACTGCCCGGGTCCGAGCCGT - 3' 
 
 
 Vectors for hERG mutants were constructed using Gibson Assembly of PCR amplified 
pcDNA3-hERG (see Table 5-2 for primers). Fusions of mutant hERG with GFP and eDHFR 
were created using the same protocol and primers above.  
 
Table 5-2 : Primers for mutagenesis of the hERG gene 
Construct Primers 
pcDNA-hERG:N470D 
5' - GACTTCCGCACCACCTACGTC - 3' 
5' - GACGTAGGTGGTGCGGAAGTCGATGAGGATGTCCACAATG- 3' 
pcDNA-hERG:G601S 
5' - AGCCTGGGCGGCCCCTCCATC - 3' 
5' - GATGGAGGGGCCGCCCAGGCTGCTGCTGTTGTAGGGTTTG - 3' 
pcDNA-hERG:R752W 
5' - TGGGCCCTGGCCATGAAGTTC - 3' 
5' - GAACTTCATGGCCAGGGCCCAAAGGCAGCCCTTGGTGGCC - 3' 
pcDNA-hERG:F805C 
5' - TGGGGAGCCTCTGAACCTGT - 3' 
5' - ACAGGTTCAGAGGCTCCCCACAGATGTCATTCTTCCCCAG - 3' 
 
 
 HEK 293T cells were cultured in Dulbecco's Modified Eagle Medium (DMEM) 
w/ glutamine (Gibco #11995) with 10% v/v fetal bovine serum (FBS) and 1% v/v PenStrep 
plated in 6 well plates at 500,000 cells per well 12 hours before transfection. Cells were 
transfected with the hERG expression plas id (2 μg per well) using Xtre e Gene HP (Roche). 
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12 hours after transfection, cells were replated in a 1:2 ratio onto 35 mm Fluorodish cell culture 
dishes. All cells were maintained under 5% CO2 at 37°C. For cells expressing TMP-tagged 
proteins, cells were incubated with 1 M of TMP-fluorescein diacetate (Active Motif) for 1 hour, 
followed by two washes with fresh media before imaging.  
 For immunofluorescence imaging, cells washed three times with sterile PBS and fixed 
using 4% formaldehyde in PBS for 15 minutes at room temperature. Cells were washed three 
times with PBS and blocked with 10% BSA, 0.02% Triton X-100, and 0.05% azide in PBS for 1 
hour at room temperature. Cells were washed three times with PBS before incubation with rabbit 
anti-hERG antibody (Sigma) 1:40 overnight at 4C. Cells were washed three times with PBS 
before imaging. 
 All confocal images were obtained using an Zeiss LSM 700 confocal microscope. Images 
were processed by Zeiss Zen image processing software.  
 
5.4 Results and Discussion 
  
 The application of the TMP-tag for evaluating trafficking of hERG ion channels requires 
demonstrating the TMP-tag is convenient to use, reduces impact on ion channel trafficking, 
improves image quality, and labels channels similar selectivity compared to using GFP or 
immunofluorescence. Consequently, immunofluorescence images of HEK293T cells expressing 
wild type hERG ion channels were first evaluated for labeling specificity and image resolution. 
Cells were fixed and immunostained with a fluorescent anti-hERG antibody (Figure 5-3). Both 
transfected cells expressing hERG ion channels and non-transfected cells exhibited fluorescence 
throughout cell and membrane. Since the hERG ion channel is not endogenously expressed by 
HEK293T cells, fluorescence in non-transfected cells is likely due to nonspecific labeling. The 
non-transfected cells are less fluorescent and have lower labeling than the hERG transfected 
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cells, indicating that the antibody does exhibit some preference for binding to the hERG ion 
channel. However, the degree of nonspecific labeling observed in this investigation could make 
membrane-localized fluorescence from successfully trafficked hERG ion channels difficult to 
distinguish in future investigations. Overall, immunofluorescence is not reliable for selectively 
labeling and visualizing hERG ion channels localization.  
 
 
Figure 5-3: Immunofluorescence labeling of hERG ion channels 
Confocal microscopy images of fixed and permeabilized HEK293T cells with a) no transfection and b) wild type 
hERG ion channel expression are labeled with fluorescent anti-hERG antibody. Scale bar = 20 m. Images from left 
to right: (1) green fluorescence (488nm excitation), (2) transmitted light, (3) merged image.  
 
 The nonspecific labeling observed with immunofluorescence highlights some of the 
challenges of using antibody labeling for evaluating ion channel trafficking. 
Immunofluorescence has been widely used for hERG ion channel imaging, but those reports 
used in-house produced anti-hERG antibodies that are not commercially available.
12,32
 These 
antibodies as well as other commercially available antibodies not employed in this work could 
exhibit higher specificity for hERG and lower nonspecific interactions. In addition, recent reports 
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indicate that nonspecific antibody labeling is likely not attributed to technical errors performed 
during cell fixation or blocking steps, further confirming that the observed labeling is due to poor 
antibody selectivity.
33
 The potentially differing performance of antibodies raises additional 
challenges in using immunofluorescence for imaging of hERG ion channel trafficking in cells.  
 Next, we examined whether hERG ion channels labeled with the TMP-tag would produce 
higher resolution cell images and exhibit less trafficking interference compared to hERG ion 
channels labeled with GFP. HEK293T cells were transiently transfected with a hERG-GFP 
fusion or a hERG-eDHFR fusion, which was labeled with TMP-fluorescein before imaging 
(Figure 5-4). Both hERG ion channel fusions have similar fluorescence distributions throughout 
the cell and on the membrane. Interestingly, thin cell membrane protrusions are visualized in 
cells with TMP-tagged hERG ion channels and not observed in cells with the hERG-GFP fusion. 
These thin areas of the membranes could be more easily detected and imaged because the TMP-
tag uses organic fluorophores that are brighter than GFP. As a result, the TMP-tag could more 
easily identify successfully trafficking hERG ion channel based on the presence of these cell 
features. Alternatively, the smaller size of the TMP-tag may reduce cell stress with trafficking 
hERG fusions, allowing the membrane to form more points of cell adhesion. Further study into 
differences between cell health and image quality of cells labeled with the TMP-tag and GFP can 
be used to more completely determine the advantages of the TMP-tag for visualize hERG ion 








Figure 5-4: Live cell images of hERG fusion proteins  
Confocal microscopy images of live HEK293T cells with a) no transfection, b) wild type hERG expression, c) 
hERG-eDHFR expression labeled with TMP-fluorescein, and d) hERG-GFP fusion expression. Scale bar = 20 m. 
Images from left to right: (1) green fluorescence (488nm excitation), (2) transmitted light, (3) merged image. 
 
 The overall similar localization of hERG ion channel fusions with eDHFR and GFP 
illustrates that the TMP-tag is, at the very least, a viable substitute for GFP as a fluorescent label. 
The hERG ion channel fusions examined here were both C-terminal fusions, with the C-terminal 
GFP fusion having previously been shown to not inhibit hERG trafficking and funcion.
25
 Like 
GFP, the TMP-tag based on a hERG ion channel C-terminal eDHFR fusion also does not 
interfere with normal hERG trafficking. Since hERG ion channels with N-terminal GFP fusions 
have impacted membrane trafficking, a demonstration of proper localization of hERG ion 
channel with N-terminal eDHFR fusion would confirm the benefit of the TMP-tag over GFP.
25
 
The eDHFR domain is two-thirds the size of GFP, so it remains uncertain whether the size 
reduction would be sufficient to eliminate impacts on cellular trafficking. More likely, the well 
behaved folding of the eDHFR domain in comparison to GFP could reduce destabilizing effects 
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of the fusion. Additional studies using the TMP-tag in place of GFP fusion-induced trafficking 
defects could clearly establish the benefit of the TMP-tag over GFP for ion channel labeling and 
imaging.  
 Finally, the effect of the TMP-tag on labeling and imaging trafficking-deficient hERG 
ion channel mutants was examined. Four hERG ion channel misfolding and trafficking mutants 
with known mechanisms of rescue, N470D, G601S, R752W, and F805C, were evaluated for 
eDHFR and GFP induced impacts on trafficking. HEK293T cells were transiently transfected 
with mutant hERG-eDHFR and mutant hERG-GFP fusions and imaged (Figure 5-5 and Figure 
5-6). In general, less membrane fluorescence was observed in the hERG trafficking mutants in 
both GFP and eDHFR fusions. In addition, cells expressing the hERG trafficking mutants 
exhibited rounded cell morphologies that are characteristic of unhealthy or dying cells. In 
comparison to cells expressing wild type hERG ion channel fusions, cells expressing mutant 
hERG ion channels are considerably less healthy. This is consistent with the known cellular 
distress caused by accumulation of hERG trafficking mutants in the endoplasmic reticulum.
1
 
Unfortunately, the rounded shape of unhealthy cells increases the difficulty of differentiating 
hERG ion channel localization between the cell membrane and endoplasmic reticulum. The 
rescue of cell morphology itself could be used as a indirect indicator of proper hERG localization 
that could be further confirmed using fluorescence imaging. Overall, these results indicate that 
the TMP-tag has similar labeling capabilities and impacts on ion channel trafficking and cell 








Figure 5-5: Live cell images of hERG-eDHFR mutants  
 
Confocal microscopy images of live HEK293T cells with a) no transfection, b) hERG-eDHFR expression, c) hERG-
eDHFR: N470D expression, d) hERG-eDHFR:G601S expression, and e) hERG-eDHFR:F805C expression. All cells 
were labeled with TMP-fluorescein. Scale bar = 20 m. Images from left to right: (1) green fluorescence (488nm 











Figure 5-6: Live cell images of hERG-GFP mutants 
Confocal microscopy images of live HEK293T cells with a) no transfection, b) hERG-GFP expression, c) hERG-
GFP: N470D expression, d) hERG-GFP:G601S expression, e) hERG-GFP:R752W expression, and e) hERG-
GFP:F805C expression. Scale bar = 20 m. Images from left to right: (1) green fluorescence (488nm excitation), (2) 
transmitted light, (3) merged image. 
 
 Further evaluations are needed to see whether the TMP-tag can better visualize 
membrane fluorescence from rescued mutant hERG ion channel trafficking in response to 
pharmacological chaperones. At the same time, the impact of the TMP-tag itself also needs to be 
assessed for any potential effects on hERG ion channel pharmacological rescue. Because the 
eDHFR domain is very stable and well-folded, the TMP-tag may actually act as a chaperone for 
mutant hERG ion channel ions. Because this behavior has been previously observed with 
eDHFR fusions, the TMP-tag may overselect for small molecules that only partial or minimal 
pharmacological chaperoning activity and rescuing capability.
34
 As a result, the impact of both 
the GFP and TMP-tag on folding stability of wild-type and mutant hERG ion channel should be 
further studied to determine which label has the least impact.  
155 
 
5.5 Conclusion and Outlook 
 
 In this study, labeling hERG potassium ion channels with the TMP-tag did not impact 
protein trafficking any differently than using GFP labeling. The ability to label hERG ion 
channels with organic fluorophores enabled improved resolution of fluorescent cell membrane 
protrusions that could used to rapidly identify properly trafficked hERG to the cell membrane. 
Unfortunately, the benefit of small size and stable folding of the TMP-tag for labeling hERG ion 
channels and identifying pharmacological chaperones has yet to be determined. Overall, the 
ability to image hERG ion channel in live cell with the TMP-tag does present the advantage of 
direct observation of trafficking and mistrafficking. With future development, the TMP-tag could 
be used as a robust assay to identify pharmacological chaperones of hERG ion channels and 
other ion channels responsible for diseases.  
 The prospect of using the TMP-tag for SM imaging of ion channel in live cells is very 
appealing. Protein trafficking is a whole cell phenomena, requiring compartmentalization of 
organelles that is simply not feasible to reconstitute in vitro. Live cell labeling and imaging 
techniques can provide mechanistic insights into trafficking. In particular, SM imaging of 
channels starting from synthesis to membrane localization could offer a more comprehensive 
understanding of this complex cellular activity. With the heterogeneity of other biological 
systems revealed by SM studies, live cell SM imaging of ion channels would undoubtedly 
provide remarkable insights into protein trafficking.  
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